
<html lang="en"     class="pb-page"  data-request-id="3eb5e677-8139-4ec0-be5e-ae18a83489a5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b00083;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors" /></meta><meta name="dc.Creator" content="Zongxing  Qiu" /></meta><meta name="dc.Creator" content="Xianfeng  Lin" /></meta><meta name="dc.Creator" content="Weixing  Zhang" /></meta><meta name="dc.Creator" content="Mingwei  Zhou" /></meta><meta name="dc.Creator" content="Lei  Guo" /></meta><meta name="dc.Creator" content="Buelent  Kocer" /></meta><meta name="dc.Creator" content="Guolong  Wu" /></meta><meta name="dc.Creator" content="Zhisen  Zhang" /></meta><meta name="dc.Creator" content="Haixia  Liu" /></meta><meta name="dc.Creator" content="Houguang  Shi" /></meta><meta name="dc.Creator" content="Buyu  Kou" /></meta><meta name="dc.Creator" content="Taishan  Hu" /></meta><meta name="dc.Creator" content="Yimin  Hu" /></meta><meta name="dc.Creator" content="Mengwei  Huang" /></meta><meta name="dc.Creator" content="S. Frank  Yan" /></meta><meta name="dc.Creator" content="Zhiheng  Xu" /></meta><meta name="dc.Creator" content="Zheng  Zhou" /></meta><meta name="dc.Creator" content="Ning  Qin" /></meta><meta name="dc.Creator" content="Yue Fen  Wang" /></meta><meta name="dc.Creator" content="Shuang  Ren" /></meta><meta name="dc.Creator" content="Hongxia  Qiu" /></meta><meta name="dc.Creator" content="Yuxia  Zhang" /></meta><meta name="dc.Creator" content="Yi  Zhang" /></meta><meta name="dc.Creator" content="Xiaoyue  Wu" /></meta><meta name="dc.Creator" content="Kai  Sun" /></meta><meta name="dc.Creator" content="Sheng  Zhong" /></meta><meta name="dc.Creator" content="Jianxun  Xie" /></meta><meta name="dc.Creator" content="Giorgio  Ottaviani" /></meta><meta name="dc.Creator" content="Yuan  Zhou" /></meta><meta name="dc.Creator" content="Lina  Zhu" /></meta><meta name="dc.Creator" content="Xiaojun  Tian" /></meta><meta name="dc.Creator" content="Liping  Shi" /></meta><meta name="dc.Creator" content="Fang  Shen" /></meta><meta name="dc.Creator" content="Yi  Mao" /></meta><meta name="dc.Creator" content="Xue  Zhou" /></meta><meta name="dc.Creator" content="Lu  Gao" /></meta><meta name="dc.Creator" content="John A. T.  Young" /></meta><meta name="dc.Creator" content="Jim Zhen  Wu" /></meta><meta name="dc.Creator" content="Guang  Yang" /></meta><meta name="dc.Creator" content="Alexander V.  Mayweg" /></meta><meta name="dc.Creator" content="Hong C.  Shen" /></meta><meta name="dc.Creator" content="Guozhi  Tang" /></meta><meta name="dc.Creator" content="Wei  Zhu" /></meta><meta name="dc.Description" content="Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl ..." /></meta><meta name="Description" content="Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00083" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00083" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00083" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00083" /></link>
        
    
    

<title>Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00083" /></meta><meta property="og:title" content="Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0015.jpeg" /></meta><meta property="og:description" content="Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl group as novel HBV capsid inhibitors. This new series of 4-H HAPs showed improved anti-HBV activity and better drug-like properties compared to the first- and second-generation 4-H HAPs. X-ray crystallographic study of analogue 12 (HAP_R01) with Cp149 Y132A mutant hexamer clearly elucidated the role of C6 carboxyl group played for the increased binding affinity, which formed strong hydrogen bonding interactions with capsid protein and coordinated waters. The representative analogue 10 (HAP_R10) was extensively characterized in vitro (ADMET) and in vivo (mouse PK and PD) and subsequently selected for further development as oral anti-HBV infection agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00083"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00083">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00083&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00083&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00083&amp;href=/doi/10.1021/acs.jmedchem.7b00083" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3352-3371</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01904" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00138" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zongxing++Qiu">Zongxing Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianfeng++Lin">Xianfeng Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weixing++Zhang">Weixing Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingwei++Zhou">Mingwei Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Guo">Lei Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Buelent++Kocer">Buelent Kocer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guolong++Wu">Guolong Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhisen++Zhang">Zhisen Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haixia++Liu">Haixia Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Houguang++Shi">Houguang Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Buyu++Kou">Buyu Kou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taishan++Hu">Taishan Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yimin++Hu">Yimin Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mengwei++Huang">Mengwei Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S.+Frank++Yan">S. Frank Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiheng++Xu">Zhiheng Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Zhou">Zheng Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Qin">Ning Qin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue+Fen++Wang">Yue Fen Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuang++Ren">Shuang Ren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongxia++Qiu">Hongxia Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuxia++Zhang">Yuxia Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Zhang">Yi Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyue++Wu">Xiaoyue Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kai++Sun">Kai Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Zhong">Sheng Zhong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianxun++Xie">Jianxun Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Ottaviani">Giorgio Ottaviani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Zhou">Yuan Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lina++Zhu">Lina Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojun++Tian">Xiaojun Tian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liping++Shi">Liping Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fang++Shen">Fang Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Mao">Yi Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xue++Zhou">Xue Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lu++Gao">Lu Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.+T.++Young">John A. T. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim+Zhen++Wu">Jim Zhen Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guang++Yang">Guang Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+V.++Mayweg">Alexander V. Mayweg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong+C.++Shen">Hong C. Shen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guozhi++Tang">Guozhi Tang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7131-4678" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Zhu">Wei Zhu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4701-2474" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Roche Innovation Center Shanghai, <sup>‡</sup>Roche Innovation Center Basel, <sup>§</sup>Medicinal Chemistry, <sup>∥</sup>Chemical Biology, <sup>⊥</sup>Pharmaceutical Sciences, <sup>#</sup>Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>For Wei Zhu: phone, +86 21 28946743; fax, +86 21 50790293; E-mail, <a href="/cdn-cgi/l/email-protection#5f283a367125372a7128256e1f2d303c373a713c3032"><span class="__cf_email__" data-cfemail="d9aebcb0f7a3b1acf7aea3e899abb6bab1bcf7bab6b4">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For Hong C. Shen: phone, +86 21 28946738; E-mail, <a href="/cdn-cgi/l/email-protection#523a3d3c357c213a373c7c3a216312203d313a377c313d3f"><span class="__cf_email__" data-cfemail="4d2522232a633e25282363253e7c0d3f222e2528632e2220">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For Guozhi Tang: phone, +86 21 51320651; E-mail, <a href="/cdn-cgi/l/email-protection#0562706a7f6d6c71646b6234456d6a7168646c692b666a68"><span class="__cf_email__" data-cfemail="f89f8d978290918c99969fc9b890978c95999194d69b9795">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00083&amp;href=/doi/10.1021%2Facs.jmedchem.7b00083" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3352–3371</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 24, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 January 2017</li><li><span class="item_label"><b>Published</b> online</span>5 April 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00083" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00083</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3352%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZongxing%2BQiu%252C%2BXianfeng%2BLin%252C%2BWeixing%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b00083%26title%3DDiscovery%2Band%2BPre-Clinical%2BCharacterization%2Bof%2BThird-Generation%2B4-H%2BHeteroaryldihydropyrimidine%2B%2528HAP%2529%2BAnalogues%2Bas%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%2BCapsid%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3371%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00083"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2865</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00083" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zongxing&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Xianfeng&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Weixing&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Mingwei&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Buelent&quot;,&quot;last_name&quot;:&quot;Kocer&quot;},{&quot;first_name&quot;:&quot;Guolong&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Zhisen&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Haixia&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Houguang&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Buyu&quot;,&quot;last_name&quot;:&quot;Kou&quot;},{&quot;first_name&quot;:&quot;Taishan&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Yimin&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Mengwei&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;S.&quot;,&quot;last_name&quot;:&quot;Frank Yan&quot;},{&quot;first_name&quot;:&quot;Zhiheng&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Yue&quot;,&quot;last_name&quot;:&quot;Fen Wang&quot;},{&quot;first_name&quot;:&quot;Shuang&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;Hongxia&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Yuxia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiaoyue&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Kai&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Zhong&quot;},{&quot;first_name&quot;:&quot;Jianxun&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Ottaviani&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Lina&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Xiaojun&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Liping&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Fang&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Xue&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Lu&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. T. Young&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Zhen Wu&quot;},{&quot;first_name&quot;:&quot;Guang&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;V. Mayweg&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;C. Shen&quot;},{&quot;first_name&quot;:&quot;Guozhi&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3352-3371&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00083&quot;},&quot;abstract&quot;:&quot;Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl group as novel HBV capsid inhibitors. This new series of 4-H HAPs showed improved anti-HBV activity and better drug-like properties compared to the first- and second-generation 4-H HAPs. X-ray crystallographic study of analogue 12 (HAP_R01) with Cp149 Y132A mutant hexamer clearly elucidated the role of C6 carboxyl group played for the increased binding affinity, which formed strong hydrogen bonding interactions with capsid protein and coordinated waters. The representative analogue 10 (HAP_R10) was extensively characterized in vitro (ADMET) and in vivo (mouse PK and PD) and subsequently selected for further development as oral anti-HBV infection agent.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00083&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00083" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00083&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00083" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00083&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00083" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00083&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00083&amp;href=/doi/10.1021/acs.jmedchem.7b00083" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00083" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00083" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00083%26sid%3Dliteratum%253Aachs%26pmid%3D28339215%26genre%3Darticle%26aulast%3DQiu%26date%3D2017%26atitle%3DDiscovery%2Band%2BPre-Clinical%2BCharacterization%2Bof%2BThird-Generation%2B4-H%2BHeteroaryldihydropyrimidine%2B%2528HAP%2529%2BAnalogues%2Bas%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%2BCapsid%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D8%26spage%3D3352%26epage%3D3371%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292084" title="Carboxyls">Carboxyls</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/jmcmar.2017.60.issue-8/20170427/jmcmar.2017.60.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl group as novel HBV capsid inhibitors. This new series of 4-H HAPs showed improved anti-HBV activity and better drug-like properties compared to the first- and second-generation 4-H HAPs. X-ray crystallographic study of analogue <b>12</b> (HAP_R01) with Cp149 Y132A mutant hexamer clearly elucidated the role of C6 carboxyl group played for the increased binding affinity, which formed strong hydrogen bonding interactions with capsid protein and coordinated waters. The representative analogue <b>10</b> (HAP_R10) was extensively characterized in vitro (ADMET) and in vivo (mouse PK and PD) and subsequently selected for further development as oral anti-HBV infection agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis B virus (HBV) infection is a major public health problem. Currently, it is estimated that 240 million people worldwide are chronically infected with HBV. Approximately one-third of these individuals will die from the end stage of liver diseases caused by HBV infection such as cirrhosis, hepatocellular carcinoma, and liver failure, if left untreated.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Current therapies include nucleos(t)ide analogues (lamivudine, adefovir, tenofovir, telbivudine, and entecavir) and interferon alpha (INF-α, including nonpegylated and pegylated). Although both therapies can reduce HBV DNA and normalize liver enzymes, neither treatment offers a high rate of clinical cure as defined by the loss of HBV surface antigen (HBsAg) (with or without seroconversion).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In addition, IFN-based therapies are poorly tolerated; while nucleos(t)ide analogues frequently require prolonged or possibly life-long treatment, and some are associated with a high risk of viral resistance. As such, there remains a tremendous unmet medical need to discover and develop efficacious and safe anti-HBV agents with novel mechanisms of action to improve disease cure rate.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">HBV capsid is formed by the assembly of HBV core proteins, and it protects the enclosed viral genome and creates the environment for reverse transcription of pregenomic RNA (pgRNA) to DNA. The assembly and disassembly of HBV capsids are essential steps in the HBV life cycle and interruption of the normal capsid assembly process will block the HBV replication.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> There are several classes of HBV capsid assembly effectors reported to date with two distinct mechanism of actions. Most of the known capsid assembly effectors including compound <b>1</b> (AT-130),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a><b>2</b> (DVR-23),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and NVR 3-778 (structure unknown)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> act as HBV pgRNA encapsidation blockers by accelerating the assembly of normal-sized but empty capsids (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> By contrast, the heteroaryldihydropyrimidine (HAP) compounds represented by compound <b>3</b> (Bay 41-4109)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> is a unique chemical class of capsid assembly inhibitor, which can prevent the normal assembly of core proteins and lead to an aberrant formation of capsid. The misassembled capsid will be subsequently degraded by host proteasomes.<a onclick="showRef(event, 'ref6 ref12'); return false;" href="javascript:void(0);" class="ref ref6 ref12">(6, 12)</a> Thus, the misassembly and depletion of HBV core proteins result in the inhibition of HBV replication. Moreover, it is hypothesized that the depletion of core proteins may suppress the function of viral covalently closed circular DNA (cccDNA)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and help restore the innate immune response.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> HAPs thus represent a promising chemical class of anti-HBV agents with the potential to be the first new direct acting anti-HBV agent since the launch of nucleosides in 1998. However, the current HAPs have not been optimized in terms of drug-like properties for oral anti-HBV treatment and there is a significant need existing for the discovery of new HAPs with improved anti-HBV activity, pharmacokinetic, and safety profiles for clinical use.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative HBV capsid assembly effectors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article, we describe the design and discovery of a new generation of 4-H HAPs featuring the introduction of a C6 carboxyl group with improved anti-HBV activity and better drug-like properties. Furthermore, the elaboration of this chemical series culminates in a potential clinical candidate selection.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and SAR</h3><div class="NLM_p">Compound <b>3</b> is the prototype of the first-generation HAP-based capsid assembly inhibitors. It showed moderate activity against HBV genome replication in HepG2.2.15 cells with EC<sub>50</sub> values in the range of 0.05–0.08 μM (internal and literature data<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>). Compound <b>3</b> also demonstrated in vivo anti-HBV efficacy in HBV transgenic mice<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and Alb-uPA/SCID mice.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Further development of <b>3</b> was not pursued with undisclosed reason. However, it was reported that <b>3</b> could induce hepatotoxicity in rats at high doses.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We identified that <b>3</b> has an unfavorable cytotoxicity profile with a CC<sub>50</sub> of 13 μM in HepDE19 cells. The C2 thiazol-2-yl HAP analogue <b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), however, could lead to an improved CC<sub>50</sub> and maintain a similar EC<sub>50</sub> to that of <b>3</b>. Subsequently, the 4-H HAP series of capsid inhibitors were evolved with the discovery of more potent second-generation analogues featuring the introduction of C6 morpholinyl group, which included <b>4a</b> (example <b>31</b>, WO 01/68640),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>4b</b> (GLS-4),<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a><b>4c</b> (NVR-010–001-E2),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and an internal reference compound <b>6</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Presumably, the C6 morpholinyl group brings additional interactions with HBV capsid proteins,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> which in turn contributes to the improved anti-HBV activity as observed for analogue <b>6</b> compared to <b>5</b>. The second-generation 4-H HAP <b>6</b> also demonstrated a more favorable cytotoxicity profile (CC<sub>50</sub> of <b>6</b> is >100 μM) than that of the first-generation 4-H HAPs <b>3</b> and <b>5</b>. However, compound <b>6</b> showed high liver microsome clearance. It also demonstrated a strong hERG inhibition with an IC<sub>20</sub> of 0.48 μM, which was likely ascribed to dual effects of both the moderate basicity of morpholine “N” (p<i>K</i><sub>a</sub> = 6.3) and the high lipophilicity of <b>6</b> (log <i>P</i> = 3.2) as documented.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In our design of the third-generation 4-H HAPs, we would like to discover more potent and drug-like analogues by reducing both the basicity and lipophilicity of the second-generation 4-H HAPs through introduction of a polar substituent such as hydroxyl, sulfonamide, carboxamide, or carboxyl. However, it remains unclear whether a polar substituent as described above on 4-H HAPs can be tolerated in the largely hydrophobic binding pocket located at the interface of capsid dimers.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22, 24)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Discovery of C6 Morpholine Carboxylic Acid 4-H HAP Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0006.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0007.gif" alt="" id="GRAPHIC-d7e812-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> is the mean value for reduction of HBV DNA by 50% in HepG.2.2.15 cells. Experiments were run in duplicate, with variation <15%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">CC<sub>50</sub> is the mean value for cytotoxicity to HepDE19 cells. Experiments were in duplicate runs with variation <15%.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Selectivity index (SI) is the ratio of CC<sub>50</sub>/EC<sub>50</sub>.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Predicted hepatic clearance obtained with human liver microsome (HLM) and mouse liver microsome (MLM) (mL min<sup>–1</sup> kg<sup>–1</sup>).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Lyophilization solubility assay (LYSA) (μg/mL).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">log <i>P</i>, predicted partition coefficient between the octanol phase and the water phase (KowlogP).</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">The highest concentration tested.</p></div></div><div></div></div><div class="NLM_p">It turned out that polar substituents such as carboxyl are not tolerated on the C2 thiazolyl, C4 phenyl, or C5 position of 4-H HAPs as revealed by a dramatic potency loss for analogues <b>7</b>–<b>9</b> compared to <b>5</b> (additional examples in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). To our delight, the introduction of a carboxyl group at the α-position of C6 morpholine was well tolerated. Both the (<i>S</i>)- and (<i>R</i>)-morpholine-3-carboxylic acid analogues <b>10</b> and <b>11</b> demonstrated good anti-HBV activity. The (<i>S</i>)-morpholine-3-carboxylic acid analogue <b>10</b> was 5-fold more potent than <b>6</b>, with a mean EC<sub>50</sub> value of 3 nM in HepG2.2.15 cells. The tolerance of a small, lipophilic substituent on C6 morpholine of HAP can be rationalized by the analysis of the recently disclosed cocrystal structure (5E0I) of Cp149 Y132A with <b>4C</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, to our pleasant surprise, this negatively charged carboxyl on C6 morpholine was tolerated and even brought increased binding affinity to HBV capsid as reflected by the improved anti-HBV activity of <b>10</b> compared to <b>6</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of SAR at the C5 and C2 Positions of the Thirrd-Generation 4-H HAPs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0008.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0009.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0010.gif" alt="" id="GRAPHIC-d7e932-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Definitions as the same as that described before.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Diasteroisomer mixture at C4 position.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">The highest concentration tested.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of SAR at the C4 Position of Third-Generation 4-H HAPs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0011.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0012.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0013.gif" alt="" id="GRAPHIC-d7e957-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0014.gif" alt="" id="GRAPHIC-d7e958-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Definitions as the same as that described before.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Diasteroisomer mixture at C4 position.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">The highest concentration tested.</p></div></div><div></div></div><div class="NLM_p">The introduction of an ionizable carboxyl group significantly reduced the lipophilicity of analogue <b>10</b> (log <i>P</i> = 0.3) and increased aqueous solubility (LYSA > 666 μg/mL). The CC<sub>50</sub> of <b>10</b> was >100 μM in HepDE19 cells, and the selectivity index (SI, defined by CC<sub>50</sub>/EC<sub>50</sub>) was >33333. In the preliminary ADME (absorption, distribution, metabolism, and excretion) and in vitro safety assessment, compound <b>10</b> showed significantly improved human/mouse liver microsome stability and no sign of hERG inhibition (IC<sub>20</sub> > 10 μM) compared to that of the representative first- and the second-generation 4-H HAP analogues, likely as a result of both reduced lipophilicity and basicity (p<i>K</i><sub>a</sub> is now 5.8). Moreover, compound <b>10</b> showed a moderate to high permeability (1.4 × 10<sup>–6</sup> cm/s) in the PAMPA (parallel artificial membrane permeability assay) test despite an apparently zwitterionic structure.</div><div class="NLM_p">During the optimization of the second-generation 4-H HAPs (unpublished results), we identified <i>gem</i>-difluoropyrrolidine as a good bioisostere of morpholine with the corresponding analogue showing comparable anti-HBV activity (EC<sub>50</sub> is ca.10 nM) to that of <b>6</b> in HepG2.2.15 cells. Recently, we have published the 4-Me HAP series where a C6 (2<i>S</i>)-4,4-difluoroproline analogue showed the best anti-HBV activity within the series.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In parallel with the 4-Me HAP work, we also synthesized 4-H HAP analogue <b>12</b> with a C6 (2<i>S</i>)-4,4-difluoroproline moiety. Compared to <b>10</b>, compound <b>12</b> showed equally potent anti-HBV activity but a less favorable CC<sub>50</sub> and microsome stability. As a result of that, in the further exploration of the third-generation 4-H HAPs, we focused on the C6 morpholine carboxylic acid analogues.</div><div class="NLM_p">Further SAR studies around <b>10</b> revealed that both the substitution position and chain length of the carboxyl group are crucial for anti-HBV activity. The corresponding morpholine-2-carboxylic acid analogue <b>13</b> was much less active than <b>10</b> in HepG2.2.15 cells. The extended carboxylic acid analogues <b>14</b> and <b>15</b> also demonstrated remarkably reduced anti-HBV activity. Additional substituents like methyl or isopropyl can be tolerated on the C6 morpholine-3-carboxylic acid group, but the anti-HBV activity is sensitive to both regio- and stereochemistry as only analogues <b>17</b> and <b>18</b> show comparable potency to that of <b>10</b> among the analogues explored. The α-methyl analogue <b>16</b> was less active than <b>10</b>, with an EC<sub>50</sub> value of 0.02 μM. Further derivatization of carboxylic acid of <b>10</b> gave ester <b>19</b>, carboxamide <b>20</b>, alcohol <b>21</b>, and sulfonamide <b>22</b>, all of which maintained high anti-HBV activity. However, those analogues all showed high microsomal clearance despite the lower lipophilicity than that of <b>6</b> as reflected by their log <i>P</i> values. This observation highlighted the unique profile of the carboxyl group for the improved drug-like properties of <b>10</b>. Meanwhile, bioisostere replacements of the C6 morpholine-3-carboxylic acid were explored as well. Among all the attempts, the piperidine, piperazine, or <i>N</i>-acetylpiperazine analogue <b>23</b>–<b>25</b> all led to a total loss of anti-HBV activity. The thiomorpholine analogue <b>26</b>, however, maintained a moderate EC<sub>50</sub> value of 0.038 μM.</div><div class="NLM_p">Compound <b>10</b> appeared to be a promising candidate for further ADME and in vitro safety assessment. In the meantime, we performed thorough SAR studies on C2, C4, and C5 positions of the third-generation 4-H HAPs (see structure of <b>3</b> for numbering convention) in order to identify a set of contenders of compound <b>10</b> for comparisons in further ADME and safety assessments. The results are shown in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">We first explored the SAR at the C5 position of 4-H HAP. The ethyl ester analogue <b>27</b> afforded a similar or slightly better EC<sub>50</sub> than that of analogue <b>10</b>. However, compound <b>27</b> was prone to metabolism in mouse liver microsome with a clearance of 54 mL min<sup>–1</sup> kg<sup>–1</sup>. It was found that the size of C5 ester group had a significant impact on the anti-HBV activity as the <i>n</i>-propyl ester analogue <b>28</b>, <i>iso</i>-propyl ester analogue <b>29</b>, and trifluoroethyl ester analogue <b>30</b> all showed reduced anti-HBV activity compared to that of <b>10</b> and <b>27</b>. The bulky <i>tert</i>-butyl ester analogue <b>31</b> had a much reduced anti-HBV activity. The polar C5 substituents (reflected by their log <i>P</i> values), including carboxylic acid (<b>9</b> in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), methoxyethyl ester (<b>32</b>), amide (<b>33</b>), and nitrile (<b>34</b>), were not tolerated with a dramatic drop of anti-HBV activities, which indicated a lipophilic environment at this binding position of capsid. Overall, the methyl ester and ethyl ester were well tolerated in terms of anti-HBV activity at the C5 position of HAP.</div><div class="NLM_p">The C2 substituent of the 4-H HAP series was indicated as an important moiety for capsid binding but was less explored previously.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22, 24)</a> We decided to extensively study the substitution effect and bioisostere replacement of the C2 thiazolyl moiety. First, consistent with the previous observation for <b>3</b>, difluoropyridinyl was well tolerated at the C2 position and the corresponding analogue <b>35</b> showed good anti-HBV activity but also a high cytotoxicity. Most of our attempts to replace the C2 thiazolyl with other bioisosteres did not lead to appreciable anti-HBV activity, as exemplified by C2 oxazolyl and pyrimidinyl analogues <b>36</b> and <b>37</b>, which reflect a narrow SAR at the C2 position of 4-H HAP. Nevertheless, we did identify the <i>N</i>-methylimidazolyl and 5-methyloxazolyl analogues <b>38</b> and <b>39</b> with moderate anti-HBV activity. Meanwhile, small substituents on the C2 thiazole were well tolerated, as both the methyl and trifluoromethyl substituted thiazole analogues <b>40</b> and <b>42</b> showed comparable anti-HBV activity to that of <b>10</b>. However, the cyclopropyl substituted thiazole analogue <b>41</b> was less active.</div><div class="NLM_p">During the SAR work, the collective information gained from in-house photoaffinity study,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and the reported 5 Å cocrystal structure (2G34)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> indicated that the C4 position of 4-H HAP is located in a conservative, largely hydrophobic pocket, providing important interactions with capsid. As such, the SAR work at the C4 position of HAP became the chemistry focus in order to discover more potent analogues. The results are summarized in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>.</div><div class="NLM_p">First, bioisosteres of C4 phenyl, such as cyclohexyl, thiophenyl (substituted or unsubstituted), or pyridyl (substituted or unsubstituted), were not tolerated with a total loss of anti-HBV activity for the respective analogues. Replacement of the C4 phenyl with small substituent such as methyl or cyclopropyl was not successful either. The SAR exploration was thus concentrated on the substituent fine-tunings on the C4 phenyl as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>.</div><div class="NLM_p">We first investigated the <i>o</i>-substituent of the C4 phenyl group. Replacement of the <i>o</i>-Cl with <i>o</i>-H or <i>o</i>-F led to >5-fold potency drop (<b>43</b> and <b>44</b> compared to <b>27</b>). The <i>o</i>-Br and <i>o</i>-CH<sub>3</sub> with a similar Van Der Walls radius<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> as <i>o</i>-Cl were well tolerated, and the corresponding analogues <b>45</b>–<b>48</b> gave similar or slightly improved anti-HBV activity in HepG2.2.15 cells compared to that of compound <b>10</b> and <b>27</b>. However, larger substituents like trifluoromethyl or cyclopropyl were not tolerated, with a significant potency reduction (analogues <b>49</b> and <b>50</b>). This SAR observation indicated that the <i>o</i>-Cl of C4 phenyl of compound <b>10</b> might tightly fit into the capsid binding pocket.</div><div class="NLM_p">We subsequently explored the SAR of the <i>p</i>-substituent of the C4 phenyl. In general, the <i>p</i>-F of C4 phenyl could be successfully replaced with <i>p</i>-Cl, <i>p</i>-Br, and <i>p</i>-CH<sub>3</sub> with equal or even better anti-HBV activity in some cases (<b>52</b>–<b>55</b>). However, the <i>p</i>-Cl, <i>p</i>-Br analogues <b>54</b> and <b>55</b> showed moderate cytotoxicity in HepDE19 cells. The <i>p</i>-H analogue <b>51</b> showed a 7-fold potency drop with an EC<sub>50</sub> value of 0.014 μM. Analogue <b>56</b>, bearing a bulky <i>p</i>-CF<sub>3</sub>, displayed an EC<sub>50</sub> of >0.1 μM. The analogues containing polar substituents such as <i>p</i>-OCH<sub>3</sub> and <i>p</i>-CN gave significantly reduced anti-HBV activities (<b>57</b> and <b>58</b> vs <b>51</b>).</div><div class="NLM_p">In the first- and the second-generation HAP series, the <i>m</i>-position of C4 phenyl has been barely explored. We have identified that the introduction of a <i>m</i>-F substituent on the C4 phenyl could further improve the anti-HBV activity, with analogues <b>60</b> and <b>61</b> showing sub-nM potency in HepG2.2.15 cells. However, <i>m-</i>Cl and <i>m</i>-CN substituents were not tolerated as analogues <b>62</b> and <b>63</b> showed EC<sub>50</sub>s > 0.1 μM.</div><div class="NLM_p last">So far, the SAR studies suggest that the preferred substituents at each position of the C4 phenyl are (1) <i>ortho</i> position: −Cl, −Br, and methyl; (2) <i>meta</i> position: −H and −F; (3) <i>para</i> position: −F, −Cl, and −Br. With this SAR understanding in mind, several <i>tri</i>-substituted C4 phenyl analogues were designed and synthesized. As expected, all the analogues showed excellent anti-HBV activity, among which, analogues <b>65</b>, <b>67</b>, and <b>69</b> demonstrated sub-nM EC<sub>50</sub> values in HepG2.2.15 cells.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> X-ray Crystal Structure</h3><div class="NLM_p">We have recently solved the cocrystal structure of Cp149 Y132A mutant hexamer in complex with analogue <b>12</b> (named as HAP_R01, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE">5WRE</a>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> which nicely elucidated why the introduction of a carboxyl group on the C6 substituent (e.g., <i>gem</i>-difluoropyrrolidine and morpholine) of 4-H HAP can bring improved anti-HBV activity. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, the carboxylic acid moiety forms strong bidentate hydrogen bonds with the backbone NH and the side chain hydroxyl of S141. The high resolution structure (1.95 Å) also reveals the water network including a well-defined water molecule that coordinates the C6 carboxyl group and the N atom of C2 thiazolyl group (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) These hydrogen bonding interactions contribute to the increased binding affinity of the third-generation 4-H HAPs such as <b>10</b> and <b>12</b>, as reflected by the improved anti-HBV activity compared to the corresponding noncarboxylic acid analogues (<b>10</b> vs <b>6</b> as an example). It was speculated that the reduced anti-HBV activity of the diastereoisomer <b>11</b>, regioisomer <b>13</b>, or the extended carboxylic acid analogues <b>14</b> and <b>15</b>, relative to compound <b>10</b>, could be ascribed to the complete or partial disruption of this H-bonding interaction network. On the other hand, the carboxylic acid derivatives <b>19</b>–<b>22</b> could at least partially maintain the H-bonding interactions and thus retain the good anti-HBV activity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of Cp149 Y132A in complex with <b>12</b>. Compound <b>12</b> is highlighted in cyan sticks. The dimer forming the concave for the binding pocket is shown in light green. The dimer forming the cap for the binding pocket is colored in dark green. Black dash lines represent the key hydrogen bonds. PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE">5WRE</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Consistent with our SAR findings, the C2 thiazolyl, C4 phenyl, and C5 methyl ester of <b>12</b> bind to a largely hydrophobic pocket of capsid and make multiple van der Waals (VDW) contacts, contributing to additional binding affinity. This explains why the introduction of a polar substituent at those positions will lead to an anti-HBV activity drop.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> DMPK, in Vivo Efficacy, and Early Safety Assessment of the Selected Third-Generation 4-H HAPs</h3><div class="NLM_p">On the basis of anti-HBV activity, cytotoxicity, human/mouse metabolic stability, and structural diversity, analogues <b>10</b>, <b>60</b>, and <b>68</b> were selected for further physicochemical and ADME characterizations. The data are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Physicochemical and ADME Properties of <b>10</b>, <b>60</b>, and <b>68</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="/" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (acid/base)</th><th class="colsep0 rowsep0" align="center" char=".">Lysa<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="/">HLM/MLM<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char="/">PPB (human/mouse)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char="/">1.8/5.8</td><td class="colsep0 rowsep0" align="char" char=".">>666</td><td class="colsep0 rowsep0" align="char" char="/">5/10</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="/">5.7/7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char="/">1.8/5.7</td><td class="colsep0 rowsep0" align="char" char=".">>679</td><td class="colsep0 rowsep0" align="char" char="/">2/12</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char="/">2.0/2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char="/"><2.5/5.7</td><td class="colsep0 rowsep0" align="char" char=".">>604</td><td class="colsep0 rowsep0" align="char" char="/">2/14</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char="/">5.4/6.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Apparent partition coefficients at pH 7.4.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Ionization constant.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Definitions as the same as described before.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Parallel artificial membrane permeability assay (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Plasma protein binding assay (% unbound fraction).</p></div></div></div><div class="NLM_p">High solubility is a critical factor for the development of oral anti-HBV agents to enable formulation development and maintain high plasma drug levels in vivo. It is also very important for HAP analogues to have a moderate or low liver clearance, as this often leads to a good oral bioavailability and high systemic exposure. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, the third-generation 4-H HAP analogues with an ionizable carboxylic acid group have demonstrated high solubility and low human/mouse microsome clearance. In the cryopreserved human and mouse hepatocytes incubation studies of these analogues, the unchanged parent compounds are the major form and the detectable metabolites are mainly from the oxidation of C6-morpholine ring and a phase II glucuronide conjugation of carboxylic acid. The hydrolysis of C5-ester is almost negligible, especially in the human hepatocyte. Moreover, all three compounds show a medium to high permeability determined in the PAMPA assay and appreciable free fraction in human/mouse plasma as reflected by their PPB (plasma protein binding) values. On the basis of the favorable physicochemical (log <i>D</i> and p<i>K</i><sub>a</sub>) and in vitro ADME properties, these compounds were tested for in vivo PK studies in mice following single dose intravenous (IV) and oral (PO) administrations. The results are summarized in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Single-Dose Pharmacokinetics of <b>10</b>, <b>60</b> and <b>68</b> in Mice<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th><th class="colsep0 rowsep0" align="center"><b>68</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">Plasma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (IV, h)</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">3.0</td><td class="colsep0 rowsep0" align="center">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (IV, L/kg)</td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="center">4.1</td><td class="colsep0 rowsep0" align="center">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (IV) (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">66</td><td class="colsep0 rowsep0" align="center">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (PO, μg/L)</td><td class="colsep0 rowsep0" align="center">413</td><td class="colsep0 rowsep0" align="center">783</td><td class="colsep0 rowsep0" align="center">283</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞)</sub> (IV, μg/L·h)</td><td class="colsep0 rowsep0" align="center">878</td><td class="colsep0 rowsep0" align="center">253</td><td class="colsep0 rowsep0" align="center">379</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞)</sub> (PO, μg/L·h)</td><td class="colsep0 rowsep0" align="center">962</td><td class="colsep0 rowsep0" align="center">624</td><td class="colsep0 rowsep0" align="center">344</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">Liver</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞)</sub> (PO, μg/L·h)</td><td class="colsep0 rowsep0" align="center">11800</td><td class="colsep0 rowsep0" align="center">2005</td><td class="colsep0 rowsep0" align="center">9210</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞), liver</sub>/AUC<sub>(0–∞), plasma</sub> (PO)</td><td class="colsep0 rowsep0" align="center">12.3</td><td class="colsep0 rowsep0" align="center">3.2</td><td class="colsep0 rowsep0" align="center">27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The single-dose pharmacokinetics (SDPK) study of selected compounds were carried out in mice as indicated according to the standard procedures (IV, 1 mg/kg; PO, 3 mg/kg). Major parameters, including plasma clearance (CL), volume of distribution at steady state (<i>V</i><sub>ss</sub>), <i>t</i><sub>1/2</sub> (IV), maximal concentration (<i>C</i><sub>max</sub>), area under the curve (AUC), and oral bioavailability (<i>F</i>) are reported.</p></div></div></div><div class="NLM_p">4-H HAP analogues such as <b>10</b> and <b>60</b> showed good oral absorption, as reflected by their respective values of oral <i>C</i><sub>max</sub>, AUC, and <i>F</i>%. Analogue <b>68</b> showed relatively lower exposure as expressed by <i>C</i><sub>max</sub> and AUC than that of compounds <b>10</b> and <b>68</b>. Interestingly, all three compounds, especially compounds <b>10</b> and <b>68</b>, demonstrated a higher liver exposure than their corresponding plasma levels, which is considered as a desirable attribute for liver targeting drugs such as HBV capsid inhibitors. The high liver-to-plasma exposure ratio (from 3.2 to 27) might point to a potential involvement of uptake hepatic transporters in governing the preferable liver disposition of these compounds and it could also explain the underestimation of the in vivo clearance from in vitro mouse microsomes.</div><div class="NLM_p">Compound <b>10</b> was the most advanced analogue and was further assessed against HBV infection in the hydrodynamic injection (HDI) mouse model.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In this study, female BALB/c mice were hydrodynamically injected with replication-competent HBV DNA plasmid through the tail vein. Twenty hours post plasmid injection, mice were orally dosed by blank vehicle, entecavir (ETV, 0.1 mg/kg, once daily as the positive control), or different doses (3 and 12.5 mg/kg per dose, twice daily) of compound <b>10</b> for 5 days. Plasma and liver samples were collected at the indicated time points for HBV DNA quantification by real-time quantitative polymerase chain reaction (qPCR). As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, with treatment of compound <b>10</b>, HBV DNA copy numbers were rapidly and markedly reduced by about 100-fold in plasma and were no longer detectable in liver tissues, demonstrating a strong anti-HBV effect of <b>10</b> upon oral administration. The maximum efficacy of <b>10</b> was comparable to the maximum efficacy of ETV in this model.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Levels of HBV DNA in plasma (A) and liver (B) of HBV HDI mice upon treatment with the vehicle control, ETV control, and compound <b>10</b>. The HBV DNA copy numbers were quantified by real-time qPCR. Error bars indicate standard error of the mean (six mice per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>10</b> was further profiled in an effort to identify any early safety flags and to define DDI (drug–drug interaction) liabilities. The in vitro toxicology profiles of compound <b>10</b> were favorable with no signs of hERG, GSH (glutathione adduction), mutagenicity (Ames assay), or clastogenicity (micronucleus assay) liability. A 5-day in vivo toxicology assessment in rats supported further development of compound <b>10</b> that showed a supportive safety margin as defined by ratio of the plasma exposure (<i>C</i><sub>max</sub> and AUC) in rat at NOAEL (no observed adverse effect level) versus the exposure at a projected human efficacious dose. In the in vitro DDI assessment, compound <b>10</b> displayed IC<sub>50</sub> values of >50 μM for CYP inhibition in a panel of five enzymes (CYP3A4, 2D6, 2C9, 2C19, and 1A2). Compound <b>10</b> had no time dependent inhibition (TDI) flags to CYP3A4 inhibition. However, this compound was identified as a strong CYP3A4 inducer in primary human hepatocytes as determined by the CYP3A4 mRNA levels (111% increase compared to the positive control rifampicin at 10 μM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This observation of CYP3A4 induction is likely related to 4-H HAP core as over 250 compounds of the third-generation 4-H HAPs were screened and most of them demonstrated more or less CYP3A4 induction liabilities. The data of a few selected analogues is shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Relative Induction Values of CYP3A4 mRNA by Selected Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">% of positive control (10 μM rifampicin)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">109</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">183</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">144</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">As exemplified by the synthesis of compound <b>10</b>, the third-generation 4-H HAP analogues described herein were mostly prepared according to the procedure shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. First, amidine <b>10A-1</b> was prepared by reacting thiazole-2-carbonitrile with sodium methoxide followed by treatment with NH<sub>4</sub>Cl. Next, a three-component reaction of methyl acetoacetate, 2-chloro-4-fluorobenzaldehyde, and amidine <b>10A-1</b> was conducted to give dihydropyrimidine <b>10A-2</b>. The racemic <b>10A-</b>2 was then subjected to SFC (supercritical fluid chromatography) chiral separation to afford the enantiomerically pure (<i>R</i>)-<b>10A-2</b> as the desired intermediate (compound <b>5</b> in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and its antipode (<i>S</i>)-<b>10A-2</b>. The absolute stereochemistry of <b>5</b> was unambiguously determined by X-ray diffraction study.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Bromination of <b>5</b> gave <b>10A</b>, which was finally reacted with (3<i>S</i>)-morpholine-3-carboxylic acid hydrochloride salt to provide <b>10</b> after HPLC purification. This short and concise synthetic route was successfully applied to the synthesis of the third-generation 4-H HAPs described in this paper, which greatly facilitated and expedited our SAR studies.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe, MeOH, rt, 3 h, then NH<sub>4</sub>Cl, overnight, 100% (crude); (b) KOAc, CF<sub>3</sub>CH<sub>2</sub>OH, reflux, 16 h, 60% for two steps from thiazole-2-carbonitrile; (c) SFC chiral separation; (d) NBS, CCl<sub>4</sub>, rt, 1 h, 77%; (e) DIPEA, DCM, ca. 1 h, 55%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have discovered the third-generation 4-H HAPs, which feature the introduction of a carboxyl group at the C6 position of 4-H HAP. This carboxyl group brings an increased binding affinity with capsid, which leads to an improved anti-HBV activity compared to that of the first- and second-generation 4-H HAPs. The high resolution X-ray crystal structure of analogue <b>12</b> bound into Cp149 Y132A mutant hexamer reveals that this carboxyl group facilitates the formation of a strong hydrogen bonding interaction network between <b>12</b>, coordinated waters, and capsid. Besides the improved anti-HBV activity, compared to the first- and second-generation 4-H HAPs, the third-generation 4-H HAP compounds represented by <b>10</b> are more drug-like with an improved solubility and metabolic stability. The favorable in vitro biological activity and ADME properties of compound <b>10</b> are well translated in vivo as demonstrated in mice PK and PD studies, where a low clearance, good oral bioavailability, preferential liver distribution, and strong anti-HBV effects were demonstrated. The favorable in vitro and short-term rat tox profiles also support the nomination of <b>10</b> (named as HAP_R10) for further development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthetic Chemistry General Comments</h3><div class="NLM_p last">All of the intermediates were purified by silica gel chromatography using either a Biotage SP1 system or an ISCO CombiFlash chromatography instrument. All of the final compounds were purified by preparative HPLC (prep-HPLC) on a reversed-phase column using a Waters XBridge OBD Phenyl (30 mm × 100 mm, 5 μm) or OBD RP18 (30 mm × 100 mm, 5 μm) column under acidic conditions (A, 0.1% formic acid in H<sub>2</sub>O; B, 0.1% formic acid in acetonitrile) or basic conditions (A, 0.1% ammonia in H<sub>2</sub>O; B, acetonitrile). For SFC chiral separation, the intermediates were separated using a chiral column (Daicel Chiralpak IC, 30 mm × 250 mm, 5 μm) on a Mettler Teledo SFC-Multigram system (solvent system of 95% CO<sub>2</sub> and 5% IPA (0.5% TEA in IPA), backpressure of 100 bar, UV detection at 254 nm). Optical rotation was measured using a Rudolph Autopol V automatic polarimeter at a wavelength of 589 nm. LC–MS spectra were obtained using a MicroMass Platform LC (Waters Alliance 2795-ZQ2000). NMR spectra were obtained using Bruker AVANCE 400 MHz spectrometer, operating at 400.13 MHz (<sup>1</sup>H) and 100.62 MHz (<sup>13</sup>C). <sup>1</sup>H NMR spectra were obtained using the single pulse zg30. <sup>13</sup>C{<sup>1</sup>H} NMR spectra were obtained using composite pulse zgpg30 for proton decoupling. The chemical shifts were referenced against internal TMS(<sup>1</sup>H,<sup>13</sup>C), and the coupling constants were calculated as a whole of H,H and H,F. All of the starting materials were obtained commercially. All of the final compounds had purities greater than 95% based upon HPLC, LC–MS, and <sup>1</sup>H NMR analyses. All of the reported yields are for isolated products and are not optimized.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Synthetic Procedures for the Synthesis of Third-Generation 4-H HAPs with (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>10</b>) Exemplified</h3><div class="NLM_p">To a stirred solution of thiazole-2-carbonitrile (1.50 g, 14 mmol) in 5 mL of dry MeOH was added dropwise a solution of sodium methoxide (0.74 g, 14 mmol) in 10 mL of dry methanol. The reaction mixture was stirred at room temperature until the disappearance of starting material monitored by LC–MS. After that, ammonium chloride (1.50 g, 28 mmol) was added in one portion and the reaction mixture was stirred overnight. The undissolved material was removed by filtration, and the filtrate was concentrated in vacuo to afford the thiazole-2-carboxamidine hydrochloride (compound <b>10A-1</b>) as a gray solid which was used directly in the next step without further purification. MS: calcd 128 (MH<sup>+</sup>), measured 128 (MH<sup>+</sup>).</div><div class="NLM_p">To a stirred solution of thiazole-2-carboxamidine hydrochloride (<b>10A-1</b>, 0.15 g, crude, ca. 1.0 mmol), methyl acetoacetate (0.12 g, 1.0 mmol), and 2-chloro-4-fluorobenzaldehyde (0.16 g, 1.0 mmol) in CF<sub>3</sub>CH<sub>2</sub>OH (8 mL) was added potassium acetate (0.20 g, 2.0 mmol). The reaction mixture was refluxed for 16 h in a nitrogen atmosphere. After it was cooled to room temperature, the reaction mixture was concentrated and the residue was dissolved in ethyl acetate and washed with brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed, and the residue was purified by silica gel column chromatography (ethyl acetate/petroleum ether: 1/4 to 1/2) to afford methyl 4-(2-chloro-4-fluoro-phenyl)-6-methyl-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate (compound <b>10A-2</b>) as a yellow solid (219 mg, 60%). MS: calcd (MH<sup>+</sup>) 366, measured (MH<sup>+</sup>) 366. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ ppm 9.98 (s, 1H), 7.97 (d, <i>J</i> = 4.0 Hz, 1H), 7.90 (d, <i>J</i> = 4.0 Hz, 1H), 7.41 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 7.35 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H), 7.18 (td, <i>J</i> = 8.0, 4.0 Hz, 1H), 5.98 (s, 1H), 3.53 (s, 3H), 2.47 (s, 3H).</div><div class="NLM_p">The racemic compound <b>10A-2</b> was subjected to SFC chiral separation. The desired (−)-enantiomer methyl (4<i>R</i>)-4-(2-chloro-4-fluoro-phenyl)-6-methyl-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate ((<i>R</i>)-<b>10A-2</b>) has a relatively short retention time. The absolute stereochemistry of (<i>R</i>)-<b>10A-2</b> was determined by X-ray diffraction study (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>).<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/jm-2017-00083p_m001.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/jm-2017-00083p_m002.gif" alt="" /></img></span></div><div class="NLM_p">To a stirred solution of compound (<i>R</i>)-<b>10A-2</b> (0.37 g, 1.0 mmol) in CCl<sub>4</sub> (5 mL) was added NBS (0.20 g, 1.1 mmol) in portions. After the reaction mixture was stirred at room temperature for 1 h, the solvent was removed in vacuo and the residue was purified by column chromatography to give methyl (4<i>R</i>)-6-(bromomethyl)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate (compound <b>10A</b>) as a yellow solid (342 mg, 77%). MS: calcd 445 (MH<sup>+</sup>), measured 445 (MH<sup>+</sup>).</div><div class="NLM_p last">To a stirred solution of compound <b>10A</b> (0.049 g, 0.11 mmol) and (3<i>S</i>)-morpholine-3-carboxylic acid hydrochloride salt (CAS: 1187929-04-9, 0.029 g, 0.17 mmol) in dichloromethane (5 mL) was added dropwise DIPEA (0.078 mL, 0.45 mmol). The reaction mixture was stirred at room temperature until the disappearance of <b>10A</b>. The mixture was diluted with EtOAc (10 mL) and washed successively with saturated aqueous NH<sub>4</sub>Cl solution and brine. The organic layer was separated and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was concentrated in vacuo, and the residue was purified by prep-HPLC to give (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid (compound <b>10</b>) as a light-yellow solid (30 mg, 55%). Melting point: 136–137 °C. MS: calcd (MH<sup>+</sup>) 495, measured (MH<sup>+</sup>) 495. HRMS: calcd (MH<sup>+</sup>) 495.0899, measured (MH<sup>+</sup>) 495.0893. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ ppm 12.88 (br. s, 1H), 9.87 (s, 1H), 8.04 (d, <i>J</i> = 4.0 Hz, 1H), 7.95 (d, <i>J</i> = 4.0 Hz, 1H), 7.44–7.39 (m, 2H), 7.15 (td, <i>J</i> = 8.76, 2.62 Hz, 1H), 6.04 (s, 1H), 4.25 (d, <i>J</i> = 20 Hz, 1H), 4.07–3.97 (m, 2H), 3.86–3.61 (m, 4H), 3.51 (s, 3H), 3.12–3.07 (m, 1H), 2.45–2.39 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ ppm 172.8, 166.2, 162.5, 161.1 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 246.33 Hz, FC), 148.0, 144.8, 144.1, 138.7 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 2.83 Hz, FC), 133.1 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 10.52 Hz, FC), 131.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.56 Hz, FC), 125.1, 117.1 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 25.74 Hz, FC), 115.3 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 20.42 Hz, FC), 96.3, 69.4, 67.2, 62.0, 56.3, 54.8, 51.4, 48.7.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> For the Following Third-Generation 4-H HAPs, Except Described Specifically, All the Analogues Are Prepared in Analogy to <b>10</b> from the Commercially Available Building Blocks</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> ((3<i>R</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>11</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 495, measured (MH<sup>+</sup>) 495. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ ppm 12.86 (br s, 1H), 9.88 (s, 1H), 8.07–7.85 (m, 2H), 7.47–7.29 (m, 2H), 7.16 (td, <i>J</i> = 8.5, 2.6 Hz, 1H), 6.03 (s, 1H), 4.18–4.02 (m, 2H), 3.93–3.80 (m, 2H), 3.77–3.58 (m, 2H), 3.47–3.24 (m, 4H), 3.14–2.99 (m, 1H), 1.38–1.12 ppm (m, 1H).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (2<i>S</i>)-1-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-4,4-difluoro-pyrrolidine-2-carboxylic Acid (<b>12</b>)</h4><div class="NLM_p last">Melting point: 106–107 °C. MS: calcd (MH<sup>+</sup>) 515, measured (MH<sup>+</sup>) 515. HRMS: calcd (MH<sup>+</sup>) 515.0762, measured (MH<sup>+</sup>) 515.0770. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.21 (s, 2H), 7.63–7.60 (m, 1H), 7.38–7.35 (m, 1H), 7.22–7.18 (m, 1H), 6.29 (s, 1H), 4.57 (d, <i>J</i> = 16 Hz, 1H), 4.13–4.08 (m, 2H), 3.70–3.67 (m, 4H), 3.33–3.28 (m, 1H), 2.92–2.82 (m, 1H), 2.63–2.56 (m, 1H).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-2-carboxylic Acid (<b>13</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 495, measured (MH<sup>+</sup>) 495. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.02 (d, <i>J</i> = 3 Hz, 0.5H), 8.01 (d, <i>J</i> = 3 Hz, 0.5H), 7.91 (dd, <i>J</i> = 3 Hz, 0.5H), 7.90 (d, <i>J</i> = 3 Hz, 0.5H), 7.54 (dd, <i>J</i> = 6.0, 9.0 Hz, 0.5H), 7.53 (dd, <i>J</i> = 6.0, 9.0 Hz, 0.5H), 7.30 (dd, <i>J</i> = 3, 9 Hz, 1H), 7.15–7.09 (m, 1H), 6.21 (s, 1H), 4.82–4.55 (m, 3H), 4.31–4.24 (m, 1H), 4.12–3.91 (m, 2H), 3.74–3.65 (m, 1H), 3.66 (s, 3H), 3.55–3.37 (m, 2H).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-[(3<i>R</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholin-3-yl]acetic Acid (<b>14</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.01 Hz, 1H), 7.77 (d, <i>J</i> = 3.14 Hz, 1H), 7.44 (dd, <i>J</i> = 8.60, 6.21 Hz, 1H), 7.24 (dd, <i>J</i> = 8.78, 2.64 Hz, 1H), 7.06 (td, <i>J</i> = 8.38, 2.57 Hz, 1H), 6.17 (s, 1H), 4.32 (br d, <i>J</i> = 17.44 Hz, 1H), 4.07 (br s, 1H), 3.97 (br s, 1H), 3.67–3.92 (m, 4H), 3.63 (s, 3H), 3.24 (br s, 1H), 2.85–3.09 (m, 1H), 2.60 (br d, <i>J</i> = 4.77 Hz, 2H).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-[(3<i>R</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholin-3-yl]propanoic Acid (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared in analogue to <b>10</b> by using 3-[(3<i>R</i>)-morpholin-3-yl]propanoic acid trifluoroacetic acid salt (<b>15-a</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a> for its synthesis) instead of (3<i>S</i>)-morpholine-3-carboxylic acid hydrochloride salt. MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.01 (d, <i>J</i> = 3.26 Hz, 1H), 7.90 (d, <i>J</i> = 3.01 Hz, 1H), 7.57 (dd, <i>J</i> = 8.78, 6.02 Hz, 1H), 7.29 (dd, <i>J</i> = 8.78, 2.51 Hz, 1H) 7.13 (td, <i>J</i> = 8.41, 2.51 Hz, 1H), 6.21 (s, 1H), 4.99 (br d, <i>J</i> = 18.32 Hz, 1H), 4.60 (br d, <i>J</i> = 15.31 Hz, 1H), 4.00–4.16 (m, 3H), 3.91 (br s, 1H), 3.67 (s, 5H), 3.45 (dt, <i>J</i> = 13.05, 4.77 Hz, 1H), 2.48–2.67 (m, 2H), 2.35 (br d, <i>J</i> = 7.03 Hz, 1H), 2.07–2.21 (m, 1 H).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-methyl-morpholine-3-carboxylic Acid (<b>16</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ ppm 8.06 (d, <i>J</i> = 3.0 Hz, 1H), 7.85 (d, <i>J</i> = 3.0 Hz, 1H), 7.36 (dd, <i>J</i> = 8.8, 5.8 Hz, 1H), 7.28 (s, 1H), 7.20 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 6.30 (s, 1H), 4.46 (d, <i>J</i> = 17.1 Hz, 1H), 4.21 (br d, <i>J</i> = 17.1 Hz, 1H), 3.93–4.09 (m, 2H), 3.78–3.89 (m, 2H), 3.66 (s, 3H), 3.18–3.31 (m, 1H), 2.97–3.10 (m, 1H), 1.58 (s, 3H).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (2<i>R</i>,3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-2-methyl-morpholine-3-carboxylic Acid (<b>17</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. HRMS: calcd (MH<sup>+</sup>) 509.1056, measured (MH<sup>+</sup>) 509.1054. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.03 (d, <i>J</i> = 3.14 Hz, 1H), 7.90 (d, <i>J</i> = 3.14 Hz, 1H), 7.51 (dd, <i>J</i> = 5.96, 8.72 Hz, 1H), 7.28 (dd, <i>J</i> = 2.64, 8.66 Hz, 1H), 7.11 (dt, <i>J</i> = 2.64, 8.34 Hz,1H), 6.19 (s, 1H), 4.41 (d, <i>J</i> = 16.56 Hz, 1H), 4.20(d, <i>J</i> = 16.44 Hz, 1H), 4.00–4.13 (m, 1H), 3.75–3.98 (m, 3H), 3.63 (s, 3H), 3.51 (d, <i>J</i> = 8.91 Hz, 1H), 3.06 (dt, <i>J</i> = 3.51, 11.80 Hz, 1H), 1.36 (d, <i>J</i> = 6.27 Hz, 3H).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>R</i>,3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-2-isopropyl-morpholine-3-carboxylic Acid (<b>18</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 537, measured (MH<sup>+</sup>) 537. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.01 (d, <i>J</i> = 3.14 Hz, 1H), 7.70–7.95 (m, 1H), 7.50 (dd, <i>J</i> = 5.96, 8.72 Hz, 1H), 7.28 (dd, <i>J</i> = 2.64, 8.78 Hz, 1H), 7.10 (dt, <i>J</i> = 2.70, 8.38 Hz, 1H), 6.02–6.27 (m, 1H), 4.35–4.61 (m, 1H), 4.21–4.35 (m, 1H), 4.11 (td, <i>J</i> = 3.00, 12.20 Hz, 1H), 3.72–3.97 (m, 2H), 3.67–3.71 (m, 1H), 3.65 (s,3H), 3.35–3.46 (m, 1H), 2.95–3.17 (m, 1H), 2.10 (m, 1H), 1.07 (dd, <i>J</i> = 4.83, 6.84 Hz, 6H).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylate (<b>19</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.0 Hz, 1H), 7.76 (d, <i>J</i> = 3.3 Hz, 1H), 7.42 (dd, <i>J</i> = 8.7, 6.1 Hz, 1H), 7.24 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.04 (td, <i>J</i> = 8.4, 2.8 Hz, 1H), 6.17 (s, 1H), 4.40 (d, <i>J</i> = 17.8 Hz, 1H), 3.96–4.15 (m, 3H), 3.76–3.88 (m, 4H), 3.57–3.69 (m, 3H), 3.13–3.31 (m, 3H), 2.50 (dt, <i>J</i> = 11.9, 3.9 Hz, 1H).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl (4<i>R</i>)-6-[[(3<i>S</i>)-3-Carbamoylmorpholin-4-yl]methyl]-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate (<b>20</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 494, measured (MH<sup>+</sup>) 494. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.01 Hz, 1H), 7.71–7.81 (m, 1H), 7.42 (t, <i>J</i> = 6.76 Hz, 1H), 7.23 (dd, <i>J</i> = 2.32, 8.85 Hz, 1H), 7.06 (dt, <i>J</i> = 2.70, 8.38 Hz, 1H), 6.08–6.20 (m, 1H), 4.08–4.27 (m, 1H), 4.01 (dd, <i>J</i> = 3.26, 11.29 Hz, 1H), 3.67–3.92 (m, 4H), 3.57–3.64 (s, 3H), 3.35–3.43 (m, 1H), 3.00–3.09 (m, 1H), 2.50–2.68 (m, 1H).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl (4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-6-[[3-(hydroxymethyl)morpholin-4-yl]methyl]-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate (<b>21</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 481 measured (MH<sup>+</sup>) 481. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98–8.02 (m, 1H), 7.91 (dd, <i>J</i> = 3.01, 0.75 Hz, 1H), 7.57 (dd, <i>J</i> = 8.66, 5.90 Hz, 1H), 7.30 (dd, <i>J</i> = 8.66, 2.64 Hz, 1H) 7.12 (td, <i>J</i> = 8.41, 2.76 Hz, 1H), 6.19–6.23 (m, 1H), 5.01 (br d, <i>J</i> = 15.56 Hz, 0.5H), 4.85 (d, <i>J</i> = 6.53 Hz, 1H), 4.70 (d, <i>J</i> = 15.56 Hz, 0.5H), 4.05–4.18 (m, 3H), 3.90–4.01 (m, 3H), 3.70–3.79 (m, 2H), 3.67 (d, <i>J</i> = 1.51 Hz, 3H), 3.43–3.53 (m, 1 H).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl (4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-6-[[(3<i>R</i>)-3-(methanesulfonamidomethyl)morpholin-4-yl]methyl]-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was prepared in analogue to <b>10</b> by using <i>N</i>-[[(3<i>R</i>)-morpholin-3-yl]methyl]methanesulfonamide (<b>22-a</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a> for its synthesis) instead of (3<i>S</i>)-morpholine-3-carboxylic acid hydrochloride salt. MS: calcd (MH<sup>+</sup>) 558, measured (MH<sup>+</sup>) 559. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.19 (br s, 1H), 7.96 (d, <i>J</i> = 3.01 Hz, 1H), 7.76 (d, <i>J</i> = 3.26 Hz, 1H), 7.48 (dd, <i>J</i> = 8.66, 6.15 Hz, 1H), 7.22 (dd, <i>J</i> = 8.78, 2.51 Hz, 1H), 7.04 (td, <i>J</i> = 8.47, 2.64 Hz, 1H), 6.18 (s, 1H), 4.13–4.34 (m, 2H), 3.93 (dd, <i>J</i> = 11.42, 2.89 Hz, 1H), 3.77–3.83 (m, 2H), 3.72 (dd, <i>J</i> = 11.54, 6.78 Hz, 1H), 3.63 (s, 3H), 3.36–3.46 (m, 2H), 2.98 (s, 3H), 2.85–2.92 (m, 1H), 2.80 (dq, <i>J</i> = 6.68, 3.38 Hz, 1H), 2.53–2.62 (m, 1 H).</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (2<i>S</i>)-1-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]piperidine-2-carboxylic Acid (<b>23</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 493 measured (MH<sup>+</sup>) 493. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.99 (d, <i>J</i> = 3.26 Hz, 1H), 7.89 (d, <i>J</i> = 3.01 Hz, 1H), 7.55 (dd, <i>J</i> = 8.78, 6.02 Hz, 1H), 7.28 (dd, <i>J</i> = 8.66, 2.64 Hz, 1H), 7.12 (td, <i>J</i> = 8.34, 2.64 Hz, 1H), 6.19 (s, 1H), 4.80 (d, <i>J</i> = 16.31 Hz, 1H), 4.61 (d, <i>J</i> = 16.31 Hz, 1H), 4.19 (br t, <i>J</i> = 5.77 Hz, 1H), 3.80 (ddd, <i>J</i> = 12.67, 8.41, 3.76 Hz, 1H), 3.65 (s, 3H), 3.35–3.42 (m, 1H), 2.16–2.35 (m, 2H), 1.86–2.07 (m, 2H), 1.77 (br t, <i>J</i> = 5.77 Hz, 2 H).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (2<i>S</i>)-1-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]piperazine-2-carboxylic Acid (<b>24</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 494, measured (MH<sup>+</sup>) 494. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.07–8.22 (m, 2H), 7.58 (dd, <i>J</i> = 8.8, 6.0 Hz, 1H), 7.34 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.15 (td, <i>J</i> = 8.3, 2.6 Hz, 1H), 6.30 (s, 1H), 4.45 (d, <i>J</i> = 16.6 Hz, 1H), 4.20 (d, <i>J</i> = 16.8 Hz, 1H), 4.00 (t, <i>J</i> = 4.6 Hz, 1H), 3.54–3.69 (m, 5H), 3.16–3.41 (m, 3H), 2.95 (dt, <i>J</i> = 13.6, 4.4 Hz, 1H).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>S</i>)-4-Acetyl-1-[[(4<i>R</i>)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]piperazine-2-carboxylic Acid (<b>25</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 536, measured (MH<sup>+</sup>) 536. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98–8.15 (m, 2H), 7.58 (dd, <i>J</i> = 8.8, 6.0 Hz, 1H), 7.32 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.14 (td, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.26 (s, 1H), 4.65–4.81 (m, 1H), 4.51–4.61 (m, 1H), 4.19–4.46 (m, 2H), 3.75–4.17 (m, 2H), 3.66 (s, 3H), 3.38–3.59 (m, 2H), 2.96–3.13 (m, 1H), 2.18 (d, <i>J</i> = 16.6 Hz, 3H).</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]thiomorpholine-3-carboxylic Acid (<b>26</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 511, measured (MH<sup>+</sup>) 511. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.02–8.09 (m, 1H), 7.86–8.00 (m, 1H), 7.46–7.60 (m, 1H), 7.24–7.36 (m, 1H), 6.99–7.19 (m, 1H), 6.12–6.31 (m, 1H), 4.80–4.87 (m, 1H), 4.38–4.52 (m, 2H), 3.80–3.99 (m, 1H), 3.66 (s, 3H), 3.36–3.51 (m, 2H), 3.10–3.29 (m, 2H), 2.76–2.89 (m, 1 H).</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>27</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. HRMS: calcd (MH<sup>+</sup>) 509.1056, measured (MH<sup>+</sup>) 509.1049. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.08 (d, <i>J</i> = 3.0 Hz, 1H), 8.01 (d, <i>J</i> = 3.3 Hz, 1H), 7.60 (dd, <i>J</i> = 5.9, 8.7 Hz, 1H), 7.32 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 7.15 (dt, <i>J</i> = 2.6, 8.3 Hz, 1H), 6.26 (s, 1H), 4.88 (d, <i>J</i> = 16.3 Hz, 1H), 4.59 (d, <i>J</i> = 16.6 Hz, 1H), 4.34–4.27 (m, 1H), 4.22 (d, <i>J</i> = 4.0 Hz, 2H), 4.11 (q, <i>J</i> = 7.1 Hz, 2H), 4.06–3.92 (m, 2H), 3.78 (ddd, <i>J</i> = 3.6, 8.4, 12.5 Hz, 1H), 3.27 (td, <i>J</i> = 3.7, 12.9 Hz, 1H), 1.16 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (3<i>S</i>)-4-[[4-(2-Chloro-4-fluoro-phenyl)-5-propoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>28</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 523, measured (MH<sup>+</sup>) 523. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98–7.96 (m, 1H), 7.79 (d, <i>J</i> = 3.0 Hz, 1H), 7.53–7.44 (m, 1H), 7.28–7.22 (m, 1H), 7.11–7.04 (m, 1H), 6.19 (s, 1H), 4.59–4.37 (m, 1H), 4.35–4.18 (m, 1H), 4.15–3.86 (m, 6H), 3.65 (br d, <i>J</i> = 19.3 Hz, 1H), 3.47–3.35 (m, 1H), 2.78 (br s, 1H), 1.63–1.51 (m, 2H), 0.84–0.77 (m, 3H).</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-isopropoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 523, measured (MH<sup>+</sup>) 523. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.0 Hz, 1H), 7.80 (d, <i>J</i> = 2.8 Hz, 1H), 7.49 (dd, <i>J</i> = 6.1, 8.7 Hz, 1H), 7.26 (dd, <i>J</i> = 2.6, 8.7 Hz, 1H), 7.08 (dt, <i>J</i> = 2.6, 8.3 Hz, 1H), 6.17 (s, 1H), 4.96–4.90 (m, 1H), 4.51 (br s, 1H), 4.39–4.19 (m, 1H), 4.19–4.04 (m, 2H), 3.88 (br s, 2H), 3.70 (br s, 1H), 3.36–3.34 (m, 1H), 2.72 (br s, 1H), 1.24 (d, <i>J</i> = 6.3 Hz, 3H), 0.99 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>30</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 563, measured (MH<sup>+</sup>) 563. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98 (d, <i>J</i> = 3.3 Hz, 1H), 7.77 (d, <i>J</i> = 3.0 Hz, 1H), 7.45 (dd, <i>J</i> = 6.0, 8.5 Hz, 1H), 7.24 (dd, <i>J</i> = 2.6, 8.7 Hz, 1H), 7.06 (dt, <i>J</i> = 2.8, 8.4 Hz, 1H), 6.20 (s, 1H), 4.61–4.44 (m, 2H), 4.35 (br s, 1H), 4.20 (br s, 1H), 4.06 (br d, <i>J</i> = 4.3 Hz, 1H), 4.09–4.01 (m, 1H), 3.93–3.79 (m, 2H), 3.67–3.51 (m, 2H), 2.66 (br d, <i>J</i> = 17.8 Hz, 1H).</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (3<i>S</i>)-4-[[5-<i>tert</i>-Butoxycarbonyl-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>31</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 537, measured (MH<sup>+</sup>) 537. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.96 (s, 1H), 7.79(s, 1H), 7.47 (m, 1H) 7.27 (m, 1H), 7.09 (m, 1H), 6.12 (s, 1H), 4.37–4.58 (m, 2 Hz), 3.99–4.23 (m, 2H), 3.80–3.97 (m, 2H), 3.68 (m, 1H), 3.45(m, 1H) 2.82 (m, 1H), 1.35 (s, 9H).</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-(2-methoxyethoxycarbonyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>32</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 539, measured (MH<sup>+</sup>) 539. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.79 (d, <i>J</i> = 3.0 Hz, 1H), 7.48 (dd, <i>J</i> = 6.3, 8.8 Hz, 1H), 7.25 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 7.07 (dt, <i>J</i> = 2.8, 8.4 Hz, 1H), 6.20 (s, 1H), 4.50 (br s, 1H), 4.39–4.22 (m, 1H), 4.22–4.06 (m, 4H), 3.97–3.81 (m, 2H), 3.68 (br s, 1H), 3.55–3.48 (m, 2H), 3.48–3.35 (m, 1H), 3.29 (s, 3H), 2.77 (br s, 1H).</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-(ethylcarbamoyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>33</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 508, measured (MH<sup>+</sup>) 508. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.96 (d, <i>J</i> = 3.14 Hz, 1H), 7.79 (br d, <i>J</i> = 2.89 Hz, 1H), 7.49 (dd, <i>J</i> = 6.15, 8.53 Hz, 1H), 7.25 (dd, <i>J</i> = 2.51, 8.66 Hz, 1H), 7.09 (dt, <i>J</i> = 2.64, 8.28 Hz, 1H), 6.13 (s, 1H), 4.05–4.31 (m, 2H), 4.01 (br d, <i>J</i> = 8.91 Hz, 1H), 3.81 (br s, 3H), 3.61 (br s, 1H), 3.02–3.29 (m, 3H), 2.70(m, 1H), 1.09 (t, <i>J</i> = 7.22 Hz, 3H).</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-cyano-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>34</b>)</h4><div class="NLM_p last">The synthetic procedure was described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>. MS: calcd (MH<sup>+</sup>) 462, measured (MH<sup>+</sup>) 462. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.01 (d, <i>J</i> = 4.0 Hz, 1H), 7.80 (br d, <i>J</i> = 3.01 Hz, 1H), 7.53 (br dd, <i>J</i> = 5.96, 8.60 Hz, 1H), 7.32 (br dd, <i>J</i> = 2.57, 8.72 Hz, 1H), 7.18–7.22 (m, 1H), 5.93 (s, 1H), 4.02(m, 2H), 3.71–3.90 (m, 3H), 3.44–3.51 (m, 2H), 2.97 (m, 1H), 2.51 (m, 1H).</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-2-(3,5-difluoro-2-pyridyl)-5-methoxycarbonyl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>35</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 525, measured (MH<sup>+</sup>) 525. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.51 (s, 1H), 8.47 (s, 2H), 7.73–7.72 (m, 1H), 7.50–7.46 (m, 1H), 7.25–7.22 (m, 1H), 7.08–7.04 (m, 1H), 6.22 (s, 1H), 4.24 (d, 1H, <i>J</i> = 16 Hz), 4.12 (d, 1H, <i>J</i> = 16 Hz), 4.07–4.04 (m, 1H), 3.89–3.79 (m, 3H), 3.62 (s, 3H), 3.47–3.44 (m, 1H), 3.25–3.19 (m, 1H), 2.67–2.65 (m, 1H).</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-oxazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>36</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 479 measured (MH<sup>+</sup>) 479. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.24 (s, 1H), 7.52–7.59 (m, 2H), 7.32 (dd, <i>J</i> = 8.53, 2.51 Hz, 1H), 7.15 (td, <i>J</i> = 8.28, 2.51 Hz, 1H), 6.25 (s, 1H), 4.40–4.51 (m, 2H), 4.15–4.21 (m, 1H), 3.85–4.09 (m, 4H), 3.66 (s, 3H), 3.50 (ddd, <i>J</i> = 12.23, 5.71, 3.39 Hz, 1H), 2.97 (ddd, <i>J</i> = 12.17, 6.53, 3.89 Hz, 1H).</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-pyrimidin-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>37</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 490, measured (MH<sup>+</sup>) 490. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 9.14 (d, <i>J</i> = 4.8 Hz, 2H), 7.86 (t, <i>J</i> = 4.9 Hz, 1H), 7.67 (dd, <i>J</i> = 5.8, 8.8 Hz, 1H), 7.37 (dd, <i>J</i> = 2.5, 8.5 Hz, 1H), 7.20 (dt, <i>J</i> = 2.6, 8.3 Hz, 1H), 6.42 (s, 1H), 4.20 (br d, <i>J</i> = 4.3 Hz, 2H), 4.11 (dd, <i>J</i> = 3.3, 11.3 Hz, 1H), 4.05–3.95 (m, 1H), 3.91–3.85 (m, 1H), 3.79 (td, <i>J</i> = 3.4, 11.5 Hz, 1H), 3.70 (s, 3H), 3.37 (s, 1H), 3.18 (ddd, <i>J</i> = 2.8, 5.9, 8.9 Hz, 1H), 2.71–2.62 (m, 1H).</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-(1-methylimidazol-2-yl)-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>38</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 492, measured (MH<sup>+</sup>) 492. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.40 (dd, <i>J</i> = 6.1, 8.7 Hz, 1H), 7.31–7.24 (m, 2H), 7.12–7.02 (m, 2H), 6.19 (s, 1H), 4.55–4.44 (m, 1H), 4.37–4.25 (m, 1H), 4.10 (dd, <i>J</i> = 4.3, 7.5 Hz, 2H), 3.99 (s, 3H), 3.92–3.77 (m, 2H), 3.71 (br t, <i>J</i> = 4.0 Hz, 1H), 3.64 (s, 3H), 3.47–3.37 (m, 1H), 2.75 (br s, 1H).</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-(5-methyloxazol-4-yl)-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>39</b>)</h4><div class="NLM_p last">Compound <b>39</b> was prepared in analogy to <b>10</b> by using 5-methyl-oxazole-4-carboxamidine (<b>39-a</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a> for its synthesis) instead of thiazole-2-carboxamidine <b>10A-1</b>. MS: calcd (MH<sup>+</sup>) 493, measured (MH<sup>+</sup>) 493. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.32 (s, 1H), 7.57 (dd, <i>J</i> = 8.66, 5.90 Hz, 1H), 7.39 (dd, <i>J</i> = 8.53, 2.51 Hz, 1H), 7.20 (td, <i>J</i> = 8.34, 2.64 Hz, 1H), 6.27 (s, 1H), 4.18–4.29 (m, 2H), 4.07 (dd, <i>J</i> = 11.42, 3.64 Hz, 1H), 3.85–3.94 (m, 2H), 3.73–3.81 (m, 1H), 3.63–3.71 (m, 4H), 3.21 (ddd, <i>J</i> = 11.98, 5.84, 3.01 Hz, 1H), 2.67–2.79 (m, 4 H).</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (3<i>S</i>)-4-[(4<i>R</i>)-6-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-(4-methyl-thiazol-2-yl)-3,6-dihydro-pyrimidin-4-ylmethyl]-morpholine-3-carboxylic Acid (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> was prepared in analogy to <b>10</b> using 4-methyl-thiazole-2-carbonitrile instead of thiazole-2-carbonitrile. MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.51–7.59 (m, 2H), 7.28–7.34 (m, 1H), 7.09–7.18 (m, 1H), 6.19–6.26 (m, 1H), 4.71–4.79 (m, 1H), 4.44–4.53 (m, 1H), 4.08–4.23 (m, 3H), 3.90–4.04 (m, 2H), 3.66 (s, 4H), 3.07–3.18 (m, 1H), 2.51 (s, 3 H).</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-fluoro-phenyl)-2-(4-cyclopropylthiazol-2-yl)-5-methoxycarbonyl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was prepared in analogy to <b>10</b> by using 4-cyclopropyl-thiazole-2-carboxamidine (<b>41-a</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a> for its synthesis) instead of thiazole-2-carboxamidine <b>10A-1</b>. MS: calcd (MH<sup>+</sup>) 535, measured (MH<sup>+</sup>) 535. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.61–7.64 (m, 1H), 7.53–7.61 (m, 1H), 7.29–7.34 (m, 1H), 7.10–7.19 (m, 1H), 6.24 (s, 1H), 4.57–4.70 (m, 1H), 4.39–4.52 (m, 1H), 4.04–4.24 (m, 3H), 3.83–4.04 (m, 2H), 3.66 (s, 3H), 3.51–3.63 (m, 1H), 3.01–3.15 (m, 1H), 2.12–2.27 (m, 1H), 0.90–1.11 (m, 4H).</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (4<i>S</i>)-4-[(4<i>R</i>)-6-(2-Chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-(4-trifluoromethyl-thiazol-2-yl)-3,6-dihydropyrimidin-4-ylmethyl]-morpholine-3-carboxylic Acid (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was prepared in analogy to <b>41</b> by using 2-bromo-4-trifluoromethyl-thiazole (CAS: 41731-39-9) instead of 2-bromo-4-cyclopropyl-thiazole <b>41-c</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>). Melting point: 122–125 °C. MS: calcd (MH<sup>+</sup>) 563, measured (MH<sup>+</sup>) 563. HRMS: calcd (MH<sup>+</sup>) 563.0774, measured (MH<sup>+</sup>) 563.0769. <sup>1</sup>H NMR (methanol, 400 MHz): δ ppm 8.46 (s, 1H), 7.53 (dd, <i>J</i> = 8.5, 6.0 Hz, 1H), 7.28 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 7.10 (td, <i>J</i> = 8.4, 2.8 Hz, 1H), 6.21 (s, 1H), 4.48 (d, <i>J</i> = 16.6 Hz, 1H), 4.11–4.30 (m, 3H), 3.90–4.05 (m, 2H), 3.73 (ddd, <i>J</i> = 12.7, 8.4, 3.8 Hz, 2H), 3.65 (s, 3H), 3.07–3.23 ppm (m, 1H).</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (3<i>S</i>)-4-[[(4<i>S</i>)-5-Ethoxycarbonyl-4-(4-fluorophenyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>43</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 475, measured (MH<sup>+</sup>) 475. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.00 (d, <i>J</i> = 3.0 Hz, 1H), 7.84 (d, <i>J</i> = 3.0 Hz, 1H), 7.45–7.38 (m, 2H), 7.07 (t, <i>J</i> = 8.8 Hz, 2H), 5.71 (s, 1H), 4.58 (br d, <i>J</i> = 16.1 Hz, 1H), 4.31 (br s, 1H), 4.21–4.05 (m, 4H), 3.99–3.83 (m, 2H), 3.71 (br s, 1H), 3.54–3.41 (m, 1H), 2.85 (br s, 1H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2,4-Difluorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>44</b>)</h4><div class="NLM_p last">MS: calcd 493 (MH<sup>+</sup>), exp 493 (MH<sup>+</sup>). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98 (d, <i>J</i> = 2.8 Hz, 1H), 7.79 (d, <i>J</i> = 2.8 Hz, 1H), 7.50–7.36 (m, 1H), 7.04–6.87 (m, 2H), 6.02–5.93 (m, 1H), 4.38–4.19 (m, 2H), 4.17–4.00 (m, 4H), 3.97–3.78 (m, 3H), 3.58 (br s, 1H), 2.71 (br s, 1H), 1.19 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Bromo-4-fluoro-phenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>45</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 554, measured (MH<sup>+</sup>) 555. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.89 (d, <i>J</i> = 3.0 Hz, 1H), 7.55 (d, <i>J</i> = 3.0 Hz, 1H), 7.33–7.42 (m, 2H), 6.97–7.09 (m, 1H), 6.21 (s, 1H), 4.36 (d, <i>J</i> = 16.1 Hz, 1H), 3.97–4.18 (m, 5H), 3.92 (d, <i>J</i> = 6.0 Hz, 1H), 3.78–3.86 (m, 1H), 3.70 (br s, 1H), 3.26 (br s, 1H), 2.76 (br s, 1H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Bromo-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>46</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 539 exp (MH<sup>+</sup>) 539. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.01 Hz, 1H), 7.78 (d, <i>J</i> = 3.01 Hz, 1H), 7.47–7.40 (m, 2H), 7.14–7.09 (m, 1H), 6.14 (s, 1H), 4.52 (d, <i>J</i> = 16.31 Hz, 1H), 4.15 (d, <i>J</i> = 16.06 Hz, 1H), 4.07 (t, <i>J</i> = 8.16 Hz, 1H), 3.61–3.73 (m, 4H), 3.21–3.31 (m, 1H), 2.78–2.94 (m, 1H), 2.48–2.66 (m, 1H).</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (3<i>S</i>)-4-[[(4<i>S</i>)-5-Ethoxycarbonyl-4-(4-fluoro-2-methyl-phenyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>47</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 489, measured (MH<sup>+</sup>) 489. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.96 (d, <i>J</i> = 3.1 Hz, 1H), 7.78 (d, <i>J</i> = 3.0 Hz, 1H), 7.33 (dd, <i>J</i> = 8.6, 5.8 Hz, 1H), 6.77–6.97 (m, 2H), 5.94 (s, 1H), 4.50 (br d, <i>J</i> = 16.1 Hz, 1H), 4.31 (br s, 1H), 4.04–4.18 (m, 3H), 3.76–3.98 (m, 2H), 3.67 (br s, 1H), 2.62 (s, 3H), 1.16 ppm (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (3<i>S</i>)-4-[[(4<i>S</i>)-4-(4-Fluoro-2-methyl-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>48</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 475, measured (MH<sup>+</sup>) 475. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.96 (d, <i>J</i> = 3.3 Hz, 1H), 7.79 (br d, <i>J</i> = 2.8 Hz, 1H), 7.23–7.41 (m, 1H), 6.79–6.99 (m, 2H), 5.93 (s, 1H), 4.22–4.62 (m, 2H), 4.01–4.17 (m, 2H), 3.67–3.94 (m, 3H), 3.63 (s, 2H), 3.26–3.4 (m, 3H), 2.61 (m, 3H).</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (3<i>S</i>)-4-[[4-[4-Fluoro-2-(trifluoromethyl)phenyl]-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>49</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 529, measured (MH<sup>+</sup>) 529. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.92–8.00 (m, 1H), 7.60–7.82 (m, 2H), 7.49 (br d, <i>J</i> = 8.8 Hz, 1H), 7.37 (br s, 1H), 6.11 (s, 1H), 4.12 (br s, 2H), 3.87 (br s, 3H), 3.57 (s, 3H), 3.34 (m, 2H), 2.68 (br s, 2H).</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (3<i>S</i>)-4-[[(4<i>S</i>)-4-(2-Cyclopropyl-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>50</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 501 measured (MH<sup>+</sup>) 501. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.01 (d, <i>J</i> = 3.26 Hz, 1H), 7.88 (d, <i>J</i> = 3.01 Hz, 1H), 7.36 (dd, <i>J</i> = 8.53, 5.77 Hz, 1H), 6.89 (td, <i>J</i> = 8.47, 2.64 Hz, 1H), 6.80 (dd, <i>J</i> = 10.67, 2.64 Hz, 1H), 6.36 (s, 1H), 4.67 (d, <i>J</i> = 16.81 Hz, 1H), 4.40 (br d, <i>J</i> = 16.81 Hz, 1H), 4.09–4.22 (m, 2H), 3.86–4.02 (m, 3H), 3.65 (s, 3H), 3.53–3.61 (m, 1H), 2.97 (br d, <i>J</i> = 11.29 Hz, 1H), 2.43–2.52 (m, 1H), 1.04–1.15 (m, 2H), 0.87–0.96 (m, 1H), 0.67–0.74 (m, 1H).</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chlorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>51</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 491, measured (MH<sup>+</sup>) 491. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 10.00 (br, 1H), 8.02 (d, <i>J</i> = 3.3 Hz, 1H), 7.93 (d, <i>J</i> = 3.0 Hz, 1H), 7.55–7.35 (m, 2H), 7.28 (dt, <i>J</i> = 2.0, 7.4 Hz, 2H), 6.09 (s, 1H), 4.32–3.77 (m, 6H), 3.77–3.45 (m, 3H), 3.14–2.97 (m, 1H), 2.41 (d, <i>J</i> = 12.3 Hz, 1H), 1.05 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-methyl-phenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>52</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 505, measured (MH<sup>+</sup>) 505. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.00 (d, <i>J</i> = 3.3 Hz, 1H), 7.86 (d, <i>J</i> = 3.3 Hz, 1H), 7.35 (d, <i>J</i> = 7.8 Hz, 1H), 7.28 (s, 1H), 7.13 (br d, <i>J</i> = 8.0 Hz, 1H), 6.19 (s, 1H), 4.63 (br d, <i>J</i> = 16.6 Hz, 1H), 4.39 (br d, <i>J</i> = 17.6 Hz, 1H), 4.00–4.20 (m, 4H), 3.80–3.98 (m, 3H), 3.47–3.63 (m, 1H), 2.97 (br s, 1H), 2.33 (s, 3H), 1.16 ppm (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-4-methyl-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>53</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 491, measured (MH<sup>+</sup>) 491. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.79 (d, <i>J</i> = 3.3 Hz, 1H), 7.22–7.35 (m, 2H), 7.10 (d, <i>J</i> = 8.0 Hz, 1H), 6.15 (s, 1H), 4.27–4.53 (m, 2H), 4.06–4.15 (m, 2H), 3.83–3.98 (m, 2H), 3.67–3.75 (m, 1H), 3.62 (s, 3H), 3.33 (m, 2H), 2.31 (s, 3H).</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2,4-Dichlorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>54</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 525, measured (MH<sup>+</sup>) 525. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.01 Hz, 1H), 7.78 (d, <i>J</i> = 3.01 Hz, 1H), 7.49 (d, <i>J</i> = 2.01 Hz, 1H), 7.44 (d, <i>J</i> = 8.28 Hz, 1H), 7.32 (dd, <i>J</i> = 8.28, 2.01 Hz, 1H), 6.18 (s, 1H), 4.33–4.49 (m, 1H), 4.17–4.30 (m, 1H), 4.07 (d, <i>J</i> = 7.03 Hz, 5H), 3.78–3.96 (m, 2H), 3.61 (br s, 1H), 2.62–2.79 (m, 1H), 1.16 (t, <i>J</i> = 7.15 Hz, 3 H).</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(4-Bromo-2-chlorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>55</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 569, measured (MH<sup>+</sup>) 569. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98 (d, <i>J</i> = 3.0 Hz, 1H), 7.80 (br s, 1H), 7.64 (br d, <i>J</i> = 1.8 Hz, 1H), 7.23–7.52 (m, 2H), 6.18 (s, 1H), 4.82 (br, 1H), 3.97–4.27 (m, 4H), 3.61–3.96 (m, 3H), 3.17–3.30 (m, 3H), 1.16 ppm (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (3<i>S</i>)-4-[[4-[2-Chloro-4-(trifluoromethyl)phenyl]-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>56</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 545, measured (MH<sup>+</sup>) 545. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.01 (dd, <i>J</i> = 3.1, 2.1 Hz, 1H), 7.87 (dd, <i>J</i> = 3.1, 1.1 Hz, 1H), 7.78 (s, 1H), 7.55–7.73 (m, 2H), 6.29 (s, 1H), 4.69 (br d, <i>J</i> = 16.8 Hz, 1H), 4.33–4.56 (m, 2H), 4.06–4.23 (m, 1H), 3.81–4.02 (m, 4H), 3.64 (d, <i>J</i> = 1.3 Hz, 2H), 2.99 ppm (br s, 2H).</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (3<i>S</i>)-4-[[(4<i>S</i>)-4-(4-Cyanophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>57</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 482, measured (MH<sup>+</sup>) 482. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.00 (d, <i>J</i> = 3.0 Hz, 1H), 7.82 (d, <i>J</i> = 3.0 Hz, 1H), 7.85–7.78 (m, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 5.51 (s, 2H), 4.41 (br d, <i>J</i> = 11.5 Hz, 1H), 4.24–4.09 (m, 2H), 4.06 (br s, 2H), 3.95–3.78 (m, 2H), 3.64–3.54 (m, 1H), 2.75–2.60 (m, 1H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (3<i>S</i>)-4-[[(4<i>S</i>)-5-Ethoxycarbonyl-4-(4-methoxyphenyl)-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>58</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 516, measured (MH<sup>+</sup>) 516. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ ppm 7.90–7.94 (m, 1H), 7.58–7.69 (m, 3H), 7.34–7.43 (m, 1H), 6.29–6.37 (m, 1H), 4.30–4.58 (m, 7H), 4.18 (br s, 1H), 4.02–4.12 (m, 3H), 3.82–3.97 (m, 3H), 3.30–3.49 (m, 1H), 2.91 (d, <i>J</i> = 12.8 Hz, 1H), 1.13 (td, <i>J</i> = 7.0, 5.0 Hz, 3H).</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-4-[(<i>R</i>)-6-(2-Chloro-3-fluorophenyl)-5-methoxycarbonyl-2-thiazol-2-yl-3,6-dihydropyrimidin-4-ylmethyl]-morpholine-3-carboxylic Acid (<b>59</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 495, measured (MH<sup>+</sup>) 495. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 2.76 Hz, 1H), 7.78 (br s, 1H), 7.24–7.38 (m, 2H), 7.10–7.21 (m, 1H), 6.23 (s, 1H), 4.40 (m, 1H), 4.25 (m, 1H), 4.07 (m, 2H), 3.87 (m, 2H), 3.62 (m, 4H), 2.70 (m, 2H).</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-3-fluorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>60</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 509, measured (MH<sup>+</sup>) 509. HRMS: calcd (MH<sup>+</sup>) 509.1056, measured (MH<sup>+</sup>) 509.1053. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.05 (d, <i>J</i> = 3.01 Hz, 1H), 7.95 (d, <i>J</i> = 3.26 Hz, 1H), 7.33–7.42 (m, 2H), 7.22–7.29 (m, 1H), 6.29 (s, 1H), 4.83 (d, <i>J</i> = 16.56 Hz, 1H), 4.52 (d, <i>J</i> = 16.56 Hz, 1H), 4.15–4.27 (m, 3H), 4.10 (q, <i>J</i> = 6.94 Hz, 2H), 3.92–4.06 (m, 2H), 3.72 (ddd, <i>J</i> = 12.55, 8.28, 4.02 Hz, 1H), 3.11–3.21 (m, 1H), 1.15 (t, <i>J</i> = 7.15 Hz, 3H).</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Bromo-3-fluorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>61</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 554, measured (MH<sup>+</sup>) 553 and 555. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.93–8.00 (m, 1H), 7.78 (d, <i>J</i> = 3.26 Hz, 1H), 7.32–7.40 (m, 1H), 7.25–7.30 (m, 1H), 7.14 (td, <i>J</i> = 8.22, 1.38 Hz, 1H), 6.25 (s, 1H), 4.50 (d, <i>J</i> = 17.32 Hz, 1H), 4.26 (d, <i>J</i> = 11.54 Hz, 1H), 4.00–4.16 (m, 4H), 3.81–3.96 (m, 2H), 3.68 (br s, 1H), 3.39 (br s, 1H), 2.75 (br s, 1H), 1.14 (t, <i>J</i> = 7.03 Hz, 3H).</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2,3-Dichlorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>62</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 525, measured (MH<sup>+</sup>) 525. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.98 (br s, 1H), 7.78 (br s, 1H), 7.53–7.36 (m, 2H), 7.34–7.21 (m, 1H), 6.26 (br s, 1H), 4.30–3.66 (m, 9H), 3.12–3.00 (m, 2H), 1.44–1.28 (m, 3H).</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (3<i>S</i>)-4-[[4-(2-Chloro-3-cyanophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>63</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 516, measured (MH<sup>+</sup>) 516. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ ppm 7.90–7.94 (m, 1H), 7.58–7.69 (m, 3H), 7.34–7.43 (m, 1H), 6.29–6.37 (m, 1H), 4.30–4.58 (m, 7H), 4.18 (br s, 1H), 4.02–4.12 (m, 3H), 3.82–3.97 (m, 3H), 3.30–3.49 (m, 1H), 2.91 (d, <i>J</i> = 12.8 Hz, 1H), 1.13 (td, <i>J</i> = 7.0, 5.0 Hz, 3H).</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-3,4-difluorophenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>64</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 513, measured (MH<sup>+</sup>) 513. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.04 (d, <i>J</i> = 3.3 Hz, 1H), 7.93 (d, <i>J</i> = 3.0 Hz, 1H), 7.34–7.41 (m, 1H), 7.24–7.33 (m, 1H), 6.22 (s, 1H), 4.84 (d, <i>J</i> = 16.6 Hz, 1H), 4.51 (d, <i>J</i> = 16.6 Hz, 1H), 4.15–4.26 (m, 3H), 3.91–4.05 (m, 2H), 3.72 (ddd, <i>J</i> = 12.6, 8.5, 3.8 Hz, 1H), 3.65 (s, 3H), 3.13–3.21 (m, 1H).</div></div><div id="sec4_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Chloro-3,4-difluoro-phenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>65</b>)</h4><div class="NLM_p last">MS: calcd 527 (MH<sup>+</sup>), exp 527 (MH<sup>+</sup>). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.78 (d, <i>J</i> = 3.0 Hz, 1H), 7.35–7.19 (m, 2H), 6.18 (s, 1H), 4.48 (d, <i>J</i> = 17.3 Hz, 1H), 4.31–4.19 (m, 1H), 4.16–4.01 (m, 4H), 3.97–3.82 (m, 2H), 3.67 (br s, 1H), 3.36 (d, <i>J</i> = 6.0 Hz, 1H), 2.80–2.63 (m, 1H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Bromo-3,4-difluorophenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>66</b>)</h4><div class="NLM_p last">Compound <b>66</b> was prepared in analogue to <b>10</b> by using 2-bromo-3,4-difluoro-benzaldehyde (<b>66-a</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a> for its synthesis) instead of 2-chloro-4-fluorobenzaldehyde. MS: calcd (MH<sup>+</sup>) 557, measured (MH<sup>+</sup>) 557. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.0 Hz, 1H), 7.70–7.83 (m, 1H), 7.17–7.37 (m, 2H), 6.18 (s, 1H), 4.76 (s, 2H), 4.48 (br s, 1H), 3.98–4.16 (m, 2H), 3.72–3.98 (m, 2H), 3.53–3.72 (m, 3H), 2.69 (br s, 2H).</div></div><div id="sec4_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (3<i>S</i>)-4-[[(4<i>R</i>)-4-(2-Bromo-3,4-difluorophenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>67</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 571 measured (MH<sup>+</sup>) 571. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 10.01 (br s, 1H), 8.03 (d, <i>J</i> = 3.0 Hz, 1H), 7.94 (d, <i>J</i> = 3.3 Hz, 1H), 7.40–7.49 (m, 1H), 7.25 (ddd, <i>J</i> = 8.8, 5.3, 1.9 Hz, 1H), 6.05 (s, 1H), 4.17–4.26 (m, 1H), 4.05 (d, <i>J</i> = 17.3 Hz, 1H), 3.95 (q, <i>J</i> = 7.0 Hz, 3H), 3.79–3.86 (m, 1H), 3.68 (td, <i>J</i> = 7.8, 3.4 Hz, 2H), 3.56 (br s, 1H), 3.02–3.12 (m, 1H), 2.36–2.45 (m, 1H), 1.05 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (3<i>S</i>)-4-[[(4<i>S</i>)-4-(3,4-Difluoro-2-methyl-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>68</b>)</h4><div class="NLM_p last">Melting point: 138–140 °C. MS: calcd (MH<sup>+</sup>) 493, measured (MH<sup>+</sup>) 493. HRMS: calcd (MH<sup>+</sup>) 493.1352, measured (MH<sup>+</sup>) 493.1344. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 8.05 (d, <i>J</i> = 3.0 Hz, 1H), 7.95 (d, <i>J</i> = 3.0 Hz, 1H), 7.23–7.32 (m, 1H), 7.03–7.15 (m, 1H), 5.99 (s, 1H), 4.75 (d, <i>J</i> = 16.8 Hz, 1H), 4.46 (d, <i>J</i> = 16.6 Hz, 1H), 4.06–4.24 (m, 3H), 3.84–4.03 (m, 2H), 3.59–3.72 (m, 3H), 2.99–3.19 (m, 2H), 2.53 (d, <i>J</i> = 2.3 Hz, 3H).</div></div><div id="sec4_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (3<i>S</i>)-4-[[(4<i>S</i>)-4-(3,4-Difluoro-2-methyl-phenyl)-5-ethoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic Acid (<b>69</b>)</h4><div class="NLM_p last">MS: calcd 507 (MH<sup>+</sup>), measured 507(MH<sup>+</sup>). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz): δ ppm 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.79 (br s, 1H), 6.97–7.24 (m, 2H), 5.93 (s, 1H), 4.21–4.60 (m, 3H), 4.09 (q, <i>J</i> = 7.1 Hz, 3H), 3.87 (br s, 2H), 3.66 (br s, 1H), 2.79 (br s, 2H), 2.56 (d, <i>J</i> = 2.5 Hz, 3H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Biology General Comments</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Cells and Culture Conditions</h4><div class="NLM_p last">HepG2.2.15 and HepDE19 are stably transfected cell lines containing the HBV genome. Both cell lines are derived from the hepatoblastoma cell line Hep G2 (American Type Culture Collection, ATCC HB-8065) by the published procedures.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Both cell lines were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)-F12 supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 0.5 mg/mL of G418. While HepG2.2.15 cells constitutively support HBV replication and production of virus particles, HepDE19 cells are inducible by tetracycline. Addition of 1 μg/mL tetracycline in culture medium suppresses HBV replication in HepDE19 cells, whereas switching to tetracycline-free medium resumes this process.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Anti-HBV Activity in Vitro</h4><div class="NLM_p last">HepG2.2.15 cells were seeded into 96-well plates (3 × 10<sup>4</sup> cells in 100 μL of media per well) and incubated overnight at 37 °C. The test compounds were serially half-log diluted in DMSO, then diluted 100 times in culture media. Then 100 μL of diluted compounds were added into the plates to reach 0.5% final concentration of DMSO in every well. Five days after compound treatment, culture supernatant was collected for further analysis. For quantitative PCR detection of extracellular HBV DNA, 100 μL of culture supernatant was collected and processed in MagNA Pure 96 nucleic acid purification system (Roche Applied Science) for viral DNA extraction. The extracted samples were subjected to HBV DNA quantification by qPCR. The effective compound concentration at which HBV replication is inhibited by 50% (EC<sub>50</sub>) was determined.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Cytotoxicity and Selectivity Index</h4><div class="NLM_p">HepDE19 cells were seeded into 96-well plates (5 × 10<sup>3</sup> cells per well) and treated with compounds for CC<sub>50</sub> determination. Five days after treatment, cell viability was measured by addition of 20 μL of CCK-8 reagent. Two hours after incubation at 37 °C, the absorbance at wavelengths of 450 and 630 nm (OD<sub>450</sub> and OD<sub>630</sub>) was recorded by a plate reader. The concentration results in the death of 50% of the host cells (CC<sub>50</sub>) of each compound were determined.</div><div class="NLM_p last">The relative effectiveness of the compound in inhibiting viral replication compared to inducing cell death was defined as the selectivity index (CC<sub>50</sub> value/EC<sub>50</sub> value). On the basis of CC<sub>50</sub> and EC<sub>50</sub> data, selectivity indexes were determined.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> LYSA Solubility Assay</h4><div class="NLM_p last">Samples are prepared in duplicate from 10 mM DMSO stock solution. After evaporation of DMSO with a centrifugal vacuum evaporator, compounds are dissolved in a 0.05 M phosphate buffer (pH 6.5), stirred for 1 h, and shaken for 2 h. After one night, the solutions are filtered using a microtiter filter plate. Then the filtrate and its 1/10 dilution are analyzed by HPLC-UV. In addition, a four-point calibration curve is prepared from the 10 mM stock solutions and used for the solubility determination of the compounds. The results are in μg/mL. In case the percentage of sample measured in solution after evaporation divided by the calculated maximum of sample amount is bigger than 80%, the solubility is reported as bigger than this value.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Microsomal Stability Assay</h4><div class="NLM_p last">Microsomes were preincubated with test compound for 10 min at 37 °C in 100 mM potassium phosphate buffer, pH 7.4. The reactions were initiated by adding NADPH regenerating system to give a final incubation volume of 400 μL. The incubations contained (finally) 1 μM test compound, 0.5 mg/mL liver microsomal protein, 3 mM glucose 6-phosphate, 1 mM NADP, 3 mM MgCl<sub>2</sub>, and 0.05 mg/mL glucose 6-phosphate dehydrogenase in 100 mM potassium phosphate buffer, pH 7.4. After incubation times of 0, 3, 6, 9, 15, and 30 min at 37 °C, 50 μL samples were removed and transferred to 150 μL of acetonitrile containing internal standard to terminating the reaction. Following precipitation and centrifugation, the amount of compound remaining in the samples were determined by LC-MS/MS.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Parallel Artificial Membrane Permeability Assay</h4><div class="NLM_p last">The permeation of drugs was measured using a “sandwich” construction. Sample stock solution (DMSO) was diluted to 150 μM (DMSO% <2%) with donor buffer, and after the filtration the solution was added into donor plate. An acceptor plate coated with phospholipids (membrane) was placed onto the donor plate containing drug solution. Finally, the upper plate was filled with buffer solution. The donor concentration was determined at t-start as reference concentration. The drug concentrations in acceptor and donor plate were detected at t-end (∼18 h). Donor buffer is 0.05 M MOPSO buffer at pH 6.5 with 0.5% (w/v) glycocholic acid, acceptor buffer is 0.05 M MOPSO buffer at pH 6.5, and the membrane is 10% (w/v) egg lecithin with 0.5% (w/v) cholesterol in dodecane.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Plasma Protein Binding Assay</h4><div class="NLM_p last">The determination of unbound compound was performed using a 96-well format equilibrium dialysis (HTDialysis, Gales Ferry, CT, USA) with a molecular weight cutoff membrane of 12–14 kDa (HTDialysis, Gales Ferry, CT, USA) and diazepam used as positive controls. Pooled human and mouse plasma were purchased from Biopredic (Rennes, France). The equilibrium dialysis device itself is made of Teflon to minimize nonspecific binding of the test substance. For the HTD device, the dialysis membranes were conditioned as recommended by the supplier, and the dialysis plate was assembled by placing conditioned membranes between rows of half-wells and tightly clamping the assembled apparatus. Compounds were tested in cassettes of 2–5 with an initial total concentration of 1000 nM, one of the cassette compounds being the positive control. By determining the unbound fraction values for the positive control in each well, the integrity of membranes was tested. Equal volumes of matrix samples containing substances and blank dialysis buffer (Soerensen buffer at pH 7.4) were loaded into the donor and acceptor compartment,respectively. The HTD dialysis block was sealed and kept for 5 h at a temperature of 37 °C and 5% CO<sub>2</sub> environment in an incubator. At the end of dialysis, the plasma and buffer samples were retrieved and the drug concentrations quantified by LC-MS/MS.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Pharmacokinetic (PK) Analysis</h4><div class="NLM_p last">Compounds <b>10</b>, <b>60</b>, and <b>68</b> were evaluated in mice (18–25 g). Nine mice in the IV group were used for blood collection, and 24 mice in the PO group were used for blood and liver collection) at IV 1 mg/kg and PO 3 mg/kg. Compounds were dissolved in 5% DMSO, 40% PEG400, 55% saline for IV dose and 1% RC-591 in water for oral dose. Blood samples were collected at each time point and placed into tubes containing sodium heparin and centrifuged at 8000 rpm for 6 min at 4 °C to separate plasma from the samples. Following centrifugation, the resulting plasma was transferred to clean tubes and stored frozen at −80 °C pending bioanalysis. Immediately after the collection of blood, liver samples of each animal in PO group were harvested, rinsed with saline, dried with filter paper, and then the liver samples placed per animal per tissue into a tube. Liver samples were snap frozen in dry ice and then stored at −80 °C until bioanalysis. Plasma concentrations and liver concentration were determined by LC–MS/MS, and the data were analyzed by a noncompartmental module of WinNonlin Professional 5.2. Any BLQs were omitted from the calculation.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> In Vivo Efficacy in HDI Mouse Model</h4><div class="NLM_p last">The study was conducted by WuXi AppTec (Shanghai) Co., Ltd. All procedures in the study were in compliance with local animal welfare legislation, the Guide for the Care and Use of Laboratory Animals, and protocols approved by the WuXi AppTec (Shanghai) IACUC (Institutional Animal Care and Use Committee). Female BALB/c mice (6–8 weeks old) were injected throughthe tail vein with 20 μg of plasmid pcDNA3.1HBV encoding a 1.1-mer HBV genome (Genotype D) in a volume of normal saline equivalent to 8% of the mouse body weight. The total volume was delivered within a few seconds. Then 7 h post injection, mice were orally dosed by blank vehicle, 0.1 mg/kg of entecavir, or 3 mpk, and 12.5 mpk of <b>10</b> at indicated frequency for 5 days, respectively. Plasma and liver samples were collected at the indicated time points for HBV DNA quantification by real-time PCR.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Cytochrome P450 (Cyp450) Induction Screening Assay_mRNA Induction</h4><div class="NLM_p">Cryopreserved human hepatocytes were supplied by Triangle Research Laboratories and seeded according to the supplier’s protocol in supplemented Williams E medium with serum. The hepatocytes were seeded on a 96-well collagen coated plate at a seeding density of 1 × 10<sup>6</sup> hepatocytes/mL (100 μL per well). The plate was incubated at 37 °C for 4 h before the seeding medium was replaced with 100 μL of supplemented Williams E medium without serum.</div><div class="NLM_p">The cells were cultured for additional 24 h before addition of the test compound in serum-free culture media (0.1% DMSO content). Positive control inducer (rifampicin for CYP3A4) was incubated alongside the test compounds. Negative control wells were also included where the test compound or positive control inducer was replaced by vehicle alone (0.1% DMSO in Williams E media for positive controls and test compound). The experiment was performed in triplicate at six nonzero test compound concentrations and at three nonzero control compound concentrations. The cells were exposed to the solutions for 24 h.</div><div class="NLM_p">Upon completion of the 24 h incubation period, the hepatocytes were washed twice with Williams E media. The hepatocytes were then lysed by adding 100 μL of lysis binding solution (Applied Biosystems) to each well and agitated for 2 min. The lysate was stored at −80 °C until the RT-qPCR assay was performed.</div><div class="NLM_p">Total RNA was extracted from lysate using an Ambion 1830 MagMAXTM-96 Total RNA isolation procedure (Applied Biosystems). RNA quality (260:280 and 260:230 ratios) and quantity were assessed using a NanoDropTM 8000 spectrophotometer (Thermo Scientific). Reverse transcription was performed using the high capacity RNA-to-cDNA kit (Applied Biosystems) and Veriti 96 well thermal cycler (Applied Biosystems).</div><div class="NLM_p">Quantitative PCR analysis was performed on cDNA, using Applied Biosystems designed TaqMan gene expression assays for the target gene CYP3A4 and endogenous control (PPIA). Samples were analyzed using an ABI 7900 HT real-time PCR system (Applied Biosystems). Relative fold mRNA expression levels of the target genes were determined based on the threshold cycle (<i>C</i><sub>t</sub>) data of target gene relative to endogenous control for each reaction (Δ<i>C</i><sub>t</sub>), normalized to the negative control (ΔΔ<i>C</i><sub>t</sub>). Fold induction was calculated using the 2<sup>–ΔΔ<i>C</i>t</sup> method.</div><div class="NLM_p">To determine whether the levels of relative cytochrome P450 isoform mRNA expression were statistically different in the test compound samples compared to the appropriate negative controls, a one-way ANOVA with two-tailed Dunnett’s post-test was performed. A <i>p</i> value of less than 0.05 is considered to be a significant change.</div><div class="NLM_p last">A statistically significant increase in relative CYP expression in the presence of the test compound suggests the compound is inducing the cytochrome P450 isoform. Typically, the response of the test compound is compared to the inductive effect of the positive control.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00083">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00083" class="ext-link">10.1021/acs.jmedchem.7b00083</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed experimental procedures for the synthesis of analogues <b>14</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>20</b>, <b>26</b>, <b>32</b>, <b>33</b>, and <b>34</b>, amine intermediates <b>15-a</b> and <b>22-a</b>, amidine intermediates <b>39-a</b> and <b>41-a</b>, and aldehyde intermediate <b>66-a</b>. X-ray structure of (<i>R</i>)-<b>10A-2</b>, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectrum of <b>10</b>, and mechanism of action study of <b>10</b> with Cp149 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">PDF</a> )</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_001.csv">jm7b00083_si_001.csv (5.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf">jm7b00083_si_002.pdf (502.8 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code of <b>12</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE">5WRE</a>: Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00083" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong C. Shen</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#492126272e673a212c2767213a78093b262a212c672a2624"><span class="__cf_email__" data-cfemail="a4cccbcac38ad7ccc1ca8accd795e4d6cbc7ccc18ac7cbc9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guozhi Tang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7131-4678" title="Orcid link">http://orcid.org/0000-0002-7131-4678</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c2b3923362425382d222b7d0c242338212d2520622f2321"><span class="__cf_email__" data-cfemail="85e2f0eaffedecf1e4ebe2b4c5edeaf1e8e4ece9abe6eae8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Zhu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4701-2474" title="Orcid link">http://orcid.org/0000-0003-4701-2474</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c0b191552061409520b064d3c0e131f1419521f1311"><span class="__cf_email__" data-cfemail="bdcad8d493c7d5c893cac78cfdcfd2ded5d893ded2d0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zongxing Qiu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianfeng Lin</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weixing Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingwei Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Guo</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Buelent Kocer</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guolong Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhisen Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haixia Liu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Houguang Shi</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Buyu Kou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taishan Hu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yimin Hu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengwei Huang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">S. Frank Yan</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiheng Xu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Qin</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue Fen Wang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuang Ren</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongxia Qiu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuxia Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyue Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai Sun</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Zhong</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianxun Xie</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Ottaviani</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lina Zhu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojun Tian</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liping Shi</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fang Shen</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Mao</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lu Gao</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. T. Young</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Zhen Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guang Yang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander V. Mayweg</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Roche Innovation Center Basel, §Medicinal Chemistry, ∥Chemical Biology, ⊥Pharmaceutical Sciences, #Discovery Virology, Roche Pharma Research and Early Development, Bldg 5, 720 Cailun Road, Shanghai 201203, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5725-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Qinshan Gao, Yang Lu, Wenzhi Cheng, Liqin Chen, Peilan Ding, Leimin Wang, and Wei Zhang for purification of the final compounds and the analytical assistance. We thank the process group, including Jin She, Lei Li, Guocai Zhang, and Junli Chen, for their assistance with large scale synthesis campaigns. We also thank André Alker for the analysis of a single crystal X-ray structure of (<i>R</i>)-<b>10A-2</b>. In addition, we thank Wuxi and ChemPartner chemists for working together with us in some building block synthesis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">HAP</td><td class="NLM_def"><p class="first last">heteroaryldihydropyrimidine</p></td></tr><tr><td class="NLM_term">HBsAg</td><td class="NLM_def"><p class="first last">HBV surface antigen</p></td></tr><tr><td class="NLM_term">pgRNA</td><td class="NLM_def"><p class="first last">pregenomic RNA</p></td></tr><tr><td class="NLM_term">cccDNA</td><td class="NLM_def"><p class="first last">covalently closed circular DNA</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">LYSA</td><td class="NLM_def"><p class="first last">lyophilization solubility assay</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion and toxicity</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SDPK</td><td class="NLM_def"><p class="first last">single-dose pharmacokinetics</p></td></tr><tr><td class="NLM_term">HDI</td><td class="NLM_def"><p class="first last">hydrodynamic injection</p></td></tr><tr><td class="NLM_term">ETV</td><td class="NLM_def"><p class="first last">entecavir</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochromes P450</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">CCK-8</td><td class="NLM_def"><p class="first last">cell counting kit-8</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">2-propanol</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">prep-HPLC</td><td class="NLM_def"><p class="first last">preparative high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">quantitative polymerase chain reaction</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Hepatitis B; <span class="NLM_series">Fact Sheet no. 204</span>; <span class="NLM_publisher-name">World Health Organization (WHO)</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs204/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs204/en/</a> (accessed March 2, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+B%3B+Fact+Sheet+no.+204%3B+World+Health+Organization+%28WHO%29%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs204%2Fen%2F+%28accessed+March+2%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatitis%2520B%26pub%3DWorld%2520Health%2520Organization%2520%2528WHO%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Papatheodoridis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutimer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, G.</span><span> </span><span class="NLM_article-title">EASL clinical practice guidelines: management of chronic hepatitis B virus infection</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.jhep.2012.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.jhep.2012.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=22436845" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=167-185&author=G.+Papatheodoridisauthor=M.+Butiauthor=M.+Cornbergauthor=H.+Janssenauthor=D.+Mutimerauthor=S.+Polauthor=G.+Raimondo&title=EASL+clinical+practice+guidelines%3A+management+of+chronic+hepatitis+B+virus+infection&doi=10.1016%2Fj.jhep.2012.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DPapatheodoridis%26aufirst%3DG.%26aulast%3DButi%26aufirst%3DM.%26aulast%3DCornberg%26aufirst%3DM.%26aulast%3DJanssen%26aufirst%3DH.%26aulast%3DMutimer%26aufirst%3DD.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DRaimondo%26aufirst%3DG.%26atitle%3DEASL%2520clinical%2520practice%2520guidelines%253A%2520management%2520of%2520chronic%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D57%26spage%3D167%26epage%3D185%26doi%3D10.1016%2Fj.jhep.2012.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span> </span><span class="NLM_article-title">Novel therapeutics in discovery and development for treatment of chronic HBV infection</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/B978-0-12-417150-3.00017-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FB978-0-12-417150-3.00017-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=265-281&author=Y.+Huauthor=W.+Zhuauthor=G.+Tangauthor=A.+V.+Maywegauthor=G.+Yangauthor=J.+Z.+Wuauthor=H.+C.+Shen&title=Novel+therapeutics+in+discovery+and+development+for+treatment+of+chronic+HBV+infection&doi=10.1016%2FB978-0-12-417150-3.00017-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Novel therapeutics in discovery and development for treatment of chronic HBV infection</span></div><div class="casAuthors">Hu, Yimin; Zhu, Wei; Tang, Guozhi; Mayweg, Alexander V.; Yang, Guang; Wu, Jim Z.; Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-281, 1 Plate</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  As a leading cause of cirrhosis and liver cancer, chronic hepatitis B virus (HBV) infection poses a major public health threat.  Approx. 2 billion people worldwide carry evidence of prior HBV infection, and 350 million are chronic HBV carriers, resulting in an annual death toll of around 600,000.  In this review a overview about the current std. of care treatments for chronic HBV infections is given.  Addnl. selected direct acting antivirals and immune modulators under clin. development and nonnucleoside small mol. HBV inhibitors in discovery stage are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH_SG_Ly2vIbVg90H21EOLACvtfcHk0lhZz6pJsgSp_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FO&md5=188ab57bc9a947369382cf733cebfbd2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00017-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00017-X%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%2BZ.%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DNovel%2520therapeutics%2520in%2520discovery%2520and%2520development%2520for%2520treatment%2520of%2520chronic%2520HBV%2520infection%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D265%26epage%3D281%26doi%3D10.1016%2FB978-0-12-417150-3.00017-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Testoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durantel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span> </span><span class="NLM_article-title">Novel targets for hepatitis B virus therapy</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1111/liv.13307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1111%2Fliv.13307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=28052622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=33-39&issue=S1&author=B.+Testoniauthor=D.+Durantelauthor=F.+Zoulim&title=Novel+targets+for+hepatitis+B+virus+therapy&doi=10.1111%2Fliv.13307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Novel targets for hepatitis B virus therapy</span></div><div class="casAuthors">Testoni, Barbara; Durantel, David; Zoulim, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">Liver International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">LIINCM</span>;
        ISSN:<span class="NLM_cas:issn">1478-3223</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Treatment with either pegylated interferon-alpha (pegIFN-α) or last generation nucleos(t)ide analogs (NAs) successfully leads to serum viral load suppression in most chronically infected hepatitis B (CHB) patients, but HBsAg loss is only achieved in 10% of the cases after a 5-yr follow-up.  Thus, therapy must be administered long-term and it will not completely eliminate infection because of the persistent hepatitis B virus (HBV) minichromosome in infected cells, and cannot completely abolish the risk of developing severe sequelae such as cirrhosis and hepatocellular carcinoma.  Recent progress in the development of in vitro and in vivo models of HBV infection have helped renew interest in the investigation of the viral life cycle, as well as specific virus-host cell interactions to identify new targets for the development of new antiviral drugs.  This includes either direct inhibition of viral replication by targeting fundamental steps such as entry, cccDNA formation/stability, viral transcripts, capsid assembly and secretion or the manipulation of the host immune system for better defense against infection.  Multiple strategies are currently under investigation, including boosting endogenous innate responses and/or restoring adaptive immunity via engineering of HBV-specific T cells or via the use of inhibitors of neg. regulators, as well as therapeutic vaccines.  It is increasingly clear that multiple therapeutic strategies must be combined to reach a cure of HBV and that the definition of clin., virol. and immunol. correlates for the management of treatment are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpuA-v_62UbVg90H21EOLACvtfcHk0lieUda0trW0dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFWntA%253D%253D&md5=d6631b3098076a3795070480c7016998</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fliv.13307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fliv.13307%26sid%3Dliteratum%253Aachs%26aulast%3DTestoni%26aufirst%3DB.%26aulast%3DDurantel%26aufirst%3DD.%26aulast%3DZoulim%26aufirst%3DF.%26atitle%3DNovel%2520targets%2520for%2520hepatitis%2520B%2520virus%2520therapy%26jtitle%3DLiver%2520Int.%26date%3D2017%26volume%3D37%26issue%3DS1%26spage%3D33%26epage%3D39%26doi%3D10.1111%2Fliv.13307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">The current status and future directions of hepatitis B antiviral drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1080/17460441.2017.1255195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1080%2F17460441.2017.1255195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=27797587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSls7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=5-15&author=L.+Tangauthor=Q.+Zhaoauthor=S.+Wuauthor=J.+Chengauthor=J.+Changauthor=J.-T.+Guo&title=The+current+status+and+future+directions+of+hepatitis+B+antiviral+drug+discovery&doi=10.1080%2F17460441.2017.1255195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The current status and future directions of hepatitis B antiviral drug discovery</span></div><div class="casAuthors">Tang, Liudi; Zhao, Qiong; Wu, Shuo; Cheng, Junjun; Chang, Jinhong; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The current std. care of chronic hepatitis B fails to induce a durable off-drug control of hepatitis B virus (HBV) replication in the majority of treated patients.  The primary reasons are its inability to eliminate the covalently closed circular (ccc) DNA, the nuclear form of HBV genome, and restoration of the dysfunctional host antiviral immune response against the virus.  Accordingly, discovery and development of therapeutics to completely stop HBV replication, eliminate or functionally inactivate cccDNA as well as activate a functional antiviral immune response against HBV are the primary efforts for finding a cure for chronic hepatitis B.  Herein, the authors highlight the current efforts of HBV drug discovery and offer their opinions for the future directions of this research.  The authors believe that through a consecutive or overlapping three-stage antiviral and immunotherapy program to: (i) completely stop HBV replication and cccDNA amplification; (ii) reduce viral antigen load and induce HBV surface antigen (HBsAg) seroclearance through eradication or inactivation of cccDNA and RNA interference-mediated degrdn. of viral mRNA and (iii) activate a functional antiviral immune response against HBV through therapeutic immunization or immunotherapy, a functional cure of chronic HBV infection can be achieved in the majority of chronic HBV carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3PtMZrdkoM7Vg90H21EOLACvtfcHk0lieUda0trW0dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSls7%252FF&md5=e1425fe2bd4b239065211a78d19b2b1f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1255195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1255195%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DThe%2520current%2520status%2520and%2520future%2520directions%2520of%2520hepatitis%2520B%2520antiviral%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D5%26epage%3D15%26doi%3D10.1080%2F17460441.2017.1255195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewöhner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletzki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masantschek, R. N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groβ, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rübsamen-Waigmann, H.</span><span> </span><span class="NLM_article-title">Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schr%C3%B6derauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kr%C3%A4merauthor=U.+Niew%C3%B6hnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+A.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Gro%CE%B2author=B.+Beckermannauthor=K.-H.+Schlemmerauthor=D.+Haebichauthor=H.+R%C3%BCbsamen-Waigmann&title=Inhibition+of+hepatitis+B+virus+replication+by+drug-induced+depletion+of+nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0lieUda0trW0dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DT.%26aulast%3DNiew%25C3%25B6hner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%2BA.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGro%25CE%25B2%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.-H.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DR%25C3%25BCbsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520hepatitis%2520B%2520virus%2520replication%2520by%2520drug-induced%2520depletion%2520of%2520nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaifert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2687</span><span class="refDoi"> DOI: 10.1016/S0960-894X(00)00544-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FS0960-894X%2800%2900544-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=11128652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2687&author=R.+B.+Perniauthor=S.+C.+Conwayauthor=S.+K.+Ladnerauthor=K.+Zaifertauthor=M.+J.+Ottoauthor=R.+W.+King&title=Phenylpropenamide+derivatives+as+inhibitors+of+hepatitis+B+virus+replication&doi=10.1016%2FS0960-894X%2800%2900544-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication</span></div><div class="casAuthors">Perni, R. B.; Conway, S. C.; Ladner, S. K.; Zaifert, K.; Otto, M. J.; King, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2687-2690</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A non-nucleoside class of compds. that inhibits the replication of hepatitis B virus (HBV) in cell culture has been discovered.  A series of substituted analogs of phenylpropenamide has been prepd. and evaluated in the HepAD38 cellular assay.  Structure-activity relationships of this series are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcZcKEPcrqkbVg90H21EOLACvtfcHk0lierjd_kPBsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D&md5=4c3ee48f05dc8bee0724ba928d89f8a1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900544-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900544-8%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DConway%26aufirst%3DS.%2BC.%26aulast%3DLadner%26aufirst%3DS.%2BK.%26aulast%3DZaifert%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPhenylpropenamide%2520derivatives%2520as%2520inhibitors%2520of%2520hepatitis%2520B%2520virus%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2687%26doi%3D10.1016%2FS0960-894X%2800%2900544-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Campagna, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">6931</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.-T.+Guo&title=Sulfamoylbenzamide+derivatives+inhibit+the+assembly+of+hepatitis+B+virus+nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-α) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-α nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0lierjd_kPBsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DSulfamoylbenzamide%2520derivatives%2520inhibit%2520the%2520assembly%2520of%2520hepatitis%2520B%2520virus%2520nucleocapsids%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span>Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL; <span class="NLM_publisher-name">Novira Therapeutics, Inc.</span>: <span class="NLM_publisher-loc">Doylestown, PA</span>, 27 Apr<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://noviratherapeutics.com/pipeline/nvr3-778/" class="extLink">https://noviratherapeutics.com/pipeline/nvr3-778/</a> (accessed March 2, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novira+Therapeutics+Announces+Presentation+of+Preclinical+Antiviral+Data+for+NVR+3-778+at+EASL%3B+Novira+Therapeutics%2C+Inc.%3A+Doylestown%2C+PA%2C+27+Apr+2015%3B+https%3A%2F%2Fnoviratherapeutics.com%2Fpipeline%2Fnvr3-778%2F+%28accessed+March+2%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNovira%2520Therapeutics%2520Announces%2520Presentation%2520of%2520Preclinical%2520Antiviral%2520Data%2520for%2520NVR%25203-778%2520at%2520EASL%26pub%3DNovira%2520Therapeutics%252C%2520Inc%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1021/cb100275b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100275b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1125-1136&author=S.+P.+Katenauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Trapping+of+hepatitis+B+virus+capsid+assembly+intermediates+by+phenylpropenamide+assembly+accelerators&doi=10.1021%2Fcb100275b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators</span></div><div class="casAuthors">Katen, Sarah P.; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1125-1136</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the biol. self-assembly process of virus capsids is key to understanding the viral life cycle, as well as serving as a platform for the design of assembly-based antiviral drugs.  Here we identify and characterize the phenylpropenamide family of small mols., known to have antiviral activity in vivo, as assembly effectors of the hepatitis B virus (HBV) capsid.  We have found two representative phenylpropenamides to be assembly accelerators, increasing the rate of assembly with only modest increases in the stability of the HBV capsids; these data provide a phys.-chem. basis for their antiviral activity.  Unlike previously described HBV assembly effectors, the phenylpropenamides do not misdirect assembly; rather, the accelerated reactions proceed on-path to produce morphol. normal capsids.  However, capsid assembly in the presence of phenylpropenamides is characterized by kinetic trapping of assembly intermediates.  These traps resolve under conditions close to physiol., but we found that trapped intermediates persist under conditions that favor phenylpropenamide binding and strong core protein-protein interactions.  The phenylpropenamides serve as chem. probes of the HBV capsid assembly pathway by trapping on-path assembly intermediates, illustrating the governing influence of reaction kinetics on capsid assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sU96uRbhi7Vg90H21EOLACvtfcHk0lierjd_kPBsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL&md5=90a8728ca9cc6bb2ff3acf47694e0d50</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcb100275b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100275b%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DTrapping%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520intermediates%2520by%2520phenylpropenamide%2520assembly%2520accelerators%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1125%26epage%3D1136%26doi%3D10.1021%2Fcb100275b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1406</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span><span class="refDoi"> DOI: 10.1016/j.str.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.str.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=23871485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCgs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1406-1416&author=S.+P.+Katenauthor=Z.+Tanauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Assembly-directed+antivirals+differentially+bind+quasiequivalent+pockets+to+modify+hepatitis+B+virus+capsid+tertiary+and+quaternary+structure&doi=10.1016%2Fj.str.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary Structure</span></div><div class="casAuthors">Katen, Sarah P.; Tan, Zhenning; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1406-1416</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a major cause of liver disease.  Assembly of the HBV capsid is a crit. step in virus prodn. and an attractive target for new antiviral therapies.  We detd. the structure of HBV capsid in complex with AT-130, a member of the phenylpropenamide family of assembly effectors.  AT-130 causes tertiary and quaternary structural changes but does not disrupt capsid structure.  AT-130 binds a hydrophobic pocket that also accommodates the previously characterized heteroaryldihydropyrimidine compds. but favors a unique quasiequivalent location on the capsid surface.  Thus, this pocket is a promiscuous drug-binding site and a likely target for different assembly effectors with a broad range of mechanisms of activity.  That AT-130 successfully decreases virus prodn. by increasing capsid assembly rate without disrupting capsid structure delineates a paradigm in antiviral design, that disrupting reaction timing is a viable strategy for assembly effectors of HBV and other viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZur3DCpnS3LVg90H21EOLACvtfcHk0ljSujvw7TlxYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCgs7fF&md5=bb515fd504fb69f82755409c4c8f2079</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DAssembly-directed%2520antivirals%2520differentially%2520bind%2520quasiequivalent%2520pockets%2520to%2520modify%2520hepatitis%2520B%2520virus%2520capsid%2520tertiary%2520and%2520quaternary%2520structure%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1406%26epage%3D1416%26doi%3D10.1016%2Fj.str.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataiah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korba, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10270</span><span class="refDoi"> DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-molecule+effectors+of+hepatitis+B+virus+capsid+assembly+give+insight+into+virus+life+cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0ljSujvw7TlxYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-molecule%2520effectors%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520give%2520insight%2520into%2520virus%2520life%2520cycle%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Guo, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Z.</span><span> </span><span class="NLM_article-title">HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state</span> <span class="citation_source-journal">Epigenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.4161/epi.6.6.15815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.4161%2Fepi.6.6.15815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=21546797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=720-726&author=Y.-H.+Guoauthor=Y.-N.+Liauthor=J.-R.+Zhaoauthor=J.+Zhangauthor=Z.+Yan&title=HBc+binds+to+the+CpG+islands+of+HBV+cccDNA+and+promotes+an+epigenetic+permissive+state&doi=10.4161%2Fepi.6.6.15815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state</span></div><div class="casAuthors">Guo, Yan-Hai; Li, Yong-Nian; Zhao, Jin-Rong; Zhang, Ju; Yan, Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">720-726</span>CODEN:
                <span class="NLM_cas:coden">EPIGB6</span>;
        ISSN:<span class="NLM_cas:issn">1559-2294</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is the template for the transcription of HBV.  HBV core protein (HBc or HBcAg) is a main component of the HBV cccDNA minichromosome.  However, the function of HBc in cccDNA is not fully understood.  In light of recent findings that HBV cccDNA may be regulated epigenetically, we analyzed the binding of HBc to cccDNA and the impact of HBc on cccDNA epigenetic profile in the liver biopsy samples of 22 patients with chronic Hepatitis B (CHB).  We found that HBc binding to HBV cccDNA occurred preferentially at CpG island 2, an important region for the regulation of HBV transcription.  Furthermore, the relative abundances of HBc binding to CpG island 2 were pos. correlated with the ratios of relaxed circular DNA to cccDNA and the levels of serum HBV DNA in those patients.  Interestingly, the relative abundances of HBc binding to CpG island 2 were assocd. with the binding of CREB binding protein (CBP) and with hypomethylation in CpG island 2 of HBV cccDNA minichromosomes.  However, relatively higher amts. of HBc binding to CpG island 2 of cccDNA were accompanied by lower amts. of HDAC1 binding.  Multivariate anal. revealed that the abundances of HBc binding to CpG island 2 of cccDNA and pos. HBeAg were independent factors assocd. with the replication of HBV (p = 0.001 for both).  Apparently, HBc is a pos. regulator of HBV transcription and replication, maintaining the permissive epigenetic state in the crit. region of the HBV cccDNA minichromosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9wmAiX25lrVg90H21EOLACvtfcHk0ljSujvw7TlxYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gs7w%253D&md5=3057fac0de5c9a054f5ace2967f52a93</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fepi.6.6.15815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.6.6.15815%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.-H.%26aulast%3DLi%26aufirst%3DY.-N.%26aulast%3DZhao%26aufirst%3DJ.-R.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DHBc%2520binds%2520to%2520the%2520CpG%2520islands%2520of%2520HBV%2520cccDNA%2520and%2520promotes%2520an%2520epigenetic%2520permissive%2520state%26jtitle%3DEpigenetics%26date%3D2011%26volume%3D6%26spage%3D720%26epage%3D726%26doi%3D10.4161%2Fepi.6.6.15815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Twu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schloemer, R. H.</span><span> </span><span class="NLM_article-title">Hepatitis B virus suppresses expression of human β-interferon</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1073/pnas.85.1.252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.85.1.252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=252-256&author=J.+S.+Twuauthor=C.+H.+Leeauthor=P.+M.+Linauthor=R.+H.+Schloemer&title=Hepatitis+B+virus+suppresses+expression+of+human+%CE%B2-interferon&doi=10.1073%2Fpnas.85.1.252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.1.252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.1.252%26sid%3Dliteratum%253Aachs%26aulast%3DTwu%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DP.%2BM.%26aulast%3DSchloemer%26aufirst%3DR.%2BH.%26atitle%3DHepatitis%2520B%2520virus%2520suppresses%2520expression%2520of%2520human%2520%25CE%25B2-interferon%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D252%26epage%3D256%26doi%3D10.1073%2Fpnas.85.1.252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroga, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreno, V.</span><span> </span><span class="NLM_article-title">Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1099/vir.0.18966-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1099%2Fvir.0.18966-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12867637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvF2gsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=2073-2082&author=M.+Fernandezauthor=J.+A.+Quirogaauthor=V.+Carreno&title=Hepatitis+B+virus+downregulates+the+human+interferon-inducible+MxA+promoter+through+direct+interaction+of+precore%2Fcore+proteins&doi=10.1099%2Fvir.0.18966-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins</span></div><div class="casAuthors">Fernandez, Mario; Quiroga, Juan Antonio; Carreno, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2073-2082</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The human MxA protein is an interferon (IFN)-inducible GTPase with proven antiviral activity against diverse viruses.  IFN responsiveness is impaired in chronic hepatitis B virus (HBV) infection.  Accordingly, initial expts. showed that, in contrast to parental HepG2 cells, when HepG2-derived 2.2.15 liver cells carrying the HBV genome were treated with IFN, they could not synthesize the MxA protein.  Furthermore, MxA expression was reduced in HepG2 cells transiently transfected with the HBV genome.  To assess whether HBV-encoded precore/core (preC/C) proteins interact with the IFN-signalling pathway, HepG2, Chang and HeLa cells were transfected with preC/C expression plasmids; the levels of signal transducers remained unaffected.  Next, full-length and deletion mutants fused to the CAT reporter gene were tested to investigate whether MxA inhibition occurs at the promoter level.  In co-transfection expts., IFN-induced CAT activity was inhibited by preC/C expression in a dose-dependent manner.  Anal. of deletion mutants showed that the region affected by the preC/C proteins comprises IFN-stimulated response elements 2 and 3, upstream of the putative start codon of the MxA promoter.  In addn., HBV preC/C proteins interacted directly with the MxA promoter, as shown by electrophoretic mobility shift assays.  These results demonstrate a mechanism that HBV probably uses to downregulate an element of the IFN-induced host antiviral responses, which accounts for the impairment obsd. in HBV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ9Y0OvPeE17Vg90H21EOLACvtfcHk0liqUTsFCkDe8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvF2gsLY%253D&md5=051f79dbdb0dca9516aad5ed49091f82</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.18966-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.18966-0%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DQuiroga%26aufirst%3DJ.%2BA.%26aulast%3DCarreno%26aufirst%3DV.%26atitle%3DHepatitis%2520B%2520virus%2520downregulates%2520the%2520human%2520interferon-inducible%2520MxA%2520promoter%2520through%2520direct%2520interaction%2520of%2520precore%252Fcore%2520proteins%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2003%26volume%3D84%26spage%3D2073%26epage%3D2082%26doi%3D10.1099%2Fvir.0.18966-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagelschuer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewoehner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruebsamen-Waigmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfeil, S.</span><span> </span><span class="NLM_article-title">Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1016/S0166-3542(01)00216-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FS0166-3542%2801%2900216-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12062392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=69-78&author=O.+Weberauthor=K.+H.+Schlemmerauthor=E.+Hartmannauthor=I.+Hagelschuerauthor=A.+Paessensauthor=E.+Graefauthor=K.+Deresauthor=S.+Goldmannauthor=U.+Niewoehnerauthor=J.+Stoltefussauthor=D.+Haebichauthor=H.+Ruebsamen-Waigmannauthor=S.+Wohlfeil&title=Inhibition+of+human+hepatitis+B+virus+%28HBV%29+by+a+novel+non-nucleosidic+compound+in+a+transgenic+mouse+model&doi=10.1016%2FS0166-3542%2801%2900216-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model</span></div><div class="casAuthors">Weber, O.; Schlemmer, K.-H.; Hartmann, E.; Hagelschuer, Ina; Paessens, A.; Graef, E.; Deres, K.; Goldmann, S.; Niewoehner, U.; Stoltefuss, J.; Haebich, D.; Ruebsamen-Waigmann, H.; Wohlfeil, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BAY 41-4109 is a member of a class of heteroaryl-pyrimidines that was recently identified as potent inhibitors of human hepatitis B virus (HBV) replication.  We have investigated the antiviral activity of BAY 41-4109 (Me (R)-4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-pyrimidine-5-carboxylate) in HBV-transgenic mice (Tg [HBV1.3 fsX-3'5']).  Bay 41-4109 was administered per os using different schedules (b.i.d. or t.i.d. for up to 28 days) and dosages ranging from 3 to 30 mg/kg.  The compd. reduced viral DNA in the liver and in the plasma dose-dependently with efficacy comparable to 3TC.  In contrast to 3TC-treated mice, we found a redn. of cytoplasmic hepatitis B virus core antigen (HBcAg) in liver sections of BAY 41-4109-treated mice, which indicated a different mode of action.  Pharmacokinetic studies in mice have shown rapid absorption, a bioavailability of 30% and dose-proportional plasma concns.  We conclude that BAY 41-4109 is a new anti-HBV drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAj4XpaXvzGrVg90H21EOLACvtfcHk0liqUTsFCkDe8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVShsLg%253D&md5=bae520cd731096858f86f4ce28674231</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0166-3542%2801%2900216-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-3542%252801%252900216-9%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DHagelschuer%26aufirst%3DI.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DNiewoehner%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRuebsamen-Waigmann%26aufirst%3DH.%26aulast%3DWohlfeil%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520human%2520hepatitis%2520B%2520virus%2520%2528HBV%2529%2520by%2520a%2520novel%2520non-nucleosidic%2520compound%2520in%2520a%2520transgenic%2520mouse%2520model%26jtitle%3DAntiviral%2520Res.%26date%3D2002%26volume%3D54%26spage%3D69%26epage%3D78%26doi%3D10.1016%2FS0166-3542%2801%2900216-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Brezillon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massinet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berissi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belghiti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puerstinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsdorf, D.</span><span> </span><span class="NLM_article-title">Antiviral activity of Bay 41–4109 on hepatitis B virus in humanized Alb-uPA/SCID mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25096</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1371%2Fjournal.pone.0025096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25096&author=N.+Brezillonauthor=M.+N.+Brunelleauthor=H.+Massinetauthor=E.+Giangauthor=C.+Lamantauthor=L.+DaSilvaauthor=S.+Berissiauthor=J.+Belghitiauthor=L.+Hannounauthor=G.+Puerstingerauthor=E.+Wimmerauthor=J.+Neytsauthor=O.+Hantzauthor=P.+Soussanauthor=S.+Morosanauthor=D.+Kremsdorf&title=Antiviral+activity+of+Bay+41%E2%80%934109+on+hepatitis+B+virus+in+humanized+Alb-uPA%2FSCID+mice&doi=10.1371%2Fjournal.pone.0025096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025096%26sid%3Dliteratum%253Aachs%26aulast%3DBrezillon%26aufirst%3DN.%26aulast%3DBrunelle%26aufirst%3DM.%2BN.%26aulast%3DMassinet%26aufirst%3DH.%26aulast%3DGiang%26aufirst%3DE.%26aulast%3DLamant%26aufirst%3DC.%26aulast%3DDaSilva%26aufirst%3DL.%26aulast%3DBerissi%26aufirst%3DS.%26aulast%3DBelghiti%26aufirst%3DJ.%26aulast%3DHannoun%26aufirst%3DL.%26aulast%3DPuerstinger%26aufirst%3DG.%26aulast%3DWimmer%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHantz%26aufirst%3DO.%26aulast%3DSoussan%26aufirst%3DP.%26aulast%3DMorosan%26aufirst%3DS.%26aulast%3DKremsdorf%26aufirst%3DD.%26atitle%3DAntiviral%2520activity%2520of%2520Bay%252041%25E2%2580%25934109%2520on%2520hepatitis%2520B%2520virus%2520in%2520humanized%2520Alb-uPA%252FSCID%2520mice%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25096%26doi%3D10.1371%2Fjournal.pone.0025096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, M. Y.</span><span> </span><span class="NLM_article-title">NMR spectroscopy-based metabonomic approach to the analysis of Bay41–4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.toxlet.2007.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.toxlet.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=17826925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2007&pages=161-167&author=C.+Shiauthor=C.+Q.+Wuauthor=A.+M.+Caoauthor=H.+Z.+Shengauthor=X.+Z.+Yanauthor=M.+Y.+Liao&title=NMR+spectroscopy-based+metabonomic+approach+to+the+analysis+of+Bay41%E2%80%934109%2C+a+novel+anti-HBV+compound%2C+induced+hepatotoxicity+in+rats&doi=10.1016%2Fj.toxlet.2007.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span></div><div class="casAuthors">Shi, Chang; Wu, Chun-qi; Cao, An-min; Sheng, He-Zhang; Yan, Xian-zhong; Liao, Ming-yang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An integrated metabonomics study using high-resoln. 1H NMR spectroscopy has been applied to investigate the biochem. compn. of urine, serum, liver tissue aq. exts. (acetonitrile/water) and liver tissue lipidic exts. (chloroform/methanol) obtained from control and Bay41-4109 treated rats (10, 50, 400 mg kg-1 d-1 for 5 days, i.g.).  Principal components anal. was used to visualize similarities and differences in biochem. profiles.  The results showed the effects induced by Bay41-4109 at 400 mg kg-1 d-1 are different from those induced at 10, 50 mg kg-1 d-1.  The biochem. profiles of 400 mg kg-1 d-1 group might reflect the hepatotoxicity of Bay41-4109 more exactly.  The elevation in the level of 3-HB, lactate, 2-hydroxy-acetol and D-glucose was found in the urine, and the levels of VLDL/LDL(CH2)n, VLDL/LDL-CH3, 2-oxo-3-methyl-n-valerate, 3-HB, lactate, acetate, taurine, 2-hydroxy-isovalerate in serum were increased significantly in 400 mg kg-1 d-1 group.  The predominant changes identified in liver tissue aq. exts. included an increase in the signal intensities of lactate, 3-amino-isovalerate, pyruvate, choline, trimethylamine-N-oxide (TMAO) and a redn. in the intensities of taurine, hippurate and D-glucose.  In liver tissue chloroform/methanol exts., there was a remarkably increase in many of the lipid signals including the triglyceride terminal Me, methylene groups, and CH2CO, N+(CH3)3, CH2OPO2, CH2OCOR.  These observations all provide evidence that fatty acid metab. disorder and mitochondrial inability might contribute to the hepatotoxicity of Bay41-4109.  The application of 1H NMR spectroscopy to an array of biol. samples comprising urine, serum and liver tissue exts. yields new insight into the hepatotoxicity of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdIWT-FpgZLVg90H21EOLACvtfcHk0liTE8SRTWR_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP&md5=89bd5589fb93920c51723e5b75c99673</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%2BQ.%26aulast%3DCao%26aufirst%3DA.%2BM.%26aulast%3DSheng%26aufirst%3DH.%2BZ.%26aulast%3DYan%26aufirst%3DX.%2BZ.%26aulast%3DLiao%26aufirst%3DM.%2BY.%26atitle%3DNMR%2520spectroscopy-based%2520metabonomic%2520approach%2520to%2520the%2520analysis%2520of%2520Bay41%25E2%2580%25934109%252C%2520a%2520novel%2520anti-HBV%2520compound%252C%2520induced%2520hepatotoxicity%2520in%2520rats%26jtitle%3DToxicol.%2520Lett.%26date%3D2007%26volume%3D173%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.toxlet.2007.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Goldmann, S.; Stoltefub, J.; Niewöhner, U.; Schlemmer, K.-H.; Keldenich, J.; Paebens, A.; Graef, E.; Weber, O.; Deres, K.</span><span> </span><span class="NLM_article-title">Medicaments against viral disease</span>. PCT Int. Appl. WO 01/68640 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+Goldmann&author=J.+Stoltefub&author=U.+Niew%C3%B6hner&author=K.-H.+Schlemmer&author=J.+Keldenich&author=A.+Paebens&author=E.+Graef&author=O.+Weber&author=K.+Deres&title=Medicaments+against+viral+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoldmann%26aufirst%3DS.%26atitle%3DMedicaments%2520against%2520viral%2520disease%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. S.</span><span> </span><span class="NLM_article-title">In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.3851/IMP2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.3851%2FIMP2152" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=793-803&author=X.+Y.+Wangauthor=Z.+M.+Weiauthor=G.+Y.+Wuauthor=J.+H.+Wangauthor=Y.+J.+Zhangauthor=J.+Liauthor=H.+H.+Zhangauthor=X.+W.+Xieauthor=X.+Wangauthor=Z.+H.+Wangauthor=L.+Weiauthor=Y.+Wangauthor=H.+S.+Chen&title=In+vitro+inhibition+of+HBV+replication+by+a+novel+compound%2C+GLS4%2C+and+its+efficacy+against+adefovir-dipivoxil-resistant+HBV+mutations&doi=10.3851%2FIMP2152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3851%2FIMP2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2152%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DZ.%2BM.%26aulast%3DWu%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BH.%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BS.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520HBV%2520replication%2520by%2520a%2520novel%2520compound%252C%2520GLS4%252C%2520and%2520its%2520efficacy%2520against%2520adefovir-dipivoxil-resistant%2520HBV%2520mutations%26jtitle%3DAntiviral%2520Ther.%26date%3D2012%26volume%3D17%26spage%3D793%26epage%3D803%26doi%3D10.3851%2FIMP2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ren, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.bmc.2016.12.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1042-1056&author=Q.+Renauthor=X.+Liuauthor=Z.+Luoauthor=J.+Liauthor=C.+Wangauthor=S.+Goldmannauthor=J.+Zhangauthor=Y.+Zhang&title=Discovery+of+hepatitis+B+virus+capsid+assembly+inhibitors+leading+to+a+heteroaryldihydropyrimidine+based+clinical+candidate+%28GLS4%29&doi=10.1016%2Fj.bmc.2016.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520inhibitors%2520leading%2520to%2520a%2520heteroaryldihydropyrimidine%2520based%2520clinical%2520candidate%2520%2528GLS4%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1042%26epage%3D1056%26doi%3D10.1016%2Fj.bmc.2016.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15196</span><span class="NLM_x">–</span> <span class="NLM_lpage">15201</span><span class="refDoi"> DOI: 10.1073/pnas.1513803112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.1513803112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=26598693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15196-15201&author=K.+Klumppauthor=A.+M.+Lamauthor=C.+Lukacsauthor=R.+Vogelauthor=S.+Renauthor=C.+Espirituauthor=R.+Baydoauthor=K.+Atkinsauthor=J.+Abendrothauthor=G.+Liaoauthor=A.+Efimovauthor=G.+Hartmanauthor=O.+A.+Flores&title=High-resolution+crystal+structure+of+a+hepatitis+B+virus+replication+inhibitor+bound+to+the+viral+core+protein&doi=10.1073%2Fpnas.1513803112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span></div><div class="casAuthors">Klumpp, Klaus; Lam, Angela M.; Lukacs, Christine; Vogel, Robert; Ren, Suping; Espiritu, Christine; Baydo, Ruth; Atkins, Kateri; Abendroth, Jan; Liao, Guochun; Efimov, Andrey; Hartman, George; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15196-15201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The hepatitis B virus (HBV) core protein is essential for HBV replication and an important target for antiviral drug discovery.  We report the first, to our knowledge, high-resoln. crystal structure of an antiviral compd. bound to the HBV core protein.  The compd. NVR-010-001-E2 can induce assembly of the HBV core wild-type and Y132A mutant proteins and thermostabilize the proteins with a Tm increase of more than 10 °C.  NVR-010-001-E2 binds at the dimer-dimer interface of the core proteins, forms a new interaction surface promoting protein-protein interaction, induces protein assembly, and increases stability.  The impact of naturally occurring core protein mutations on antiviral activity correlates with NVR-010-001-E2 binding interactions detd. by crystallog.  The crystal structure provides understanding of a drug efficacy mechanism related to the induction and stabilization of protein-protein interactions and enables structure-guided design to improve antiviral potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYxV-odPonGbVg90H21EOLACvtfcHk0lgRdnEpkcXNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK&md5=bf487dda7165d1637fad0ebab8f46142</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1513803112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1513803112%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBaydo%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DEfimov%26aufirst%3DA.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520a%2520hepatitis%2520B%2520virus%2520replication%2520inhibitor%2520bound%2520to%2520the%2520viral%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15196%26epage%3D15201%26doi%3D10.1073%2Fpnas.1513803112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">For the impacts of lipophilicity and basicity on hERG, please see an excellent review:</p></div><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lgRdnEpkcXNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bourne, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11055</span><span class="NLM_x">–</span> <span class="NLM_lpage">11061</span><span class="refDoi"> DOI: 10.1128/JVI.00933-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.00933-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=16943288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11055-11061&author=C.+R.+Bourneauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Global+structural+changes+in+hepatitis+B+virus+capsids+induced+by+the+assembly+effector+HAP1&doi=10.1128%2FJVI.00933-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span></div><div class="casAuthors">Bourne, Christina R.; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11055-11061</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a leading cause of liver disease and hepatocellular carcinoma; over 400 million people are chronically infected with HBV.  Specific anti-HBV treatments, like most antivirals, target enzymes that are similar to host proteins.  Virus capsid protein has no human homolog, making its assembly a promising but undeveloped therapeutic target.  HAP1 [methyl 4-(2-chloro-4-fluorophenyl)-6-methyl-2-(pyridin-2-yl)-1,4-dihydropyrimidine-5-carboxylate], a heteroaryldihydropyrimidine, is a potent HBV capsid assembly activator and misdirector.  Knowledge of the structural basis for this activity would directly benefit the development of capsid-targeting therapeutic strategies.  This report details the crystal structures of icosahedral HBV capsids with and without HAP1.  We show that HAP1 leads to global structural changes by movements of subunits as connected rigid bodies.  The obsd. movements cause the fivefold vertices to protrude from the liganded capsid, the threefold vertices to open, and the quasi-sixfold vertices to flatten, explaining the effects of HAP1 on assembled capsids and on the assembly process.  We have identified a likely HAP1-binding site that bridges elements of secondary structure within a capsid-bound monomer, offering explanation for assembly activation.  This site also interferes with interactions between capsid proteins, leading to quaternary changes and presumably assembly misdirection.  These results demonstrate the plasticity of HBV capsids and the mol. basis for a tenable antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdf0rkzY6lbVg90H21EOLACvtfcHk0lgRdnEpkcXNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ&md5=9d176d66a1d3c2e323203877c225be6e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FJVI.00933-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00933-06%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DGlobal%2520structural%2520changes%2520in%2520hepatitis%2520B%2520virus%2520capsids%2520induced%2520by%2520the%2520assembly%2520effector%2520HAP1%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11055%26epage%3D11061%26doi%3D10.1128%2FJVI.00933-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Qiu, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G. Z.</span><span> </span><span class="NLM_article-title">Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B Virus (HBV) capsid inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7651</span><span class="NLM_x">–</span> <span class="NLM_lpage">7666</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7651-7666&author=Z.+X.+Qiuauthor=X.+F.+Linauthor=M.+W.+Zhouauthor=Y.+F.+Liuauthor=W.+Zhuauthor=W.+M.+Chenauthor=W.+X.+Zhangauthor=L.+Guoauthor=H.+X.+Liuauthor=G.+L.+Wuauthor=M.+W.+Huangauthor=M.+Jiangauthor=Z.+H.+Xuauthor=Z.+Zhouauthor=N.+Qinauthor=S.+Renauthor=H.+X.+Qiuauthor=S.+Zhongauthor=Y.+X.+Zhangauthor=Y.+Zhangauthor=X.+Y.+Wuauthor=L.+P.+Shiauthor=F.+Shenauthor=Y.+Maoauthor=X.+Zhouauthor=W.+G.+Yangauthor=J.+Z.+Wuauthor=G.+Yangauthor=A.+V.+Maywegauthor=H.+C.+Shenauthor=G.+Z.+Tang&title=Design+and+synthesis+of+orally+bioavailable+4-methyl+heteroaryldihydropyrimidine+based+hepatitis+B+Virus+%28HBV%29+capsid+inhibitors&doi=10.1021%2Facs.jmedchem.6b00879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00879%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%2BX.%26aulast%3DLin%26aufirst%3DX.%2BF.%26aulast%3DZhou%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DY.%2BF.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DH.%2BX.%26aulast%3DWu%26aufirst%3DG.%2BL.%26aulast%3DHuang%26aufirst%3DM.%2BW.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%2BH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DN.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DH.%2BX.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%2BY.%26aulast%3DShi%26aufirst%3DL.%2BP.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DWu%26aufirst%3DJ.%2BZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DTang%26aufirst%3DG.%2BZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520orally%2520bioavailable%25204-methyl%2520heteroaryldihydropyrimidine%2520based%2520hepatitis%2520B%2520Virus%2520%2528HBV%2529%2520capsid%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7651%26epage%3D7666%26doi%3D10.1021%2Facs.jmedchem.6b00879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Alcalde, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, N.</span><span> </span><span class="NLM_article-title">Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">42374</span><span class="refDoi"> DOI: 10.1038/srep42374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1038%2Fsrep42374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=28205569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=42374&author=Z.+Zhouauthor=T.+Huauthor=X.+Zhouauthor=S.+Wildumauthor=F.+Garcia-Alcaldeauthor=Z.+Xuauthor=D.+Wuauthor=Y.+Maoauthor=X.+Tianauthor=Y.+Zhouauthor=F.+Shenauthor=Z.+Zhangauthor=G.+Tangauthor=I.+Najeraauthor=G.+Yangauthor=H.+C.+Shenauthor=J.+A.+T.+Youngauthor=N.+Qin&title=Heteroaryldihydropyrimidine+%28HAP%29+and+sulfamoylbenzamide+%28SBA%29+inhibit+hepatitis+B+virus+replication+by+different+molecular+mechanisms&doi=10.1038%2Fsrep42374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms</span></div><div class="casAuthors">Zhou, Zheng; Hu, Taishan; Zhou, Xue; Wildum, Steffen; Garcia-Alcalde, Fernando; Xu, Zhiheng; Wu, Daitze; Mao, Yi; Tian, Xiaojun; Zhou, Yuan; Shen, Fang; Zhang, Zhisen; Tang, Guozhi; Najera, Isabel; Yang, Guang; Shen, Hong C.; Young, John A. T.; Qin, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42374</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) are promising non-nucleos(t)ide HBV replication inhibitors.  HAPs are known to promote core protein mis-assembly, but the mol. mechanism of abnormal assembly is still elusive.  Likewise, the assembly status of core protein induced by SBA remains unknown.  Here we show that SBA, unlike HAP, does not promote core protein mis-assembly.  Interestingly, two ref. compds. HAP_R01 and SBA_R01 bind to the same pocket at the dimer-dimer interface in the crystal structures of core protein Y132A hexamer.  The striking difference lies in a unique hydrophobic subpocket that is occupied by the thiazole group of HAP_R01, but is unperturbed by SBA_R01.  Photoaffinity labeling confirms the HAP_R01 binding pose at the dimer-dimer interface on capsid and suggests a new mechanism of HAP-induced mis-assembly.  Based on the common features in crystal structures we predict that T33 mutations generate similar susceptibility changes to both compds.  In contrast, mutations at positions in close contact with HAP-specific groups (P25A, P25S, or V124F) only reduce susceptibility to HAP_R01, but not to SBA_R01.  Thus, HAP and SBA are likely to have distinctive resistance profiles.  Notably, P25S and V124F substitutions exist in low-abundance quasispecies in treatment-naive patients, suggesting potential clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw-qU6eO7rCrVg90H21EOLACvtfcHk0lgHGL2HwuSafg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOiurs%253D&md5=1e401e3133194ae374435df0d0cfa637</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fsrep42374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep42374%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWildum%26aufirst%3DS.%26aulast%3DGarcia-Alcalde%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%2BT.%26aulast%3DQin%26aufirst%3DN.%26atitle%3DHeteroaryldihydropyrimidine%2520%2528HAP%2529%2520and%2520sulfamoylbenzamide%2520%2528SBA%2529%2520inhibit%2520hepatitis%2520B%2520virus%2520replication%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D42374%26doi%3D10.1038%2Fsrep42374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bondi, A.</span><span> </span><span class="NLM_article-title">Van der Waals volumes and radii</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1021/j100785a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100785a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADyaF2cXls1Cgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1964&pages=441-451&author=A.+Bondi&title=Van+der+Waals+volumes+and+radii&doi=10.1021%2Fj100785a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">van der Waals volumes and radii</span></div><div class="casAuthors">Bondi, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-51</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">Intermol. van der Waals radii of the nonmetallic elements were assembled into a list of recommended values for vol. calcns.  These values were arrived at by selecting from the most reliable x-ray diffraction data those which could be reconciled with crystal d. at 0°K. (to give reasonable packing d.), gas kinetic collision cross section, crit. d., and with liquid state properties.  A qual. understanding of the nature of van der Waals radii is provided by correlation with the de Broglie wavelength of the outermost valence electron.  Tentative values for the van der Waals radii of metallic elements in organometallic compds. are proposed.  A list of increments for the vol. of mols. impenetrable to thermal collision, the so-called van der Waals vol., and of the corresponding increments in area per mol. is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHeueZoao997Vg90H21EOLACvtfcHk0lgHGL2HwuSafg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXls1Cgsg%253D%253D&md5=0f25964afae4e9f761e0d314151444a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fj100785a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100785a001%26sid%3Dliteratum%253Aachs%26aulast%3DBondi%26aufirst%3DA.%26atitle%3DVan%2520der%2520Waals%2520volumes%2520and%2520radii%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1964%26volume%3D68%26spage%3D441%26epage%3D451%26doi%3D10.1021%2Fj100785a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althage, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisari, F. V.</span><span> </span><span class="NLM_article-title">Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">13825</span><span class="NLM_x">–</span> <span class="NLM_lpage">13830</span><span class="refDoi"> DOI: 10.1073/pnas.202398599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.202398599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12374864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13825-13830&author=P.+L.+Yangauthor=A.+Althageauthor=J.+Chungauthor=F.+V.+Chisari&title=Hydrodynamic+injection+of+viral+DNA%3A+A+mouse+model+of+acute+hepatitis+B+virus+infection&doi=10.1073%2Fpnas.202398599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection</span></div><div class="casAuthors">Yang, Priscilla L.; Althage, Alana; Chung, Josan; Chisari, Francis V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13825-13830</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a prototype for liver-specific pathogens in which the failure of the immune system to mount an effective response leads to chronic infection.  The authors' understanding of the immune response to HBV is incomplete, largely due to the narrow host restriction of this pathogen and the limitations of existing exptl. models.  The authors have developed a murine model for studying human HBV replication, immunogenicity, and control.  After transfection of hepatocytes in vivo with a replication-competent, over-length, linear HBV genome, viral antigens and replicative intermediates were synthesized and virus was secreted into the blood.  Viral antigens disappeared from the blood as early as 7 days after transfection, coincident with the appearance of antiviral antibodies.  HBV transcripts and replicative intermediates disappeared from the liver by day 15, after the appearance of antiviral CD8 + T cells.  In contrast, the virus persisted for at least 81 days after transfection of NOD/Scid mice, which lack functional T cells, B cells, and natural killer (NK) cells.  Thus, the outcome of hydrodynamic transfection of HBV depends on the host immune response, as it is during a natural infection.  The methods the authors describe will allow the examn. of viral dynamics in a tightly controlled in vivo system, the application of mutagenesis methods to the study of the HBV life cycle in vivo, and the dissection of the immune response to HBV using genetically modified mice whose immunoregulatory and immune effector functions have been deleted or overexpressed.  In addn., this methodol. represents a prototype for the study of other known and to-be-discovered liver-specific pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo98nNA_w5YxrVg90H21EOLACvtfcHk0liH9mJhDtyimg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKmtbw%253D&md5=0c0f40c386fe47f6c57c413fccdaf3e5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.202398599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.202398599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DAlthage%26aufirst%3DA.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DChisari%26aufirst%3DF.%2BV.%26atitle%3DHydrodynamic%2520injection%2520of%2520viral%2520DNA%253A%2520A%2520mouse%2520model%2520of%2520acute%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13825%26epage%3D13830%26doi%3D10.1073%2Fpnas.202398599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CYP induction-mediated drug interactions: in vitro assessment and clinical implications</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1007/s11095-006-0277-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1007%2Fs11095-006-0277-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=16718615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1089-1116&author=J.+H.+Lin&title=CYP+induction-mediated+drug+interactions%3A+in+vitro+assessment+and+clinical+implications&doi=10.1007%2Fs11095-006-0277-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1089-1116</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP) induction-mediated interaction is one of the major concerns in clin. practice and for the pharmaceutical industry.  There are two major issues assocd. with CYP induction: a redn. in therapeutic efficacy of comedications and an induction in reactive metabolite-induced toxicity.  Because CYP induction is a metabolic liability in drug therapy, it is highly desirable to develop new drug candidates that are not potent CYP inducer to avoid the potential of CYP induction-mediated drug interactions.  For this reason, today, many drug companies routinely include the assessment of CYP induction at the stage of drug discovery as part of the selection processes of new drug candidates for further clin. development.  The purpose of this article is to review the mol. mechanisms of CYP induction and the clin. implications, including pharmacokinetic and pharmacodynamic consequences.  In addn., factors that affect the degree of CYP induction and extrapolation of in vitro CYP induction data to in vivo situations will also be discussed.  Finally, assessment of the potential of CYP induction at the drug discovery and development stage will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEuHjd1GbZLLVg90H21EOLACvtfcHk0liH9mJhDtyimg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFCnsbc%253D&md5=a600296f442d8592adba814659960e6d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-0277-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-0277-7%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCYP%2520induction-mediated%2520drug%2520interactions%253A%2520in%2520vitro%2520assessment%2520and%2520clinical%2520implications%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1089%26epage%3D1116%26doi%3D10.1007%2Fs11095-006-0277-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sells, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acs, G.</span><span> </span><span class="NLM_article-title">Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1073/pnas.84.4.1005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.84.4.1005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=3029758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADyaL2sXhvV2qt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=1005-1009&author=M.+A.+Sellsauthor=M.+L.+Chenauthor=G.+Acs&title=Production+of+hepatitis+B+virus+particles+in+Hep+G2+cells+transfected+with+cloned+hepatitis+B+virus+DNA&doi=10.1073%2Fpnas.84.4.1005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA</span></div><div class="casAuthors">Sells, Mary Ann; Chen, Mei Ling; Acs, George</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1005-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The hepatoblastoma cell line Hep G2 was transfected with a plasmid carrying the gene that confers resistance to G418 and four 5'-3' tandem copies of the hepatitis B virus (HBV) genome positioned such that two dimers of the genomic DNA are 3'-3' with respect to one another.  Cells of one clone that grew in the presence of G418 produce high levels of hepatitis B e antigen and of hepatitis B surface antigen.  HBV DNA is carried by these cells as chromosomally integrated sequences and episomally as relaxed circular, covalently closed, and incomplete copies of the HBV genome.  Viral DNA was detected also in conditioned growth medium at the buoyant densities characteristic for infectious Dane and immature core particles.  Finally, HBV-specific components morphol. identical to the 22-nm spherical and filamentous hepatitis B surface antigen particles as well as 42-nm Dane particles were visualized by immunoelectron microscopic anal.  Therefore, the Hep G2 cell line can support the assembly and secretion not only of several of the replicative intermediates of HBV DNA but also of Dane-like particles.  This in vitro system can now be used to study the life cycle of HBV and the reaction of immunocompetent cells with cells carrying HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogbjqX6YU-W7Vg90H21EOLACvtfcHk0liH9mJhDtyimg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhvV2qt7c%253D&md5=27744d6955d4701586243f651c79ab1e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.4.1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.4.1005%26sid%3Dliteratum%253Aachs%26aulast%3DSells%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DM.%2BL.%26aulast%3DAcs%26aufirst%3DG.%26atitle%3DProduction%2520of%2520hepatitis%2520B%2520virus%2520particles%2520in%2520Hep%2520G2%2520cells%2520transfected%2520with%2520cloned%2520hepatitis%2520B%2520virus%2520DNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D1005%26epage%3D1009%26doi%3D10.1073%2Fpnas.84.4.1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">12472</span><span class="NLM_x">–</span> <span class="NLM_lpage">12484</span><span class="refDoi"> DOI: 10.1128/JVI.01123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.01123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=17804499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=12472-12484&author=H.+Guoauthor=D.+Jiangauthor=T.+Zhouauthor=A.+Cuconatiauthor=T.+M.+Blockauthor=J.-T.+Guo&title=Characterization+of+the+intracellular+deproteinized+relaxed+circular+DNA+of+hepatitis+B+virus%3A+an+intermediate+of+covalently+closed+circular+DNA+formation&doi=10.1128%2FJVI.01123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span></div><div class="casAuthors">Guo, Haitao; Jiang, Dong; Zhou, Tianlun; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12472-12484</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is formed by conversion of capsid-assocd. relaxed circular DNA (rcDNA) via unknown mechanisms and exists in the nucleus of the infected hepatocyte as a minichromosome that serves as the transcription template for viral RNAs.  To study the mol. pathway of cccDNA formation and its regulation by viral and cellular factors, we have established a cell line that supports the replication of an envelope protein-deficient HBV genome in a tetracycline-inducible manner.  Following induction of HBV replication, the cells accumulate higher levels of cccDNA as well as larger amts. of deproteinized rcDNA (DP-rcDNA) than cells that replicate wild-type HBV genomes.  These results indicate that HBV envelope proteins neg. regulate cccDNA formation, and conversion of DP-rcDNA into cccDNA is a rate-limiting step of cccDNA formation in HepG2 cells.  Detailed analyses reveal the following: (i) DP-rcDNA exists in both cytoplasm and nucleus; (ii) while nuclear DP-rcDNA is sensitive to DNase I digestion, a small fraction of cytoplasmic DP-rcDNA is DNase I resistant; (iii) both DNase I-sensitive and -resistant cytoplasmic DP-rcDNAs cosediment with capsids and can be immunopptd. with HBV core antibody; and (iv) a primer extension assay maps the 5' end of the minus strand of DP-rcDNA at the authentic end of virion rcDNA.  Hence, our results favor a hypothesis that the removal of viral polymerase protein covalently linked to the 5' end of the minus-strand DNA occurs inside the capsid in the cytoplasm and most possibly via a reaction that cleaves the phosphodiester bond between the tyrosine of the polymerase and the 5' phosphoryl group of minus-strand DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_WiB1hJ4zbVg90H21EOLACvtfcHk0lg9VYwc2OjyPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ&md5=91d6a9284b406680c85be2e35048d4ae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.01123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01123-07%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DCharacterization%2520of%2520the%2520intracellular%2520deproteinized%2520relaxed%2520circular%2520DNA%2520of%2520hepatitis%2520B%2520virus%253A%2520an%2520intermediate%2520of%2520covalently%2520closed%2520circular%2520DNA%2520formation%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D12472%26epage%3D12484%26doi%3D10.1128%2FJVI.01123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wuhong Chen, Feifei Liu, Qiliang Zhao, Xinna Ma, Dong Lu, Heng Li, Yanping Zeng, Xiankun Tong, Limin Zeng, Jia Liu, Li Yang, Jianping Zuo, <span class="NLM_string-name hlFld-ContribAuthor">Youhong Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8134-8145. <a href="https://doi.org/10.1021/acs.jmedchem.0c00346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPhthalazinone%252BDerivatives%252Bas%252BNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BInhibitors%26aulast%3DChen%26aufirst%3DWuhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D21072020%26volume%3D63%26issue%3D15%26spage%3D8134%26epage%3D8145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huihui Liu, Susumu Okazaki, <span class="NLM_string-name hlFld-ContribAuthor">Wataru Shinoda</span>. </span><span class="cited-content_cbyCitation_article-title">Heteroaryldihydropyrimidines Alter Capsid Assembly By Adjusting the Binding Affinity and Pattern of the Hepatitis B Virus Core Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5104-5110. <a href="https://doi.org/10.1021/acs.jcim.9b01010" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b01010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b01010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b01010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHeteroaryldihydropyrimidines%252BAlter%252BCapsid%252BAssembly%252BBy%252BAdjusting%252Bthe%252BBinding%252BAffinity%252Band%252BPattern%252Bof%252Bthe%252BHepatitis%252BB%252BVirus%252BCore%252BProtein%26aulast%3DLiu%26aufirst%3DHuihui%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31102019%26date%3D05122019%26date%3D22112019%26volume%3D59%26issue%3D12%26spage%3D5104%26epage%3D5110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xianfeng Lin, Houguang Shi, Weixing Zhang, Zongxing Qiu, Zheng Zhou, Fabian Dey, Sheng Zhong, Hongxia Qiu, Jianxun Xie, Xue Zhou, Guang Yang, Guozhi Tang, Hong C. Shen, <span class="NLM_string-name hlFld-ContribAuthor">Wei Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10352-10361. <a href="https://doi.org/10.1021/acs.jmedchem.9b01421" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01421%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNew%252BApproach%252Bof%252BMitigating%252BCYP3A4%252BInduction%252BLed%252Bto%252Bthe%252BDiscovery%252Bof%252BPotent%252BHepatitis%252BB%252BVirus%252B%252528HBV%252529%252BCapsid%252BInhibitor%252Bwith%252BOptimal%252BADMET%252BProfiles%26aulast%3DLin%26aufirst%3DXianfeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27082019%26date%3D18112019%26date%3D05112019%26volume%3D62%26issue%3D22%26spage%3D10352%26epage%3D10361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuexiang Zhang, Junjun Cheng, Julia Ma, Zhanying Hu, Shuo Wu, Nicky Hwang, John Kulp, Yanming Du, Ju-Tao Guo, <span class="NLM_string-name hlFld-ContribAuthor">Jinhong Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (5)
                                     , 759-768. <a href="https://doi.org/10.1021/acsinfecdis.8b00269" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00269%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDiscovery%252Bof%252BNovel%252BHepatitis%252BB%252BVirus%252BNucleocapsid%252BAssembly%252BInhibitors%26aulast%3DZhang%26aufirst%3DXuexiang%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12102018%26date%3D19122018%26date%3D10122018%26volume%3D5%26issue%3D5%26spage%3D759%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Song Feng, Lu Gao, Xingchun Han, Taishan Hu, Yimin Hu, Haixia Liu, Andrew W. Thomas, Zhipeng Yan, Song Yang, John A. T. Young, Hongying Yun, Wei Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Hong C. Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2018,</strong> <em>4 </em>
                                    (3)
                                     , 257-277. <a href="https://doi.org/10.1021/acsinfecdis.7b00144" title="DOI URL">https://doi.org/10.1021/acsinfecdis.7b00144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.7b00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.7b00144%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDiscovery%252Bof%252BSmall%252BMolecule%252BTherapeutics%252Bfor%252BTreatment%252Bof%252BChronic%252BHBV%252BInfection%26aulast%3DFeng%26aufirst%3DSong%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04092017%26date%3D12022018%26date%3D25012018%26volume%3D4%26issue%3D3%26spage%3D257%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingyun  Ren</span>, <span class="hlFld-ContribAuthor ">Xinchang  Liu</span>, <span class="hlFld-ContribAuthor ">Guanghua  Yan</span>, <span class="hlFld-ContribAuthor ">Biao  Nie</span>, <span class="hlFld-ContribAuthor ">Zhifu  Zou</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yunfu  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Wei</span>, <span class="hlFld-ContribAuthor ">Jianzhou  Huang</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Baohua  Gu</span>, <span class="hlFld-ContribAuthor ">Siegfried  Goldmann</span>, <span class="hlFld-ContribAuthor ">Jiancun  Zhang</span>, and <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1355-1374. <a href="https://doi.org/10.1021/acs.jmedchem.7b01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-%252528%252528R%252529-4-%252528%252528%252528R%252529-6-%2525282-Bromo-4-fluorophenyl%252529-5-%252528ethoxycarbonyl%252529-2-%252528thiazol-2-yl%252529-3%25252C6-dihydropyrimidin-4-yl%252529methyl%252529morpholin-2-yl%252529propanoic%252BAcid%252B%252528HEC72702%252529%25252C%252Ba%252BNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BInhibitor%252BBased%252Bon%252BClinical%252BCandidate%252BGLS4%26aulast%3DRen%26aufirst%3DQingyun%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28122017%26date%3D30012018%26date%3D08022018%26volume%3D61%26issue%3D3%26spage%3D1355%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Sauviller</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Steffen  Jaensch</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Gustin</span>, <span class="hlFld-ContribAuthor ">Danielle  Peeters</span>, <span class="hlFld-ContribAuthor ">Peter  Vermeulen</span>, <span class="hlFld-ContribAuthor ">Dirk  Wuyts</span>, <span class="hlFld-ContribAuthor ">Koen  Vandyck</span>, <span class="hlFld-ContribAuthor ">Frederik  Pauwels</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virological Methods</span><span> <strong>2021,</strong> <em>293 </em>, 114150. <a href="https://doi.org/10.1016/j.jviromet.2021.114150" title="DOI URL">https://doi.org/10.1016/j.jviromet.2021.114150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jviromet.2021.114150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jviromet.2021.114150%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virological%2520Methods%26atitle%3DDevelopment%252Bof%252Ba%252Bcellular%252Bhigh-content%25252C%252Bimmunofluorescent%252BHBV%252Bcore%252Bassay%252Bto%252Bidentify%252Bnovel%252Bcapsid%252Bassembly%252Bmodulators%252Bthat%252Binduce%252Bthe%252Bformation%252Bof%252Baberrant%252BHBV%252Bcore%252Bstructures%26aulast%3DSauviller%26aufirst%3DSarah%26date%3D2021%26volume%3D293%26spage%3D114150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Erik  Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐DNA Virus Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-41. <a href="https://doi.org/10.1002/0471266949.bmc237.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc237.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc237.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc237.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590DNA%252BVirus%252BAgents%26aulast%3DHerdewijn%26aufirst%3DPiet%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D41%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhe  Wang</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Liu</span>, <span class="hlFld-ContribAuthor ">Yunwen  Wang</span>, <span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>, 116096. <a href="https://doi.org/10.1016/j.bmc.2021.116096" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BHBV%252Bcapsid%252Bassembly%252Bmodulators%252Bby%252Bstructure-based%252Bvirtual%252Bscreening%252Band%252Bbioassays%26aulast%3DWang%26aufirst%3DYuan%26date%3D2021%26volume%3D36%26spage%3D116096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ma</span>, <span class="hlFld-ContribAuthor ">Wen-guang  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-ding  Liu</span>, <span class="hlFld-ContribAuthor ">Chang-cheng  Xi</span>, <span class="hlFld-ContribAuthor ">Fei  Xiong</span>, <span class="hlFld-ContribAuthor ">Shu-ping  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Docking and 3D-QSAR Studies on a Series of Benzenesulfonamide Derivatives as a Hepatitis B Virus Capsid Assembly Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>39 </em>, 1-16. <a href="https://doi.org/10.1080/10406638.2020.1871038" title="DOI URL">https://doi.org/10.1080/10406638.2020.1871038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1871038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1871038%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DMolecular%252BDocking%252Band%252B3D-QSAR%252BStudies%252Bon%252Ba%252BSeries%252Bof%252BBenzenesulfonamide%252BDerivatives%252Bas%252Ba%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BInhibitor%26aulast%3DMa%26aufirst%3DChao%26date%3D2021%26date%3D2021%26volume%3D39%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Verbinnen</span>, <span class="hlFld-ContribAuthor ">Ying  Tan</span>, <span class="hlFld-ContribAuthor ">Gengyan  Wang</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Neefs</span>, <span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>, <span class="hlFld-ContribAuthor ">Oliver  Lenz</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2020,</strong> <em>75 </em>
                                    (9)
                                     , 2526-2534. <a href="https://doi.org/10.1093/jac/dkaa179" title="DOI URL">https://doi.org/10.1093/jac/dkaa179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dkaa179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdkaa179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DAnti-HBV%252Bactivity%252Bof%252Bthe%252BHBV%252Bcapsid%252Bassembly%252Bmodulator%252BJNJ-56136379%252Bacross%252Bfull-length%252Bgenotype%252BA%2525E2%252580%252593H%252Bclinical%252Bisolates%252Band%252Bcore%252Bsite-directed%252Bmutants%252Bin%252Bvitro%26aulast%3DVerbinnen%26aufirst%3DThierry%26date%3D2020%26date%3D2020%26volume%3D75%26issue%3D9%26spage%3D2526%26epage%3D2534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Haiyong  Jia</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Guo</span>, <span class="hlFld-ContribAuthor ">Samuel  Desta</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Liang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (6)
                                     , 567-583. <a href="https://doi.org/10.1111/cbdd.13512" title="DOI URL">https://doi.org/10.1111/cbdd.13512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnovel%252Bheteroaryldihydropyrimidine%252Bderivatives%252Bas%252Bnon%2525E2%252580%252590nucleoside%252Bhepatitis%252BB%252Bvirus%252Binhibitors%252Bby%252Bexploring%252Bthe%252Bsolvent%2525E2%252580%252590exposed%252Bregion%26aulast%3DYu%26aufirst%3DJi%26date%3D2020%26date%3D2020%26volume%3D95%26issue%3D6%26spage%3D567%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunkyu  Ko</span>, <span class="hlFld-ContribAuthor ">Romina  Bester</span>, <span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Xu</span>, <span class="hlFld-ContribAuthor ">Christoph  Blossey</span>, <span class="hlFld-ContribAuthor ">Julia  Sacherl</span>, <span class="hlFld-ContribAuthor ">Florian W. R.  Vondran</span>, <span class="hlFld-ContribAuthor ">Lu  Gao</span>, <span class="hlFld-ContribAuthor ">Ulrike  Protzer</span>. </span><span class="cited-content_cbyCitation_article-title">A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>64 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/AAC.01440-19" title="DOI URL">https://doi.org/10.1128/AAC.01440-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01440-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01440-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DA%252BNew%252BRole%252Bfor%252BCapsid%252BAssembly%252BModulators%252BTo%252BTarget%252BMature%252BHepatitis%252BB%252BVirus%252BCapsids%252Band%252BPrevent%252BVirus%252BInfection%26aulast%3DKo%26aufirst%3DChunkyu%26date%3D2019%26volume%3D64%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-Ah  Kang</span>, <span class="hlFld-ContribAuthor ">Songwon  Kim</span>, <span class="hlFld-ContribAuthor ">Minji  Park</span>, <span class="hlFld-ContribAuthor ">Hyun-Jin  Park</span>, <span class="hlFld-ContribAuthor ">Jeong-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Sanghyeok  Park</span>, <span class="hlFld-ContribAuthor ">Jeong-Ryul  Hwang</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon  Jun Kim</span>, <span class="hlFld-ContribAuthor ">Yuri  Cho</span>, <span class="hlFld-ContribAuthor ">Mi  Sun Jin</span>, <span class="hlFld-ContribAuthor ">Sung-Gyoo  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-10200-5" title="DOI URL">https://doi.org/10.1038/s41467-019-10200-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-10200-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-10200-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DCiclopirox%252Binhibits%252BHepatitis%252BB%252BVirus%252Bsecretion%252Bby%252Bblocking%252Bcapsid%252Bassembly%26aulast%3DKang%26aufirst%3DJung-Ah%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Yan</span>, <span class="hlFld-ContribAuthor ">Daitze  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Hu</span>, <span class="hlFld-ContribAuthor ">Jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Xin  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Xu</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">John A.T.  Young</span>, <span class="hlFld-ContribAuthor ">Lu  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2019,</strong> <em>70 </em>
                                    (1)
                                     , 11-24. <a href="https://doi.org/10.1002/hep.30514" title="DOI URL">https://doi.org/10.1002/hep.30514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.30514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.30514%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DDirect%252BInhibition%252Bof%252BHepatitis%252BB%252Be%252BAntigen%252Bby%252BCore%252BProtein%252BAllosteric%252BModulator%26aulast%3DYan%26aufirst%3DZhipeng%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D1%26spage%3D11%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavitavya  Nijampatnam</span>, <span class="hlFld-ContribAuthor ">Dennis C  Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of HBV capsid assembly modulators. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>50 </em>, 73-79. <a href="https://doi.org/10.1016/j.cbpa.2019.02.009" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252BHBV%252Bcapsid%252Bassembly%252Bmodulators%26aulast%3DNijampatnam%26aufirst%3DBhavitavya%26date%3D2019%26volume%3D50%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li Ting  Song</span>, <span class="hlFld-ContribAuthor ">Rui Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Ya Jie  Meng</span>, <span class="hlFld-ContribAuthor ">Min  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2019,</strong> <em>663 </em>, 1-10. <a href="https://doi.org/10.1016/j.abb.2018.12.029" title="DOI URL">https://doi.org/10.1016/j.abb.2018.12.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2018.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2018.12.029%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DMolecular%252Bmechanisms%252Bof%252Btetrahydropyrrolo%25255B1%25252C2-c%25255Dpyrimidines%252Bas%252BHBV%252Bcapsid%252Bassembly%252Binhibitors%26aulast%3DSong%26aufirst%3DLi%2BTing%26date%3D2019%26volume%3D663%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Pan</span>, <span class="hlFld-ContribAuthor ">Yanchao  Ding</span>, <span class="hlFld-ContribAuthor ">Liyang  Wu</span>, <span class="hlFld-ContribAuthor ">Liting  Liang</span>, <span class="hlFld-ContribAuthor ">Xin  He</span>, <span class="hlFld-ContribAuthor ">Qianwen  Li</span>, <span class="hlFld-ContribAuthor ">Chuan  Bai</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 480-501. <a href="https://doi.org/10.1016/j.ejmech.2019.01.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Baminothiazole%252Bbased%252BHepatitis%252BB%252BVirus%252B%252528HBV%252529%252Bcapsid%252Binhibitors%26aulast%3DPan%26aufirst%3DTing%26date%3D2019%26volume%3D166%26spage%3D480%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Dallas L.  Pineda</span>, <span class="hlFld-ContribAuthor ">Kelsey N.  Boschert</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Wolf</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 179-192. <a href="https://doi.org/10.1016/j.ejmech.2018.12.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Aminothiophene-2%25252C4-dicarboxamide%252Banalogues%252Bas%252Bhepatitis%252BB%252Bvirus%252Bcapsid%252Bassembly%252Beffectors%26aulast%3DTang%26aufirst%3DJing%26date%3D2019%26volume%3D164%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Wolf</span>, <span class="hlFld-ContribAuthor ">Dandan  Liu</span>, <span class="hlFld-ContribAuthor ">Anna T.  Gres</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Kelsey N.  Boschert</span>, <span class="hlFld-ContribAuthor ">Maritza N.  Puray-Chavez</span>, <span class="hlFld-ContribAuthor ">Dallas L.  Pineda</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Laughlin</span>, <span class="hlFld-ContribAuthor ">Emily M.  Coonrod</span>, <span class="hlFld-ContribAuthor ">Qiongying  Yang</span>, <span class="hlFld-ContribAuthor ">Juan  Ji</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, , <span class="hlFld-ContribAuthor ">Nathan  Sherer</span>, <span class="hlFld-ContribAuthor ">Priscilla L.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells. </span><span class="cited-content_cbyCitation_journal-name">mSphere</span><span> <strong>2018,</strong> <em>3 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/mSphereDirect.00131-18" title="DOI URL">https://doi.org/10.1128/mSphereDirect.00131-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mSphereDirect.00131-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmSphereDirect.00131-18%26sid%3Dliteratum%253Aachs%26jtitle%3DmSphere%26atitle%3DThe%252BHeteroaryldihydropyrimidine%252BBay%252B38-7690%252BInduces%252BHepatitis%252BB%252BVirus%252BCore%252BProtein%252BAggregates%252BAssociated%252Bwith%252BPromyelocytic%252BLeukemia%252BNuclear%252BBodies%252Bin%252BInfected%252BCells%26aulast%3DHuber%26aufirst%3DAndrew%2BD.%26date%3D2018%26volume%3D3%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher John  Schlicksup</span>, <span class="hlFld-ContribAuthor ">Joseph Che-Yen  Wang</span>, <span class="hlFld-ContribAuthor ">Samson  Francis</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Venkatakrishnan</span>, <span class="hlFld-ContribAuthor ">William W  Turner</span>, <span class="hlFld-ContribAuthor ">Michael  VanNieuwenhze</span>, <span class="hlFld-ContribAuthor ">Adam  Zlotnick</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2018,</strong> <em>7 </em><a href="https://doi.org/10.7554/eLife.31473" title="DOI URL">https://doi.org/10.7554/eLife.31473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.31473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.31473%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DHepatitis%252BB%252Bvirus%252Bcore%252Bprotein%252Ballosteric%252Bmodulators%252Bcan%252Bdistort%252Band%252Bdisrupt%252Bintact%252Bcapsids%26aulast%3DSchlicksup%26aufirst%3DChristopher%2BJohn%26date%3D2018%26date%3D2018%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuye  Zhang</span>, <span class="hlFld-ContribAuthor ">Fusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances in the elimination of hepatitis B in China by 2030. </span><span class="cited-content_cbyCitation_journal-name">Frontiers of Medicine</span><span> <strong>2017,</strong> <em>11 </em>
                                    (4)
                                     , 490-501. <a href="https://doi.org/10.1007/s11684-017-0598-4" title="DOI URL">https://doi.org/10.1007/s11684-017-0598-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11684-017-0598-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11684-017-0598-4%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520of%2520Medicine%26atitle%3DCurrent%252Badvances%252Bin%252Bthe%252Belimination%252Bof%252Bhepatitis%252BB%252Bin%252BChina%252Bby%252B2030%26aulast%3DZhang%26aufirst%3DShuye%26date%3D2017%26date%3D2017%26volume%3D11%26issue%3D4%26spage%3D490%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Alonso</span>, <span class="hlFld-ContribAuthor ">Adriana-René  Guerra</span>, <span class="hlFld-ContribAuthor ">Lourdes  Carreira</span>, <span class="hlFld-ContribAuthor ">Juan-Ángel  Ferrer</span>, <span class="hlFld-ContribAuthor ">María-Luisa  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Conrado M.  Fernandez-Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?. </span><span class="cited-content_cbyCitation_journal-name">BMC Gastroenterology</span><span> <strong>2017,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12876-017-0726-2" title="DOI URL">https://doi.org/10.1186/s12876-017-0726-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12876-017-0726-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12876-017-0726-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Gastroenterology%26atitle%3DUpcoming%252Bpharmacological%252Bdevelopments%252Bin%252Bchronic%252Bhepatitis%252BB%25253A%252Bcan%252Bwe%252Bglimpse%252Ba%252Bcure%252Bon%252Bthe%252Bhorizon%25253F%26aulast%3DAlonso%26aufirst%3DSonia%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Muhammad  Sheraz</span>, <span class="hlFld-ContribAuthor ">Junjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Yonghe  Qi</span>, <span class="hlFld-ContribAuthor ">Qing  Su</span>, <span class="hlFld-ContribAuthor ">Andrea  Cuconati</span>, <span class="hlFld-ContribAuthor ">Lai  Wei</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>, <span class="hlFld-ContribAuthor ">Wenhui  Li</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>, . </span><span class="cited-content_cbyCitation_article-title">HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2017,</strong> <em>13 </em>
                                    (9)
                                     , e1006658. <a href="https://doi.org/10.1371/journal.ppat.1006658" title="DOI URL">https://doi.org/10.1371/journal.ppat.1006658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1006658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1006658%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DHBV%252Bcore%252Bprotein%252Ballosteric%252Bmodulators%252Bdifferentially%252Balter%252BcccDNA%252Bbiosynthesis%252Bfrom%252Bde%252Bnovo%252Binfection%252Band%252Bintracellular%252Bamplification%252Bpathways%26aulast%3DGuo%26aufirst%3DFang%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D9%26spage%3De1006658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative HBV capsid assembly effectors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of Cp149 Y132A in complex with <b>12</b>. Compound <b>12</b> is highlighted in cyan sticks. The dimer forming the concave for the binding pocket is shown in light green. The dimer forming the cap for the binding pocket is colored in dark green. Black dash lines represent the key hydrogen bonds. PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE">5WRE</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Levels of HBV DNA in plasma (A) and liver (B) of HBV HDI mice upon treatment with the vehicle control, ETV control, and compound <b>10</b>. The HBV DNA copy numbers were quantified by real-time qPCR. Error bars indicate standard error of the mean (six mice per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/medium/jm-2017-00083p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00083/20170421/images/large/jm-2017-00083p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00083&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe, MeOH, rt, 3 h, then NH<sub>4</sub>Cl, overnight, 100% (crude); (b) KOAc, CF<sub>3</sub>CH<sub>2</sub>OH, reflux, 16 h, 60% for two steps from thiazole-2-carbonitrile; (c) SFC chiral separation; (d) NBS, CCl<sub>4</sub>, rt, 1 h, 77%; (e) DIPEA, DCM, ca. 1 h, 55%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Hepatitis B; <span class="NLM_series">Fact Sheet no. 204</span>; <span class="NLM_publisher-name">World Health Organization (WHO)</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs204/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs204/en/</a> (accessed March 2, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+B%3B+Fact+Sheet+no.+204%3B+World+Health+Organization+%28WHO%29%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs204%2Fen%2F+%28accessed+March+2%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatitis%2520B%26pub%3DWorld%2520Health%2520Organization%2520%2528WHO%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Papatheodoridis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutimer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, G.</span><span> </span><span class="NLM_article-title">EASL clinical practice guidelines: management of chronic hepatitis B virus infection</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.jhep.2012.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.jhep.2012.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=22436845" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=167-185&author=G.+Papatheodoridisauthor=M.+Butiauthor=M.+Cornbergauthor=H.+Janssenauthor=D.+Mutimerauthor=S.+Polauthor=G.+Raimondo&title=EASL+clinical+practice+guidelines%3A+management+of+chronic+hepatitis+B+virus+infection&doi=10.1016%2Fj.jhep.2012.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DPapatheodoridis%26aufirst%3DG.%26aulast%3DButi%26aufirst%3DM.%26aulast%3DCornberg%26aufirst%3DM.%26aulast%3DJanssen%26aufirst%3DH.%26aulast%3DMutimer%26aufirst%3DD.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DRaimondo%26aufirst%3DG.%26atitle%3DEASL%2520clinical%2520practice%2520guidelines%253A%2520management%2520of%2520chronic%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D57%26spage%3D167%26epage%3D185%26doi%3D10.1016%2Fj.jhep.2012.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span> </span><span class="NLM_article-title">Novel therapeutics in discovery and development for treatment of chronic HBV infection</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/B978-0-12-417150-3.00017-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FB978-0-12-417150-3.00017-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=265-281&author=Y.+Huauthor=W.+Zhuauthor=G.+Tangauthor=A.+V.+Maywegauthor=G.+Yangauthor=J.+Z.+Wuauthor=H.+C.+Shen&title=Novel+therapeutics+in+discovery+and+development+for+treatment+of+chronic+HBV+infection&doi=10.1016%2FB978-0-12-417150-3.00017-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Novel therapeutics in discovery and development for treatment of chronic HBV infection</span></div><div class="casAuthors">Hu, Yimin; Zhu, Wei; Tang, Guozhi; Mayweg, Alexander V.; Yang, Guang; Wu, Jim Z.; Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-281, 1 Plate</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  As a leading cause of cirrhosis and liver cancer, chronic hepatitis B virus (HBV) infection poses a major public health threat.  Approx. 2 billion people worldwide carry evidence of prior HBV infection, and 350 million are chronic HBV carriers, resulting in an annual death toll of around 600,000.  In this review a overview about the current std. of care treatments for chronic HBV infections is given.  Addnl. selected direct acting antivirals and immune modulators under clin. development and nonnucleoside small mol. HBV inhibitors in discovery stage are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH_SG_Ly2vIbVg90H21EOLACvtfcHk0lglxG8kh7RoSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu7%252FO&md5=188ab57bc9a947369382cf733cebfbd2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00017-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00017-X%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%2BZ.%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DNovel%2520therapeutics%2520in%2520discovery%2520and%2520development%2520for%2520treatment%2520of%2520chronic%2520HBV%2520infection%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D265%26epage%3D281%26doi%3D10.1016%2FB978-0-12-417150-3.00017-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Testoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durantel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span> </span><span class="NLM_article-title">Novel targets for hepatitis B virus therapy</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1111/liv.13307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1111%2Fliv.13307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=28052622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=33-39&issue=S1&author=B.+Testoniauthor=D.+Durantelauthor=F.+Zoulim&title=Novel+targets+for+hepatitis+B+virus+therapy&doi=10.1111%2Fliv.13307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Novel targets for hepatitis B virus therapy</span></div><div class="casAuthors">Testoni, Barbara; Durantel, David; Zoulim, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">Liver International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">LIINCM</span>;
        ISSN:<span class="NLM_cas:issn">1478-3223</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Treatment with either pegylated interferon-alpha (pegIFN-α) or last generation nucleos(t)ide analogs (NAs) successfully leads to serum viral load suppression in most chronically infected hepatitis B (CHB) patients, but HBsAg loss is only achieved in 10% of the cases after a 5-yr follow-up.  Thus, therapy must be administered long-term and it will not completely eliminate infection because of the persistent hepatitis B virus (HBV) minichromosome in infected cells, and cannot completely abolish the risk of developing severe sequelae such as cirrhosis and hepatocellular carcinoma.  Recent progress in the development of in vitro and in vivo models of HBV infection have helped renew interest in the investigation of the viral life cycle, as well as specific virus-host cell interactions to identify new targets for the development of new antiviral drugs.  This includes either direct inhibition of viral replication by targeting fundamental steps such as entry, cccDNA formation/stability, viral transcripts, capsid assembly and secretion or the manipulation of the host immune system for better defense against infection.  Multiple strategies are currently under investigation, including boosting endogenous innate responses and/or restoring adaptive immunity via engineering of HBV-specific T cells or via the use of inhibitors of neg. regulators, as well as therapeutic vaccines.  It is increasingly clear that multiple therapeutic strategies must be combined to reach a cure of HBV and that the definition of clin., virol. and immunol. correlates for the management of treatment are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpuA-v_62UbVg90H21EOLACvtfcHk0lglxG8kh7RoSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFWntA%253D%253D&md5=d6631b3098076a3795070480c7016998</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fliv.13307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fliv.13307%26sid%3Dliteratum%253Aachs%26aulast%3DTestoni%26aufirst%3DB.%26aulast%3DDurantel%26aufirst%3DD.%26aulast%3DZoulim%26aufirst%3DF.%26atitle%3DNovel%2520targets%2520for%2520hepatitis%2520B%2520virus%2520therapy%26jtitle%3DLiver%2520Int.%26date%3D2017%26volume%3D37%26issue%3DS1%26spage%3D33%26epage%3D39%26doi%3D10.1111%2Fliv.13307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">The current status and future directions of hepatitis B antiviral drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1080/17460441.2017.1255195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1080%2F17460441.2017.1255195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=27797587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSls7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=5-15&author=L.+Tangauthor=Q.+Zhaoauthor=S.+Wuauthor=J.+Chengauthor=J.+Changauthor=J.-T.+Guo&title=The+current+status+and+future+directions+of+hepatitis+B+antiviral+drug+discovery&doi=10.1080%2F17460441.2017.1255195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The current status and future directions of hepatitis B antiviral drug discovery</span></div><div class="casAuthors">Tang, Liudi; Zhao, Qiong; Wu, Shuo; Cheng, Junjun; Chang, Jinhong; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The current std. care of chronic hepatitis B fails to induce a durable off-drug control of hepatitis B virus (HBV) replication in the majority of treated patients.  The primary reasons are its inability to eliminate the covalently closed circular (ccc) DNA, the nuclear form of HBV genome, and restoration of the dysfunctional host antiviral immune response against the virus.  Accordingly, discovery and development of therapeutics to completely stop HBV replication, eliminate or functionally inactivate cccDNA as well as activate a functional antiviral immune response against HBV are the primary efforts for finding a cure for chronic hepatitis B.  Herein, the authors highlight the current efforts of HBV drug discovery and offer their opinions for the future directions of this research.  The authors believe that through a consecutive or overlapping three-stage antiviral and immunotherapy program to: (i) completely stop HBV replication and cccDNA amplification; (ii) reduce viral antigen load and induce HBV surface antigen (HBsAg) seroclearance through eradication or inactivation of cccDNA and RNA interference-mediated degrdn. of viral mRNA and (iii) activate a functional antiviral immune response against HBV through therapeutic immunization or immunotherapy, a functional cure of chronic HBV infection can be achieved in the majority of chronic HBV carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3PtMZrdkoM7Vg90H21EOLACvtfcHk0ljftMywNLcyeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSls7%252FF&md5=e1425fe2bd4b239065211a78d19b2b1f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1255195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1255195%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DThe%2520current%2520status%2520and%2520future%2520directions%2520of%2520hepatitis%2520B%2520antiviral%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D5%26epage%3D15%26doi%3D10.1080%2F17460441.2017.1255195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewöhner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletzki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masantschek, R. N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groβ, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rübsamen-Waigmann, H.</span><span> </span><span class="NLM_article-title">Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schr%C3%B6derauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kr%C3%A4merauthor=U.+Niew%C3%B6hnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+A.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Gro%CE%B2author=B.+Beckermannauthor=K.-H.+Schlemmerauthor=D.+Haebichauthor=H.+R%C3%BCbsamen-Waigmann&title=Inhibition+of+hepatitis+B+virus+replication+by+drug-induced+depletion+of+nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0ljftMywNLcyeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DT.%26aulast%3DNiew%25C3%25B6hner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%2BA.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGro%25CE%25B2%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.-H.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DR%25C3%25BCbsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520hepatitis%2520B%2520virus%2520replication%2520by%2520drug-induced%2520depletion%2520of%2520nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaifert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2687</span><span class="refDoi"> DOI: 10.1016/S0960-894X(00)00544-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FS0960-894X%2800%2900544-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=11128652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2687&author=R.+B.+Perniauthor=S.+C.+Conwayauthor=S.+K.+Ladnerauthor=K.+Zaifertauthor=M.+J.+Ottoauthor=R.+W.+King&title=Phenylpropenamide+derivatives+as+inhibitors+of+hepatitis+B+virus+replication&doi=10.1016%2FS0960-894X%2800%2900544-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication</span></div><div class="casAuthors">Perni, R. B.; Conway, S. C.; Ladner, S. K.; Zaifert, K.; Otto, M. J.; King, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2687-2690</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A non-nucleoside class of compds. that inhibits the replication of hepatitis B virus (HBV) in cell culture has been discovered.  A series of substituted analogs of phenylpropenamide has been prepd. and evaluated in the HepAD38 cellular assay.  Structure-activity relationships of this series are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcZcKEPcrqkbVg90H21EOLACvtfcHk0ljftMywNLcyeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D&md5=4c3ee48f05dc8bee0724ba928d89f8a1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900544-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900544-8%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DConway%26aufirst%3DS.%2BC.%26aulast%3DLadner%26aufirst%3DS.%2BK.%26aulast%3DZaifert%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPhenylpropenamide%2520derivatives%2520as%2520inhibitors%2520of%2520hepatitis%2520B%2520virus%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2687%26doi%3D10.1016%2FS0960-894X%2800%2900544-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Campagna, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">6931</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.-T.+Guo&title=Sulfamoylbenzamide+derivatives+inhibit+the+assembly+of+hepatitis+B+virus+nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-α) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-α nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0lhaMY3XUH-Bmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DSulfamoylbenzamide%2520derivatives%2520inhibit%2520the%2520assembly%2520of%2520hepatitis%2520B%2520virus%2520nucleocapsids%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span>Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL; <span class="NLM_publisher-name">Novira Therapeutics, Inc.</span>: <span class="NLM_publisher-loc">Doylestown, PA</span>, 27 Apr<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://noviratherapeutics.com/pipeline/nvr3-778/" class="extLink">https://noviratherapeutics.com/pipeline/nvr3-778/</a> (accessed March 2, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novira+Therapeutics+Announces+Presentation+of+Preclinical+Antiviral+Data+for+NVR+3-778+at+EASL%3B+Novira+Therapeutics%2C+Inc.%3A+Doylestown%2C+PA%2C+27+Apr+2015%3B+https%3A%2F%2Fnoviratherapeutics.com%2Fpipeline%2Fnvr3-778%2F+%28accessed+March+2%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNovira%2520Therapeutics%2520Announces%2520Presentation%2520of%2520Preclinical%2520Antiviral%2520Data%2520for%2520NVR%25203-778%2520at%2520EASL%26pub%3DNovira%2520Therapeutics%252C%2520Inc%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1021/cb100275b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100275b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1125-1136&author=S.+P.+Katenauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Trapping+of+hepatitis+B+virus+capsid+assembly+intermediates+by+phenylpropenamide+assembly+accelerators&doi=10.1021%2Fcb100275b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators</span></div><div class="casAuthors">Katen, Sarah P.; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1125-1136</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the biol. self-assembly process of virus capsids is key to understanding the viral life cycle, as well as serving as a platform for the design of assembly-based antiviral drugs.  Here we identify and characterize the phenylpropenamide family of small mols., known to have antiviral activity in vivo, as assembly effectors of the hepatitis B virus (HBV) capsid.  We have found two representative phenylpropenamides to be assembly accelerators, increasing the rate of assembly with only modest increases in the stability of the HBV capsids; these data provide a phys.-chem. basis for their antiviral activity.  Unlike previously described HBV assembly effectors, the phenylpropenamides do not misdirect assembly; rather, the accelerated reactions proceed on-path to produce morphol. normal capsids.  However, capsid assembly in the presence of phenylpropenamides is characterized by kinetic trapping of assembly intermediates.  These traps resolve under conditions close to physiol., but we found that trapped intermediates persist under conditions that favor phenylpropenamide binding and strong core protein-protein interactions.  The phenylpropenamides serve as chem. probes of the HBV capsid assembly pathway by trapping on-path assembly intermediates, illustrating the governing influence of reaction kinetics on capsid assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sU96uRbhi7Vg90H21EOLACvtfcHk0lhaMY3XUH-Bmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL&md5=90a8728ca9cc6bb2ff3acf47694e0d50</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcb100275b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100275b%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DTrapping%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520intermediates%2520by%2520phenylpropenamide%2520assembly%2520accelerators%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1125%26epage%3D1136%26doi%3D10.1021%2Fcb100275b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1406</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span><span class="refDoi"> DOI: 10.1016/j.str.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.str.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=23871485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCgs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1406-1416&author=S.+P.+Katenauthor=Z.+Tanauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Assembly-directed+antivirals+differentially+bind+quasiequivalent+pockets+to+modify+hepatitis+B+virus+capsid+tertiary+and+quaternary+structure&doi=10.1016%2Fj.str.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary Structure</span></div><div class="casAuthors">Katen, Sarah P.; Tan, Zhenning; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1406-1416</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a major cause of liver disease.  Assembly of the HBV capsid is a crit. step in virus prodn. and an attractive target for new antiviral therapies.  We detd. the structure of HBV capsid in complex with AT-130, a member of the phenylpropenamide family of assembly effectors.  AT-130 causes tertiary and quaternary structural changes but does not disrupt capsid structure.  AT-130 binds a hydrophobic pocket that also accommodates the previously characterized heteroaryldihydropyrimidine compds. but favors a unique quasiequivalent location on the capsid surface.  Thus, this pocket is a promiscuous drug-binding site and a likely target for different assembly effectors with a broad range of mechanisms of activity.  That AT-130 successfully decreases virus prodn. by increasing capsid assembly rate without disrupting capsid structure delineates a paradigm in antiviral design, that disrupting reaction timing is a viable strategy for assembly effectors of HBV and other viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZur3DCpnS3LVg90H21EOLACvtfcHk0ljUPdY2bV_Oyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCgs7fF&md5=bb515fd504fb69f82755409c4c8f2079</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DAssembly-directed%2520antivirals%2520differentially%2520bind%2520quasiequivalent%2520pockets%2520to%2520modify%2520hepatitis%2520B%2520virus%2520capsid%2520tertiary%2520and%2520quaternary%2520structure%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1406%26epage%3D1416%26doi%3D10.1016%2Fj.str.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataiah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korba, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10270</span><span class="refDoi"> DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-molecule+effectors+of+hepatitis+B+virus+capsid+assembly+give+insight+into+virus+life+cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0ljUPdY2bV_Oyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-molecule%2520effectors%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520give%2520insight%2520into%2520virus%2520life%2520cycle%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Guo, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Z.</span><span> </span><span class="NLM_article-title">HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state</span> <span class="citation_source-journal">Epigenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.4161/epi.6.6.15815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.4161%2Fepi.6.6.15815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=21546797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=720-726&author=Y.-H.+Guoauthor=Y.-N.+Liauthor=J.-R.+Zhaoauthor=J.+Zhangauthor=Z.+Yan&title=HBc+binds+to+the+CpG+islands+of+HBV+cccDNA+and+promotes+an+epigenetic+permissive+state&doi=10.4161%2Fepi.6.6.15815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state</span></div><div class="casAuthors">Guo, Yan-Hai; Li, Yong-Nian; Zhao, Jin-Rong; Zhang, Ju; Yan, Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">720-726</span>CODEN:
                <span class="NLM_cas:coden">EPIGB6</span>;
        ISSN:<span class="NLM_cas:issn">1559-2294</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is the template for the transcription of HBV.  HBV core protein (HBc or HBcAg) is a main component of the HBV cccDNA minichromosome.  However, the function of HBc in cccDNA is not fully understood.  In light of recent findings that HBV cccDNA may be regulated epigenetically, we analyzed the binding of HBc to cccDNA and the impact of HBc on cccDNA epigenetic profile in the liver biopsy samples of 22 patients with chronic Hepatitis B (CHB).  We found that HBc binding to HBV cccDNA occurred preferentially at CpG island 2, an important region for the regulation of HBV transcription.  Furthermore, the relative abundances of HBc binding to CpG island 2 were pos. correlated with the ratios of relaxed circular DNA to cccDNA and the levels of serum HBV DNA in those patients.  Interestingly, the relative abundances of HBc binding to CpG island 2 were assocd. with the binding of CREB binding protein (CBP) and with hypomethylation in CpG island 2 of HBV cccDNA minichromosomes.  However, relatively higher amts. of HBc binding to CpG island 2 of cccDNA were accompanied by lower amts. of HDAC1 binding.  Multivariate anal. revealed that the abundances of HBc binding to CpG island 2 of cccDNA and pos. HBeAg were independent factors assocd. with the replication of HBV (p = 0.001 for both).  Apparently, HBc is a pos. regulator of HBV transcription and replication, maintaining the permissive epigenetic state in the crit. region of the HBV cccDNA minichromosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9wmAiX25lrVg90H21EOLACvtfcHk0ljUPdY2bV_Oyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gs7w%253D&md5=3057fac0de5c9a054f5ace2967f52a93</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fepi.6.6.15815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.6.6.15815%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.-H.%26aulast%3DLi%26aufirst%3DY.-N.%26aulast%3DZhao%26aufirst%3DJ.-R.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DHBc%2520binds%2520to%2520the%2520CpG%2520islands%2520of%2520HBV%2520cccDNA%2520and%2520promotes%2520an%2520epigenetic%2520permissive%2520state%26jtitle%3DEpigenetics%26date%3D2011%26volume%3D6%26spage%3D720%26epage%3D726%26doi%3D10.4161%2Fepi.6.6.15815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Twu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schloemer, R. H.</span><span> </span><span class="NLM_article-title">Hepatitis B virus suppresses expression of human β-interferon</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1073/pnas.85.1.252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.85.1.252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=252-256&author=J.+S.+Twuauthor=C.+H.+Leeauthor=P.+M.+Linauthor=R.+H.+Schloemer&title=Hepatitis+B+virus+suppresses+expression+of+human+%CE%B2-interferon&doi=10.1073%2Fpnas.85.1.252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.1.252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.1.252%26sid%3Dliteratum%253Aachs%26aulast%3DTwu%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DP.%2BM.%26aulast%3DSchloemer%26aufirst%3DR.%2BH.%26atitle%3DHepatitis%2520B%2520virus%2520suppresses%2520expression%2520of%2520human%2520%25CE%25B2-interferon%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D252%26epage%3D256%26doi%3D10.1073%2Fpnas.85.1.252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroga, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreno, V.</span><span> </span><span class="NLM_article-title">Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1099/vir.0.18966-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1099%2Fvir.0.18966-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12867637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvF2gsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=2073-2082&author=M.+Fernandezauthor=J.+A.+Quirogaauthor=V.+Carreno&title=Hepatitis+B+virus+downregulates+the+human+interferon-inducible+MxA+promoter+through+direct+interaction+of+precore%2Fcore+proteins&doi=10.1099%2Fvir.0.18966-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins</span></div><div class="casAuthors">Fernandez, Mario; Quiroga, Juan Antonio; Carreno, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2073-2082</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The human MxA protein is an interferon (IFN)-inducible GTPase with proven antiviral activity against diverse viruses.  IFN responsiveness is impaired in chronic hepatitis B virus (HBV) infection.  Accordingly, initial expts. showed that, in contrast to parental HepG2 cells, when HepG2-derived 2.2.15 liver cells carrying the HBV genome were treated with IFN, they could not synthesize the MxA protein.  Furthermore, MxA expression was reduced in HepG2 cells transiently transfected with the HBV genome.  To assess whether HBV-encoded precore/core (preC/C) proteins interact with the IFN-signalling pathway, HepG2, Chang and HeLa cells were transfected with preC/C expression plasmids; the levels of signal transducers remained unaffected.  Next, full-length and deletion mutants fused to the CAT reporter gene were tested to investigate whether MxA inhibition occurs at the promoter level.  In co-transfection expts., IFN-induced CAT activity was inhibited by preC/C expression in a dose-dependent manner.  Anal. of deletion mutants showed that the region affected by the preC/C proteins comprises IFN-stimulated response elements 2 and 3, upstream of the putative start codon of the MxA promoter.  In addn., HBV preC/C proteins interacted directly with the MxA promoter, as shown by electrophoretic mobility shift assays.  These results demonstrate a mechanism that HBV probably uses to downregulate an element of the IFN-induced host antiviral responses, which accounts for the impairment obsd. in HBV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ9Y0OvPeE17Vg90H21EOLACvtfcHk0lgPwzduMXCU9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvF2gsLY%253D&md5=051f79dbdb0dca9516aad5ed49091f82</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.18966-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.18966-0%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DQuiroga%26aufirst%3DJ.%2BA.%26aulast%3DCarreno%26aufirst%3DV.%26atitle%3DHepatitis%2520B%2520virus%2520downregulates%2520the%2520human%2520interferon-inducible%2520MxA%2520promoter%2520through%2520direct%2520interaction%2520of%2520precore%252Fcore%2520proteins%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2003%26volume%3D84%26spage%3D2073%26epage%3D2082%26doi%3D10.1099%2Fvir.0.18966-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagelschuer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewoehner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruebsamen-Waigmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfeil, S.</span><span> </span><span class="NLM_article-title">Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1016/S0166-3542(01)00216-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2FS0166-3542%2801%2900216-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12062392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=69-78&author=O.+Weberauthor=K.+H.+Schlemmerauthor=E.+Hartmannauthor=I.+Hagelschuerauthor=A.+Paessensauthor=E.+Graefauthor=K.+Deresauthor=S.+Goldmannauthor=U.+Niewoehnerauthor=J.+Stoltefussauthor=D.+Haebichauthor=H.+Ruebsamen-Waigmannauthor=S.+Wohlfeil&title=Inhibition+of+human+hepatitis+B+virus+%28HBV%29+by+a+novel+non-nucleosidic+compound+in+a+transgenic+mouse+model&doi=10.1016%2FS0166-3542%2801%2900216-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model</span></div><div class="casAuthors">Weber, O.; Schlemmer, K.-H.; Hartmann, E.; Hagelschuer, Ina; Paessens, A.; Graef, E.; Deres, K.; Goldmann, S.; Niewoehner, U.; Stoltefuss, J.; Haebich, D.; Ruebsamen-Waigmann, H.; Wohlfeil, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BAY 41-4109 is a member of a class of heteroaryl-pyrimidines that was recently identified as potent inhibitors of human hepatitis B virus (HBV) replication.  We have investigated the antiviral activity of BAY 41-4109 (Me (R)-4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-pyrimidine-5-carboxylate) in HBV-transgenic mice (Tg [HBV1.3 fsX-3'5']).  Bay 41-4109 was administered per os using different schedules (b.i.d. or t.i.d. for up to 28 days) and dosages ranging from 3 to 30 mg/kg.  The compd. reduced viral DNA in the liver and in the plasma dose-dependently with efficacy comparable to 3TC.  In contrast to 3TC-treated mice, we found a redn. of cytoplasmic hepatitis B virus core antigen (HBcAg) in liver sections of BAY 41-4109-treated mice, which indicated a different mode of action.  Pharmacokinetic studies in mice have shown rapid absorption, a bioavailability of 30% and dose-proportional plasma concns.  We conclude that BAY 41-4109 is a new anti-HBV drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAj4XpaXvzGrVg90H21EOLACvtfcHk0lgPwzduMXCU9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVShsLg%253D&md5=bae520cd731096858f86f4ce28674231</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0166-3542%2801%2900216-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-3542%252801%252900216-9%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DHagelschuer%26aufirst%3DI.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DNiewoehner%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRuebsamen-Waigmann%26aufirst%3DH.%26aulast%3DWohlfeil%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520human%2520hepatitis%2520B%2520virus%2520%2528HBV%2529%2520by%2520a%2520novel%2520non-nucleosidic%2520compound%2520in%2520a%2520transgenic%2520mouse%2520model%26jtitle%3DAntiviral%2520Res.%26date%3D2002%26volume%3D54%26spage%3D69%26epage%3D78%26doi%3D10.1016%2FS0166-3542%2801%2900216-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Brezillon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massinet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berissi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belghiti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puerstinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsdorf, D.</span><span> </span><span class="NLM_article-title">Antiviral activity of Bay 41–4109 on hepatitis B virus in humanized Alb-uPA/SCID mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25096</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1371%2Fjournal.pone.0025096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25096&author=N.+Brezillonauthor=M.+N.+Brunelleauthor=H.+Massinetauthor=E.+Giangauthor=C.+Lamantauthor=L.+DaSilvaauthor=S.+Berissiauthor=J.+Belghitiauthor=L.+Hannounauthor=G.+Puerstingerauthor=E.+Wimmerauthor=J.+Neytsauthor=O.+Hantzauthor=P.+Soussanauthor=S.+Morosanauthor=D.+Kremsdorf&title=Antiviral+activity+of+Bay+41%E2%80%934109+on+hepatitis+B+virus+in+humanized+Alb-uPA%2FSCID+mice&doi=10.1371%2Fjournal.pone.0025096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025096%26sid%3Dliteratum%253Aachs%26aulast%3DBrezillon%26aufirst%3DN.%26aulast%3DBrunelle%26aufirst%3DM.%2BN.%26aulast%3DMassinet%26aufirst%3DH.%26aulast%3DGiang%26aufirst%3DE.%26aulast%3DLamant%26aufirst%3DC.%26aulast%3DDaSilva%26aufirst%3DL.%26aulast%3DBerissi%26aufirst%3DS.%26aulast%3DBelghiti%26aufirst%3DJ.%26aulast%3DHannoun%26aufirst%3DL.%26aulast%3DPuerstinger%26aufirst%3DG.%26aulast%3DWimmer%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHantz%26aufirst%3DO.%26aulast%3DSoussan%26aufirst%3DP.%26aulast%3DMorosan%26aufirst%3DS.%26aulast%3DKremsdorf%26aufirst%3DD.%26atitle%3DAntiviral%2520activity%2520of%2520Bay%252041%25E2%2580%25934109%2520on%2520hepatitis%2520B%2520virus%2520in%2520humanized%2520Alb-uPA%252FSCID%2520mice%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25096%26doi%3D10.1371%2Fjournal.pone.0025096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, M. Y.</span><span> </span><span class="NLM_article-title">NMR spectroscopy-based metabonomic approach to the analysis of Bay41–4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.toxlet.2007.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.toxlet.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=17826925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2007&pages=161-167&author=C.+Shiauthor=C.+Q.+Wuauthor=A.+M.+Caoauthor=H.+Z.+Shengauthor=X.+Z.+Yanauthor=M.+Y.+Liao&title=NMR+spectroscopy-based+metabonomic+approach+to+the+analysis+of+Bay41%E2%80%934109%2C+a+novel+anti-HBV+compound%2C+induced+hepatotoxicity+in+rats&doi=10.1016%2Fj.toxlet.2007.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span></div><div class="casAuthors">Shi, Chang; Wu, Chun-qi; Cao, An-min; Sheng, He-Zhang; Yan, Xian-zhong; Liao, Ming-yang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An integrated metabonomics study using high-resoln. 1H NMR spectroscopy has been applied to investigate the biochem. compn. of urine, serum, liver tissue aq. exts. (acetonitrile/water) and liver tissue lipidic exts. (chloroform/methanol) obtained from control and Bay41-4109 treated rats (10, 50, 400 mg kg-1 d-1 for 5 days, i.g.).  Principal components anal. was used to visualize similarities and differences in biochem. profiles.  The results showed the effects induced by Bay41-4109 at 400 mg kg-1 d-1 are different from those induced at 10, 50 mg kg-1 d-1.  The biochem. profiles of 400 mg kg-1 d-1 group might reflect the hepatotoxicity of Bay41-4109 more exactly.  The elevation in the level of 3-HB, lactate, 2-hydroxy-acetol and D-glucose was found in the urine, and the levels of VLDL/LDL(CH2)n, VLDL/LDL-CH3, 2-oxo-3-methyl-n-valerate, 3-HB, lactate, acetate, taurine, 2-hydroxy-isovalerate in serum were increased significantly in 400 mg kg-1 d-1 group.  The predominant changes identified in liver tissue aq. exts. included an increase in the signal intensities of lactate, 3-amino-isovalerate, pyruvate, choline, trimethylamine-N-oxide (TMAO) and a redn. in the intensities of taurine, hippurate and D-glucose.  In liver tissue chloroform/methanol exts., there was a remarkably increase in many of the lipid signals including the triglyceride terminal Me, methylene groups, and CH2CO, N+(CH3)3, CH2OPO2, CH2OCOR.  These observations all provide evidence that fatty acid metab. disorder and mitochondrial inability might contribute to the hepatotoxicity of Bay41-4109.  The application of 1H NMR spectroscopy to an array of biol. samples comprising urine, serum and liver tissue exts. yields new insight into the hepatotoxicity of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdIWT-FpgZLVg90H21EOLACvtfcHk0lhAIonoq-kjew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP&md5=89bd5589fb93920c51723e5b75c99673</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%2BQ.%26aulast%3DCao%26aufirst%3DA.%2BM.%26aulast%3DSheng%26aufirst%3DH.%2BZ.%26aulast%3DYan%26aufirst%3DX.%2BZ.%26aulast%3DLiao%26aufirst%3DM.%2BY.%26atitle%3DNMR%2520spectroscopy-based%2520metabonomic%2520approach%2520to%2520the%2520analysis%2520of%2520Bay41%25E2%2580%25934109%252C%2520a%2520novel%2520anti-HBV%2520compound%252C%2520induced%2520hepatotoxicity%2520in%2520rats%26jtitle%3DToxicol.%2520Lett.%26date%3D2007%26volume%3D173%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.toxlet.2007.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Goldmann, S.; Stoltefub, J.; Niewöhner, U.; Schlemmer, K.-H.; Keldenich, J.; Paebens, A.; Graef, E.; Weber, O.; Deres, K.</span><span> </span><span class="NLM_article-title">Medicaments against viral disease</span>. PCT Int. Appl. WO 01/68640 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+Goldmann&author=J.+Stoltefub&author=U.+Niew%C3%B6hner&author=K.-H.+Schlemmer&author=J.+Keldenich&author=A.+Paebens&author=E.+Graef&author=O.+Weber&author=K.+Deres&title=Medicaments+against+viral+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoldmann%26aufirst%3DS.%26atitle%3DMedicaments%2520against%2520viral%2520disease%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. S.</span><span> </span><span class="NLM_article-title">In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.3851/IMP2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.3851%2FIMP2152" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=793-803&author=X.+Y.+Wangauthor=Z.+M.+Weiauthor=G.+Y.+Wuauthor=J.+H.+Wangauthor=Y.+J.+Zhangauthor=J.+Liauthor=H.+H.+Zhangauthor=X.+W.+Xieauthor=X.+Wangauthor=Z.+H.+Wangauthor=L.+Weiauthor=Y.+Wangauthor=H.+S.+Chen&title=In+vitro+inhibition+of+HBV+replication+by+a+novel+compound%2C+GLS4%2C+and+its+efficacy+against+adefovir-dipivoxil-resistant+HBV+mutations&doi=10.3851%2FIMP2152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3851%2FIMP2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2152%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DZ.%2BM.%26aulast%3DWu%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BH.%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BS.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520HBV%2520replication%2520by%2520a%2520novel%2520compound%252C%2520GLS4%252C%2520and%2520its%2520efficacy%2520against%2520adefovir-dipivoxil-resistant%2520HBV%2520mutations%26jtitle%3DAntiviral%2520Ther.%26date%3D2012%26volume%3D17%26spage%3D793%26epage%3D803%26doi%3D10.3851%2FIMP2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ren, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1016%2Fj.bmc.2016.12.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1042-1056&author=Q.+Renauthor=X.+Liuauthor=Z.+Luoauthor=J.+Liauthor=C.+Wangauthor=S.+Goldmannauthor=J.+Zhangauthor=Y.+Zhang&title=Discovery+of+hepatitis+B+virus+capsid+assembly+inhibitors+leading+to+a+heteroaryldihydropyrimidine+based+clinical+candidate+%28GLS4%29&doi=10.1016%2Fj.bmc.2016.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520inhibitors%2520leading%2520to%2520a%2520heteroaryldihydropyrimidine%2520based%2520clinical%2520candidate%2520%2528GLS4%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1042%26epage%3D1056%26doi%3D10.1016%2Fj.bmc.2016.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15196</span><span class="NLM_x">–</span> <span class="NLM_lpage">15201</span><span class="refDoi"> DOI: 10.1073/pnas.1513803112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.1513803112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=26598693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15196-15201&author=K.+Klumppauthor=A.+M.+Lamauthor=C.+Lukacsauthor=R.+Vogelauthor=S.+Renauthor=C.+Espirituauthor=R.+Baydoauthor=K.+Atkinsauthor=J.+Abendrothauthor=G.+Liaoauthor=A.+Efimovauthor=G.+Hartmanauthor=O.+A.+Flores&title=High-resolution+crystal+structure+of+a+hepatitis+B+virus+replication+inhibitor+bound+to+the+viral+core+protein&doi=10.1073%2Fpnas.1513803112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span></div><div class="casAuthors">Klumpp, Klaus; Lam, Angela M.; Lukacs, Christine; Vogel, Robert; Ren, Suping; Espiritu, Christine; Baydo, Ruth; Atkins, Kateri; Abendroth, Jan; Liao, Guochun; Efimov, Andrey; Hartman, George; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15196-15201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The hepatitis B virus (HBV) core protein is essential for HBV replication and an important target for antiviral drug discovery.  We report the first, to our knowledge, high-resoln. crystal structure of an antiviral compd. bound to the HBV core protein.  The compd. NVR-010-001-E2 can induce assembly of the HBV core wild-type and Y132A mutant proteins and thermostabilize the proteins with a Tm increase of more than 10 °C.  NVR-010-001-E2 binds at the dimer-dimer interface of the core proteins, forms a new interaction surface promoting protein-protein interaction, induces protein assembly, and increases stability.  The impact of naturally occurring core protein mutations on antiviral activity correlates with NVR-010-001-E2 binding interactions detd. by crystallog.  The crystal structure provides understanding of a drug efficacy mechanism related to the induction and stabilization of protein-protein interactions and enables structure-guided design to improve antiviral potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYxV-odPonGbVg90H21EOLACvtfcHk0li5V2TFxQWngg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK&md5=bf487dda7165d1637fad0ebab8f46142</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1513803112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1513803112%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBaydo%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DEfimov%26aufirst%3DA.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520a%2520hepatitis%2520B%2520virus%2520replication%2520inhibitor%2520bound%2520to%2520the%2520viral%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15196%26epage%3D15201%26doi%3D10.1073%2Fpnas.1513803112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">For the impacts of lipophilicity and basicity on hERG, please see an excellent review:</p></div><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0li5V2TFxQWngg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bourne, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11055</span><span class="NLM_x">–</span> <span class="NLM_lpage">11061</span><span class="refDoi"> DOI: 10.1128/JVI.00933-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.00933-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=16943288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11055-11061&author=C.+R.+Bourneauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Global+structural+changes+in+hepatitis+B+virus+capsids+induced+by+the+assembly+effector+HAP1&doi=10.1128%2FJVI.00933-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span></div><div class="casAuthors">Bourne, Christina R.; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11055-11061</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a leading cause of liver disease and hepatocellular carcinoma; over 400 million people are chronically infected with HBV.  Specific anti-HBV treatments, like most antivirals, target enzymes that are similar to host proteins.  Virus capsid protein has no human homolog, making its assembly a promising but undeveloped therapeutic target.  HAP1 [methyl 4-(2-chloro-4-fluorophenyl)-6-methyl-2-(pyridin-2-yl)-1,4-dihydropyrimidine-5-carboxylate], a heteroaryldihydropyrimidine, is a potent HBV capsid assembly activator and misdirector.  Knowledge of the structural basis for this activity would directly benefit the development of capsid-targeting therapeutic strategies.  This report details the crystal structures of icosahedral HBV capsids with and without HAP1.  We show that HAP1 leads to global structural changes by movements of subunits as connected rigid bodies.  The obsd. movements cause the fivefold vertices to protrude from the liganded capsid, the threefold vertices to open, and the quasi-sixfold vertices to flatten, explaining the effects of HAP1 on assembled capsids and on the assembly process.  We have identified a likely HAP1-binding site that bridges elements of secondary structure within a capsid-bound monomer, offering explanation for assembly activation.  This site also interferes with interactions between capsid proteins, leading to quaternary changes and presumably assembly misdirection.  These results demonstrate the plasticity of HBV capsids and the mol. basis for a tenable antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdf0rkzY6lbVg90H21EOLACvtfcHk0li5V2TFxQWngg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ&md5=9d176d66a1d3c2e323203877c225be6e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FJVI.00933-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00933-06%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DGlobal%2520structural%2520changes%2520in%2520hepatitis%2520B%2520virus%2520capsids%2520induced%2520by%2520the%2520assembly%2520effector%2520HAP1%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11055%26epage%3D11061%26doi%3D10.1128%2FJVI.00933-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Qiu, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G. Z.</span><span> </span><span class="NLM_article-title">Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B Virus (HBV) capsid inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7651</span><span class="NLM_x">–</span> <span class="NLM_lpage">7666</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7651-7666&author=Z.+X.+Qiuauthor=X.+F.+Linauthor=M.+W.+Zhouauthor=Y.+F.+Liuauthor=W.+Zhuauthor=W.+M.+Chenauthor=W.+X.+Zhangauthor=L.+Guoauthor=H.+X.+Liuauthor=G.+L.+Wuauthor=M.+W.+Huangauthor=M.+Jiangauthor=Z.+H.+Xuauthor=Z.+Zhouauthor=N.+Qinauthor=S.+Renauthor=H.+X.+Qiuauthor=S.+Zhongauthor=Y.+X.+Zhangauthor=Y.+Zhangauthor=X.+Y.+Wuauthor=L.+P.+Shiauthor=F.+Shenauthor=Y.+Maoauthor=X.+Zhouauthor=W.+G.+Yangauthor=J.+Z.+Wuauthor=G.+Yangauthor=A.+V.+Maywegauthor=H.+C.+Shenauthor=G.+Z.+Tang&title=Design+and+synthesis+of+orally+bioavailable+4-methyl+heteroaryldihydropyrimidine+based+hepatitis+B+Virus+%28HBV%29+capsid+inhibitors&doi=10.1021%2Facs.jmedchem.6b00879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00879%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%2BX.%26aulast%3DLin%26aufirst%3DX.%2BF.%26aulast%3DZhou%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DY.%2BF.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DH.%2BX.%26aulast%3DWu%26aufirst%3DG.%2BL.%26aulast%3DHuang%26aufirst%3DM.%2BW.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%2BH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DN.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DH.%2BX.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%2BY.%26aulast%3DShi%26aufirst%3DL.%2BP.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DWu%26aufirst%3DJ.%2BZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DTang%26aufirst%3DG.%2BZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520orally%2520bioavailable%25204-methyl%2520heteroaryldihydropyrimidine%2520based%2520hepatitis%2520B%2520Virus%2520%2528HBV%2529%2520capsid%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7651%26epage%3D7666%26doi%3D10.1021%2Facs.jmedchem.6b00879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Alcalde, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, N.</span><span> </span><span class="NLM_article-title">Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">42374</span><span class="refDoi"> DOI: 10.1038/srep42374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1038%2Fsrep42374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=28205569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=42374&author=Z.+Zhouauthor=T.+Huauthor=X.+Zhouauthor=S.+Wildumauthor=F.+Garcia-Alcaldeauthor=Z.+Xuauthor=D.+Wuauthor=Y.+Maoauthor=X.+Tianauthor=Y.+Zhouauthor=F.+Shenauthor=Z.+Zhangauthor=G.+Tangauthor=I.+Najeraauthor=G.+Yangauthor=H.+C.+Shenauthor=J.+A.+T.+Youngauthor=N.+Qin&title=Heteroaryldihydropyrimidine+%28HAP%29+and+sulfamoylbenzamide+%28SBA%29+inhibit+hepatitis+B+virus+replication+by+different+molecular+mechanisms&doi=10.1038%2Fsrep42374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms</span></div><div class="casAuthors">Zhou, Zheng; Hu, Taishan; Zhou, Xue; Wildum, Steffen; Garcia-Alcalde, Fernando; Xu, Zhiheng; Wu, Daitze; Mao, Yi; Tian, Xiaojun; Zhou, Yuan; Shen, Fang; Zhang, Zhisen; Tang, Guozhi; Najera, Isabel; Yang, Guang; Shen, Hong C.; Young, John A. T.; Qin, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42374</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) are promising non-nucleos(t)ide HBV replication inhibitors.  HAPs are known to promote core protein mis-assembly, but the mol. mechanism of abnormal assembly is still elusive.  Likewise, the assembly status of core protein induced by SBA remains unknown.  Here we show that SBA, unlike HAP, does not promote core protein mis-assembly.  Interestingly, two ref. compds. HAP_R01 and SBA_R01 bind to the same pocket at the dimer-dimer interface in the crystal structures of core protein Y132A hexamer.  The striking difference lies in a unique hydrophobic subpocket that is occupied by the thiazole group of HAP_R01, but is unperturbed by SBA_R01.  Photoaffinity labeling confirms the HAP_R01 binding pose at the dimer-dimer interface on capsid and suggests a new mechanism of HAP-induced mis-assembly.  Based on the common features in crystal structures we predict that T33 mutations generate similar susceptibility changes to both compds.  In contrast, mutations at positions in close contact with HAP-specific groups (P25A, P25S, or V124F) only reduce susceptibility to HAP_R01, but not to SBA_R01.  Thus, HAP and SBA are likely to have distinctive resistance profiles.  Notably, P25S and V124F substitutions exist in low-abundance quasispecies in treatment-naive patients, suggesting potential clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw-qU6eO7rCrVg90H21EOLACvtfcHk0lgJU2lqJDNqSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOiurs%253D&md5=1e401e3133194ae374435df0d0cfa637</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fsrep42374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep42374%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWildum%26aufirst%3DS.%26aulast%3DGarcia-Alcalde%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%2BT.%26aulast%3DQin%26aufirst%3DN.%26atitle%3DHeteroaryldihydropyrimidine%2520%2528HAP%2529%2520and%2520sulfamoylbenzamide%2520%2528SBA%2529%2520inhibit%2520hepatitis%2520B%2520virus%2520replication%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D42374%26doi%3D10.1038%2Fsrep42374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bondi, A.</span><span> </span><span class="NLM_article-title">Van der Waals volumes and radii</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1021/j100785a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100785a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADyaF2cXls1Cgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1964&pages=441-451&author=A.+Bondi&title=Van+der+Waals+volumes+and+radii&doi=10.1021%2Fj100785a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">van der Waals volumes and radii</span></div><div class="casAuthors">Bondi, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-51</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">Intermol. van der Waals radii of the nonmetallic elements were assembled into a list of recommended values for vol. calcns.  These values were arrived at by selecting from the most reliable x-ray diffraction data those which could be reconciled with crystal d. at 0°K. (to give reasonable packing d.), gas kinetic collision cross section, crit. d., and with liquid state properties.  A qual. understanding of the nature of van der Waals radii is provided by correlation with the de Broglie wavelength of the outermost valence electron.  Tentative values for the van der Waals radii of metallic elements in organometallic compds. are proposed.  A list of increments for the vol. of mols. impenetrable to thermal collision, the so-called van der Waals vol., and of the corresponding increments in area per mol. is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHeueZoao997Vg90H21EOLACvtfcHk0lgJU2lqJDNqSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXls1Cgsg%253D%253D&md5=0f25964afae4e9f761e0d314151444a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fj100785a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100785a001%26sid%3Dliteratum%253Aachs%26aulast%3DBondi%26aufirst%3DA.%26atitle%3DVan%2520der%2520Waals%2520volumes%2520and%2520radii%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1964%26volume%3D68%26spage%3D441%26epage%3D451%26doi%3D10.1021%2Fj100785a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althage, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chisari, F. V.</span><span> </span><span class="NLM_article-title">Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">13825</span><span class="NLM_x">–</span> <span class="NLM_lpage">13830</span><span class="refDoi"> DOI: 10.1073/pnas.202398599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.202398599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=12374864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13825-13830&author=P.+L.+Yangauthor=A.+Althageauthor=J.+Chungauthor=F.+V.+Chisari&title=Hydrodynamic+injection+of+viral+DNA%3A+A+mouse+model+of+acute+hepatitis+B+virus+infection&doi=10.1073%2Fpnas.202398599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection</span></div><div class="casAuthors">Yang, Priscilla L.; Althage, Alana; Chung, Josan; Chisari, Francis V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13825-13830</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a prototype for liver-specific pathogens in which the failure of the immune system to mount an effective response leads to chronic infection.  The authors' understanding of the immune response to HBV is incomplete, largely due to the narrow host restriction of this pathogen and the limitations of existing exptl. models.  The authors have developed a murine model for studying human HBV replication, immunogenicity, and control.  After transfection of hepatocytes in vivo with a replication-competent, over-length, linear HBV genome, viral antigens and replicative intermediates were synthesized and virus was secreted into the blood.  Viral antigens disappeared from the blood as early as 7 days after transfection, coincident with the appearance of antiviral antibodies.  HBV transcripts and replicative intermediates disappeared from the liver by day 15, after the appearance of antiviral CD8 + T cells.  In contrast, the virus persisted for at least 81 days after transfection of NOD/Scid mice, which lack functional T cells, B cells, and natural killer (NK) cells.  Thus, the outcome of hydrodynamic transfection of HBV depends on the host immune response, as it is during a natural infection.  The methods the authors describe will allow the examn. of viral dynamics in a tightly controlled in vivo system, the application of mutagenesis methods to the study of the HBV life cycle in vivo, and the dissection of the immune response to HBV using genetically modified mice whose immunoregulatory and immune effector functions have been deleted or overexpressed.  In addn., this methodol. represents a prototype for the study of other known and to-be-discovered liver-specific pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo98nNA_w5YxrVg90H21EOLACvtfcHk0lglo7QB0QMj6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKmtbw%253D&md5=0c0f40c386fe47f6c57c413fccdaf3e5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.202398599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.202398599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DAlthage%26aufirst%3DA.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DChisari%26aufirst%3DF.%2BV.%26atitle%3DHydrodynamic%2520injection%2520of%2520viral%2520DNA%253A%2520A%2520mouse%2520model%2520of%2520acute%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13825%26epage%3D13830%26doi%3D10.1073%2Fpnas.202398599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CYP induction-mediated drug interactions: in vitro assessment and clinical implications</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1007/s11095-006-0277-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1007%2Fs11095-006-0277-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=16718615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1089-1116&author=J.+H.+Lin&title=CYP+induction-mediated+drug+interactions%3A+in+vitro+assessment+and+clinical+implications&doi=10.1007%2Fs11095-006-0277-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1089-1116</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP) induction-mediated interaction is one of the major concerns in clin. practice and for the pharmaceutical industry.  There are two major issues assocd. with CYP induction: a redn. in therapeutic efficacy of comedications and an induction in reactive metabolite-induced toxicity.  Because CYP induction is a metabolic liability in drug therapy, it is highly desirable to develop new drug candidates that are not potent CYP inducer to avoid the potential of CYP induction-mediated drug interactions.  For this reason, today, many drug companies routinely include the assessment of CYP induction at the stage of drug discovery as part of the selection processes of new drug candidates for further clin. development.  The purpose of this article is to review the mol. mechanisms of CYP induction and the clin. implications, including pharmacokinetic and pharmacodynamic consequences.  In addn., factors that affect the degree of CYP induction and extrapolation of in vitro CYP induction data to in vivo situations will also be discussed.  Finally, assessment of the potential of CYP induction at the drug discovery and development stage will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEuHjd1GbZLLVg90H21EOLACvtfcHk0lglo7QB0QMj6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFCnsbc%253D&md5=a600296f442d8592adba814659960e6d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-0277-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-0277-7%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCYP%2520induction-mediated%2520drug%2520interactions%253A%2520in%2520vitro%2520assessment%2520and%2520clinical%2520implications%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1089%26epage%3D1116%26doi%3D10.1007%2Fs11095-006-0277-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sells, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acs, G.</span><span> </span><span class="NLM_article-title">Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1073/pnas.84.4.1005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1073%2Fpnas.84.4.1005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=3029758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADyaL2sXhvV2qt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=1005-1009&author=M.+A.+Sellsauthor=M.+L.+Chenauthor=G.+Acs&title=Production+of+hepatitis+B+virus+particles+in+Hep+G2+cells+transfected+with+cloned+hepatitis+B+virus+DNA&doi=10.1073%2Fpnas.84.4.1005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA</span></div><div class="casAuthors">Sells, Mary Ann; Chen, Mei Ling; Acs, George</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1005-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The hepatoblastoma cell line Hep G2 was transfected with a plasmid carrying the gene that confers resistance to G418 and four 5'-3' tandem copies of the hepatitis B virus (HBV) genome positioned such that two dimers of the genomic DNA are 3'-3' with respect to one another.  Cells of one clone that grew in the presence of G418 produce high levels of hepatitis B e antigen and of hepatitis B surface antigen.  HBV DNA is carried by these cells as chromosomally integrated sequences and episomally as relaxed circular, covalently closed, and incomplete copies of the HBV genome.  Viral DNA was detected also in conditioned growth medium at the buoyant densities characteristic for infectious Dane and immature core particles.  Finally, HBV-specific components morphol. identical to the 22-nm spherical and filamentous hepatitis B surface antigen particles as well as 42-nm Dane particles were visualized by immunoelectron microscopic anal.  Therefore, the Hep G2 cell line can support the assembly and secretion not only of several of the replicative intermediates of HBV DNA but also of Dane-like particles.  This in vitro system can now be used to study the life cycle of HBV and the reaction of immunocompetent cells with cells carrying HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogbjqX6YU-W7Vg90H21EOLACvtfcHk0lglo7QB0QMj6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhvV2qt7c%253D&md5=27744d6955d4701586243f651c79ab1e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.4.1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.4.1005%26sid%3Dliteratum%253Aachs%26aulast%3DSells%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DM.%2BL.%26aulast%3DAcs%26aufirst%3DG.%26atitle%3DProduction%2520of%2520hepatitis%2520B%2520virus%2520particles%2520in%2520Hep%2520G2%2520cells%2520transfected%2520with%2520cloned%2520hepatitis%2520B%2520virus%2520DNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D1005%26epage%3D1009%26doi%3D10.1073%2Fpnas.84.4.1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.-T.</span><span> </span><span class="NLM_article-title">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">12472</span><span class="NLM_x">–</span> <span class="NLM_lpage">12484</span><span class="refDoi"> DOI: 10.1128/JVI.01123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=10.1128%2FJVI.01123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=17804499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=12472-12484&author=H.+Guoauthor=D.+Jiangauthor=T.+Zhouauthor=A.+Cuconatiauthor=T.+M.+Blockauthor=J.-T.+Guo&title=Characterization+of+the+intracellular+deproteinized+relaxed+circular+DNA+of+hepatitis+B+virus%3A+an+intermediate+of+covalently+closed+circular+DNA+formation&doi=10.1128%2FJVI.01123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span></div><div class="casAuthors">Guo, Haitao; Jiang, Dong; Zhou, Tianlun; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12472-12484</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is formed by conversion of capsid-assocd. relaxed circular DNA (rcDNA) via unknown mechanisms and exists in the nucleus of the infected hepatocyte as a minichromosome that serves as the transcription template for viral RNAs.  To study the mol. pathway of cccDNA formation and its regulation by viral and cellular factors, we have established a cell line that supports the replication of an envelope protein-deficient HBV genome in a tetracycline-inducible manner.  Following induction of HBV replication, the cells accumulate higher levels of cccDNA as well as larger amts. of deproteinized rcDNA (DP-rcDNA) than cells that replicate wild-type HBV genomes.  These results indicate that HBV envelope proteins neg. regulate cccDNA formation, and conversion of DP-rcDNA into cccDNA is a rate-limiting step of cccDNA formation in HepG2 cells.  Detailed analyses reveal the following: (i) DP-rcDNA exists in both cytoplasm and nucleus; (ii) while nuclear DP-rcDNA is sensitive to DNase I digestion, a small fraction of cytoplasmic DP-rcDNA is DNase I resistant; (iii) both DNase I-sensitive and -resistant cytoplasmic DP-rcDNAs cosediment with capsids and can be immunopptd. with HBV core antibody; and (iv) a primer extension assay maps the 5' end of the minus strand of DP-rcDNA at the authentic end of virion rcDNA.  Hence, our results favor a hypothesis that the removal of viral polymerase protein covalently linked to the 5' end of the minus-strand DNA occurs inside the capsid in the cytoplasm and most possibly via a reaction that cleaves the phosphodiester bond between the tyrosine of the polymerase and the 5' phosphoryl group of minus-strand DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_WiB1hJ4zbVg90H21EOLACvtfcHk0lgr8DXDNTnEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ&md5=91d6a9284b406680c85be2e35048d4ae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.01123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01123-07%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DCharacterization%2520of%2520the%2520intracellular%2520deproteinized%2520relaxed%2520circular%2520DNA%2520of%2520hepatitis%2520B%2520virus%253A%2520an%2520intermediate%2520of%2520covalently%2520closed%2520circular%2520DNA%2520formation%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D12472%26epage%3D12484%26doi%3D10.1128%2FJVI.01123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE','PDB','5WRE'); return false;">PDB: 5WRE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00083">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42150"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00083">10.1021/acs.jmedchem.7b00083</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed experimental procedures for the synthesis of analogues <b>14</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>20</b>, <b>26</b>, <b>32</b>, <b>33</b>, and <b>34</b>, amine intermediates <b>15-a</b> and <b>22-a</b>, amidine intermediates <b>39-a</b> and <b>41-a</b>, and aldehyde intermediate <b>66-a</b>. X-ray structure of (<i>R</i>)-<b>10A-2</b>, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectrum of <b>10</b>, and mechanism of action study of <b>10</b> with Cp149 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf">PDF</a> )</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_001.csv">jm7b00083_si_001.csv (5.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00083/suppl_file/jm7b00083_si_002.pdf">jm7b00083_si_002.pdf (502.8 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code of <b>12</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WRE">5WRE</a>: Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00083&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00083%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00083" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996d8f4f913c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
